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Abstract
Successful  pancreatic  islet  transplantation  depends  on  the  number  of i slets 
transplanted, islet viability and extent of early islet loss due to ischaemia reperfusion 
injury. Novel pancreas preservation techniques which can improve these variables can 
increase the utilisation of non-heart-beating-donor pancreases for islet transplantation. 
A  non-heart-beating-donor  rat  pancreas  preservation  model  was  developed. 
Pancreases preserved by either static cold storage, hypothermic machine perfusion or 
portal venous oxygen persufflation underwent islet isolation and purification. The yield, 
viability and in vitro function of isolated islets were compared. Portal venous oxygen 
persufflation improved the islet yield, viability and morphology as compared to static 
cold  storage.  The  percentage  of  pancreases  with  functional  islets  (stimulation  index 
greater than 1.0) was also higher after oxygen persufflation as compared to static cold 
storage.
Severity of reperfusion injury in pancreases preserved by static cold storage or portal 
venous oxygen persufflation was compared after in vitro warm reperfusion. Amylase, 
lipase and glycerol levels in the portal effluent were measured. Lipid peroxidation and 
apoptosis  in  reperfused  pancreas  were  measured  using  thio-barbituric  acid  reactive 
substances assay and caspase 3 assay respectively. Expression of genes relevant to 
ischaemia reperfusion was compared using RNA microarrays. 
Severity of ischaemia reperfusion injury was similar in both groups. Microarray analysis 
revealed  increased  expression  of  genes  related  to  apoptosis  in  the  portal  venous 
oxygen  persufflation  group.  This  group  also  showed  up-regulation of  pro-survival 6
cellular pathways and over-expression of genes related to cellular repair as compared 
to static cold storage.  
This  project  has  for  the  first  time  evaluated  oxygen  persufflation  as  a  method  of 
pancreas preservation and investigated changes in global gene expression after this 
form  of  preservation.  Overall,  the  project  suggests  that  portal  venous  oxygen 
persufflation improves the recovery of non-heart-beating-donor rat pancreas. Further 
investigation  to  examine  its  role  in  the  preservation of  large  animal  pancreases  is 
needed.7
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1.1 Diabetes
1.1.1 Background
Polyuric states have been described over 3500 years ago in Egyptian papyrus 
writings[1]. The involvement of the  pancreas in the pathogenesis of diabetes 
was first suspected by Oskar Minkowski and Josef von Mering in 1889[2]. In 
1921,  Frederick  Banting  and  Charles  Best  working  at  Toronto  University 
discovered insulin in extracts of pancreas and used them for treating the first 
patient with diabetic ketosis[3, 4]. Even today, treatment with insulin remains the 
cornerstone of treatment for Type 1 diabetes.
Diabetes  mellitus  is a  g lobal  problem. There  are  an  estimated  2.35  million 
people with diabetes in England[5]. Around 5 per cent of total National Health 
Service spend (and up to 10 per cent of hospital in-patient spend) is used for the 
care of people with diabetes[6]. Type 1 diabetes constitutes 10% of all diabetes 
patients but consumes a  disproportionate  portion of these resources. Type 1 
diabetes  is c aused  by  a  total  lack  of e ndogenous  insulin  production.  It is 
characterised  by  the  progressive  destruction  of  β  cells  in  the  islets  of 
Langerhans which is visualised as lymphocyte infiltration of the islets (insulitis). 
The  destruction is considered to  be an autoimmune response triggered by a 
combination of genetic and environmental factors[7]. 
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1.1.2 Clinical features
The diagnosis of diabetes is based on the presence of clinical symptoms such 
as polyuria, polydipsia, loss of weight and the documentation of elevated blood 
glucose levels[8]. Patients with type 1 diabetes are at risk of both acute and 
chronic complications. Acute complications are diabetic keto-acidosis and acute 
hypoglycaemic episodes. Both are potentially fatal, and the latter greatly limits 
the everyday life of patients.
Chronic complications can involve any organ in the body. Nephropathy can lead 
to end stage renal failure, retinopathy and cataracts lead to blindness, peripheral 
neuropathy  and  peripheral  vascular  disease  cause  non-healing  ulcers,  foot 
infections and  gangrene. Vascular  involvement  also  causes increased risk  of 
cerebrovascular accidents and coronary artery disease.   
1.1.3 Treatment
Insulin therapy is the main treatment modality available for type 1 diabetes. It 
effectively controls hyperglycaemia and can delay the development of chronic 
complications. Glycaemic control is however difficult to achieve in some patients 
with high insulin sensitivity [9]. Intensive insulin therapy using an insulin pump 
improves  glycaemic c ontrol  but  increases  the  risk  of  life-threatening 
hypoglycaemia[10]. Transplantation of the whole pancreas leads to normalised 
blood  glucose  levels,  delays  the  progression  of   c hronic  organ  damage  and 
improves  the  quality o f  life[11].  It  is h owever  a  major  undertaking  and  the 20
procedure  is  still  associated  with  significant  operative  morbidity[12].  Islet 
transplantation can be an alternative therapeutic modality in selected patients 
with  type  1  diabetes  with  low  insulin  requirements  and  high  incidence  of 
hypoglycaemia related complications[13]. 
1.2 Pancreatic Islet Transplantation 
Pancreatic  islet  transplantation  involves  the  transplantation  of  islets  of 
Langerhans.  A  human  pancreas  contains  over  a  million  islets[14].  Each  islet 
contains  cell  populations  producing  all  hormones  involved  in  glucose 
homeostasis (insulin, glucagon and somatostatin). Early attempts at clinical islet 
transplantation were rarely successful at achieving insulin independence[15, 16]. 
Islet  transplantation  was  finally  recognised  as  an  achievable  goal when  the 
Edmonton group reported their success  in seven type 1 diabetes patients who 
remained insulin independent a year after islet transplantation[17]. This event 
has spurred an enormous amount of clinical and experimental research in this 
field.
1.2.1 Pancreatic islet transplantation- The procedure
Islet transplantation as currently practised is a complicated procedure carried 
out in specialised units. The entire procedure includes several important phases
(Figure 1).21
Pancreas recovery and transport for islet transplantation
Recovery  of  donor  pancreas  for  islet transplantation  is t echnically  similar  to 
recovery for whole organ transplant. Careful handling of the pancreas, minimal 
warm  phase  dissection  and  quick  cooling  of t he  pancreas  after  aortic  cross 
clamping are essential for good quality grafts [18]. Once retrieved, the pancreas 
is  transported  at  4°C  in U niversity  of W isconsin (UW) solution  to  the  islet 
isolation  centre.  This  is s tatic  cold s torage  and  is t he  simplest  form  of 
preservation. The use of oxygenated perfluorocarbon solution  along with UW
solution (Two-layer-method) has been shown in experimental studies to improve 
the  islet  yield[19].  However  results  from  clinical  studies  have  been 
inconclusive[20, 21].
Islet isolation
This is a multi-step process and includes pancreas digestion using collagenase, 
de-activation of the enzyme after completion of digestion and separation of the 
islet fraction from exocrine tissue[22]. 
The pancreas is dissected in a cold chamber, the pancreatic duct is identified 
and cannulated. Cold enzyme solution is injected into the duct to distend the 
pancreas. Digestion is started in a closed chamber called the 'Ricordi chamber' 
at 3 7°C.  Mechanical  agitation of t he  chamber  aids  the  digestion  process. 
Intermittent sampling of the digest is carried out to confirm the completion of 
digestion.  Once  digestion  is  complete,  the  enzyme  is  rapidly  inactivated  by 
adding large volumes of cold buffer solution with albumin. The digest is collected 
by  centrifugation  and  immediately  purified  by c ontinuous  density g radient 22
separation. The islet rich fractions are collected, washed and stored in an islet 
storage medium. The yield and viability of the isolated islets is confirmed. Islets 
vary in size (25µm to 500µm) and absolute count of islets does not give a true 
measure of islet yield. Islet yield is instead reported in terms of islet equivalents 
(IEQ)  which  takes  into  account  the  relative  numbers  of i slets  in  each  size 
category. This gives a better estimate of the actual islet mass that is recovered 
from a donor pancreas or transplanted into a patient. 
Recipient procedure
The transplantation procedure takes place in a radiology intervention suite. The 
portal  vein  of  the  recipient  is  cannulated under  local  anaesthesia.  The  islet 
suspension is infused by gravity into the portal vein with intermittent monitoring 
of p ortal  pressures.  Once  transfusion  is c omplete,  the  track  is s ealed  to 
minimise  bleeding  complications.  Insulin  therapy  may  be  required  in  the 
immediate post-operative period until the graft starts functioning. Post-transplant 
immunosuppression  is  based  on  rapamycin,  low  dose  tacrolimus  and 
dacluzimab[17].23
Figure 1 Schematic diagram of the steps involved in pancreatic islet transplantation. 
Picture downloaded from 
http://commons.wikimedia.org/wiki/File:Islet_transplantation_PLoS_Medicine.jpg [23].
Pancreas from the donor is retrieved usually as  part of a multi-organ recovery 
procedure. The pancreas is transported to an islet isolation facility where it is processed 
to isolate islets of Langerhans. The islets are then transplanted into the recipient by 
injecting into the portal vein. Islets are deposited in the portal vein radicals where they 
develop neo-vascularisation over a period of days. Insulin production from the islets 
occurs in response to glucose levels in the portal venous blood.24
1.2.2. Complications of islet transplantation
Post-procedural  complications  are  usually  related  to  portal  cannulation.  They 
may present as bleeding from the cannulation site, portal vein thrombosis and 
portal hypertension due to multiple transplantation procedures[24, 25]. Delayed 
graft function and primary graft failure may occur due to poor quality of islets, 
insufficient  number of  transplanted  islets  or  the  early  destruction  of i slets by 
inflammatory  and  immune  mechanisms. The  latter  termed  the  instant blood-
mediated inflammatory reaction (IBMIR) can lead to the death of transplanted 
islets within hours of the transplantation procedure[26]. Tissue factor (also called 
thrombokinase or factor  III) and  collagen  on  the  surface  of damaged  islets 
initiate  a  strong  innate  immune  response in  the  recipient's  portal  circulation. 
IBMIR is characterised by platelet and complement activation, fibrin deposition 
around the islets and leukocyte infiltration[27]. It can lead up  to 50%  loss  of 
transplanted islets.
1.2.3 Outcome after islet transplantation
Since the year 2000 over 500 islet transplantations have been performed in the 
United  States,  Europe  and  Asia[28].  The  success  of  islet  transplantation 
depends on a sufficient mass of viable islets being transplanted. Clinical data 
suggests that a dose of 9000-12000 islet equivalents/kg body weight is required 
to  achieve  insulin  independence[28,  29].  This  would  normally  require 
transplantation of islets from 2-3 donor pancreases. Adherence to this guideline 25
routinely achieves insulin independence in over 80% of recipients at one year. 
Follow up data of 44 patients published in 2005 has shown that only 10% of 
patients remain insulin independent after five years[30]. Patients who return to 
insulin  therapy have  improved glycaemic  stability  and  better  awareness  of 
hypoglycaemia. Hence islet transplantation can be a valuable therapeutic option 
for  selected  type  1  diabetic  patients  with  high risk  of s evere  hypoglycaemia 
episodes [28]. 
1.2.4 Expanding islet transplantation
The  availability  of d onor  pancreases  is  the  key  to e xpanding  islet 
transplantation. Two to three donor  pancreases are needed for the successful 
treatment of each patient [31, 32]. This demand for organs can lead to direct 
competition with whole organ pancreas transplant programs in many centres. 
Donor  pancreas  availability  for  islet  transplantation  programs  can  be  greatly 
improved  by  utilising  pancreases  from  marginal  donors  such  as  non-heart-
beating-donors (NHBD) which are not routinely used for whole organ pancreas 
transplantation. 
1.3 Non-heart-beating-donation 
'Non-heart-beating-donation' (NHBD) or  'donation after  cardiac  death' (DCD)
implies that the donor had sustained irreversible cardiac arrest before effective 
cooling  of t he  organs  has  been  achieved[33].  Organs  from t hese  donors 26
experience a period of warm ischaemia i.e. the tissues are starved of oxygen 
and nutrients while being at normal body temperatures. Historically, non-heart-
beating-donors were the only type of donors available for organ donation. The 
development of the criteria for diagnosis of brain death in 1968 contributed to 
the legalisation of the use of brain-dead donors for organ donation[34]. This led 
to an immediate decline in the use of organs from non-heart-beating-donors for 
transplantation. Lengthening waiting lists and the increasing disparity between 
the  demand  and  supply  of  donor  organs  has  renewed  interest  in  non-heart-
beating-donors as a means of expanding the donor pool[35, 36]. Recent years 
have seen a gradual increase in the utilisation of these donors both in the United 
Kingdom[37] and the United States[38]. Non-heart-beating-donation remains the 
major form of cadaveric organ donation in countries like Japan.
1.3.1 Classification of non-heart-beating-donors
Non-heart-beating-donors  are  classified  based  on  the  circumstances  of  the 
terminal  cardiac  arrest  (Table  1).  The  Maastricht  classification  provides  an 
indication  of  the  amount  of  warm  ischaemic  damage  the  organs  have 
suffered[33].  Category  I  donors  are  rarely  used  as  the  duration  of  warm 
ischaemia is unknown though some centres in Spain have reported acceptable 
results from these donors[35]. Category II donors are utilised in a few dedicated 
centres around the world. Category III & IV donors are controlled donors and 
used in most transplant centres. 27
Non-heart-beating-donors now account for nearly 25% of all organ donors in the 
United Kingdom[39]. Kidneys were the most common organs utilised from these 
donors. Results of these kidney transplants depend on the non-heart-beating-
donor category. While category III & IV non-heart-beating-donor kidneys have 
outcomes  similar  to  heart-beating-donor  grafts,  category  II  grafts  have  an 
increased risk of delayed  graft function and early  graft failure. However their 
medium term and long term outcome is similar to heart-beating-donor grafts[40, 
41]. Use of category III non-heart-beating-donor for liver transplantation is being 
increasingly reported with satisfactory results[42]. Their use in whole pancreas 
transplants  is m ore  limited  due  to  concerns  about  increased post-operative 
morbidity. 28
Table 1 Maastricht classification of categories of non-heart-beating-donors[33]
Non-heart-beating-donors are classified based on the place where the terminal cardiac 
event takes place. Category 1 and 2 are termed uncontrolled non-heart-beating-donors 
as cardiac arrest is unexpected and takes place away from immediate medical attention. 
This increases the risk of significant warm ischaemia. Categories 3 and 4 are termed 
controlled non-heart-beating-donors as the terminal cardiac event occurs close to 
medical attention and may even be planned in patients with serious non-recoverable 
brain injury.
Donor 
category
Description  of 
terminal event
Location  in 
hospital  where 
terminal  event 
occurs
Current  status  with 
regards  to  the 
feasibility  of  organ 
recovery
I Dead on arrival Accident  and 
emergency
Not yet accessible
II Unsuccessful 
resuscitation
Accident  and
emergency, 
regular ward
Accessible  in s ome 
dedicated centres only
III Awaiting  cardiac 
arrest
Intensive  care, 
regular ward
Accessible,  high 
percentage of success
IV Cardiac  arrest 
during  or  after 
diagnosis  of b rain 
death
Intensive  care, 
operating theatre
Switch  immediately  to 
non-heart-beating-
donor  organ  recovery 
protocol29
1.3.2 Non-heart-beating-donors for pancreatic islet transplantation
Non-heart-beating-donors  are  being  studied as  possible  source  of organs  for 
islet  transplantation  [43,  44].  Islet  yield  and  function  from n on-heart-beating-
donor pancreases with short warm ischaemia times is as good as heart-beating-
donor  pancreases[45].  Studies  have  however  shown  that   i slet  yield  is 
decreased  in p ancreases  damaged  by w arm  ischaemia  longer  than  30 
minutes[46]. Reducing the duration of warm ischaemia is the most direct way to 
improve islet yield from these organs. Prolonged warm ischaemia is inevitable in 
category  II  non-heart-beating-donor  organs. Improved  preservation  of  these 
pancreases is necessary for them to be routinely utilised for islet transplantation. 
Non-heart-beating-donor  pancreases  are  being  used  for  clinical  islet 
transplantation in Japan. Their reported technique involves the placement of an 
intra-aortic balloon catheter before cardiac arrest. This enables rapid cooling of 
the intra-abdominal organs immediately after cardiac arrest. Warm ischaemia 
duration  of j ust  4  minutes  has  been  reported  with  this  technique  [47].  It  is 
unlikely  that  such  pre-mortem  interventions  to  improve  organ  quality w ill  be 
acceptable in all countries. 
1.3.3 Organ damage in the non-heart-beating-donor
Warm  ischaemia is  the  hallmark  of  the  non-heart-beating-donor[33].  This 
impacts graft quality and post-transplant graft function by several mechanisms. 
Lack  of  oxygen  prevents  aerobic  respiration  leading  to  the  depletion  of 30
intracellular reserves of ATP[48]. This causes cell membrane dysfunction and an 
influx of sodium ions and water and cellular swelling. Anaerobic respiration leads 
to lactate accumulation and acidosis [49],[48]. Depletion of glucose stores during
prolonged  ischaemia blocks glycolytic energy production. Reinstitution of blood 
supply to the ischaemic organ after transplantation leads to the production of 
large  quantities  of c ytokines  and  oxygen  free  radicals  which  cause  graft 
damage. The combination of initial ischaemia followed by reperfusion plays a 
major role in the dysfunction of the transplanted organ or tissues[50].
1.4 Ischaemia reperfusion injury
1.4.1 Background
Ischaemia-reperfusion  injury (IRI) refers  to  the  damage  caused  to  cells  or 
tissues  when  blood  supply  returns  after  a  period  of h ypoxia. I schaemia-
reperfusion injury is seen in multiple clinical situations. It was first described by 
Cerra and co-workers[51] who reported sub-endothelial haemorrhagic necrosis 
in the myocardial pedicles associated with warm ischemia in a canine model. 
They demonstrated that the extent of necrosis was proportional to the duration 
of warm ischaemia. Ischaemia-reperfusion injury has been identified as a major 
factor affecting post-transplant outcome in solid organ transplantation [52]. The 
severity of this phenomenon is much more significant in the setting of non-heart-
beating-donation.31
1.4.2 Pathophysiology of ischaemia reperfusion injury
IRI is triggered by the onset of ischaemia and arrest of aerobic respiration in an 
organ  or  tissue  [53] (Figure  2).  This  results  in  a decrease  in  ATP levels, 
accumulation of acidic metabolites and decrease in intracellular pH [54]. Cellular 
swelling  develops  due  to d ysfunction  of t he  energy-dependent s odium 
potassium  pump.  This  is  reflected  as e ndothelial  cell  swelling  which
compromises the capillary lumen[55]. Acute ischaemia also causes activation of 
endothelium  resulting  in i ncreased  permeability  and  increased  expression  of 
adhesion molecules. The severity of these changes depends on the duration of 
ischaemia[56] and  the  temperature  at  which  the  tissue  suffers  ischemia[57]. 
Small amounts of reactive oxygen species are produced during the ischaemia 
phase. 
The  reperfusion  component  of  IRI  is  initiated  when  the  ischaemic  organ  is 
perfused by blood and re-warmed to physiological temperatures. Reperfusion 
flushes the accumulated toxic metabolites from the ischaemic tissues into the 
systemic  circulation.  This  causes  a  haemodynamic response  in  the  form  of 
tachycardia and hypotension [54]. Reperfusion leads to platelet and neutrophil 
adhesion to the activated endothelium. Platelet activation releases inflammatory 
cytokines [54]. Reperfusion also stimulates the production of large amounts of 
reactive oxygen species in the mitochondria. They activate the toll like receptor
(TLR) pathway[58].  TLR  signalling  leads  to  the  up-regulation  of  multiple 
inflammatory  genes  and  pathways[59].  Reactive  oxygen  species cause  cell 32
membrane damage, lipid peroxidation[60], mitochondrial damage and activate 
mitochondrial pathway of apoptosis[61]. 
1.4.3 Outcome of ischaemia reperfusion injury
IRI initiates multiple pathways involved in cellular injury, cell death, and cellular 
repair[62].  The  options  available  to a  c ell  undergoing  ischaemia  reperfusion 
injury a re  necrotic  cell  death  or  apoptotic cell  death  or  cellular  repair  and 
survival[63] (Figure  3).  All  three  processes  have  been  found  to  occur 
concomitantly  in  experimental  and  clinical  studies  of i schaemia  reperfusion 
injury[64, 65]. The net result depends on the balance between the pro-death and 
the pro-survival processes. Several factors influence this delicate balance in the 
setting  of  non-heart-beating-donor  organs.  Factors  such  as  the  mode  of 
death[66], presence or absence of ischaemic preconditioning, durations of warm 
ischaemia  and  cold  ischaemia[67] have  the  potential  to  affect  the  outcome. 
Extensive  damage  after  ischaemia  reperfusion  injury p resents  clinically a s 
primary non-function or delayed graft function. 33
Figure 2 Pathophysiology of ischaemia-reperfusion
The intracellular changes during ischaemia reperfusion are depicted. Ischaemia leads to 
the arrest of normal aerobic respiration. This leads to a decrease in the cellular ATP 
level. ATP depletion leads to failure of the sodium potassium pump and cellular 
swelling. Small amounts of reactive oxygen species are produced during the ischaemia 
phase. The reperfusion component of IRI is initiated when the ischaemic organ is 
perfused by blood and re-warmed to physiological temperatures. Reperfusion stimulates 
cytokine production and production of large amounts of reactive oxygen species.
Reactive oxygen species have multiple roles in reperfusion injury. They also cause cell 
membrane damage, lipid peroxidation, mitochondrial damage and activate 
mitochondrial pathway of apoptosis.
Cell
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Figure 3 Outcomes after ischaemia-reperfusion injury
Ischaemia reperfusion injury initiates multiple pathways involved in cellular injury, cell 
death, and cellular repair. The options available to a cell undergoing ischaemia 
reperfusion injury are necrotic cell death or apoptotic cell death or cell survival. All 
three processes have been found to occur in experimental and clinical studies of 
ischaemia reperfusion injury. The net result depends on the balance between the pro-
death and the pro-survival processes. Several factors such as the severity and duration 
of injury, pre-injury cellular state influence this balance. 
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1.5 Apoptosis
1.5.1 Background
Apoptosis refers to a form of programmed cell death. The term ‘apoptosis’ was 
first  suggested  by K err  and  co-workers  in 1 972. who  described the 
morphological appearances of cells undergoing this form of death[68].  Apoptotic 
cells are characterised by cytoplasmic and nuclear condensation with blebbing 
of the plasma membranes. The apoptotic cell shrinks and eventually breaks up 
into multiple membrane bound particles called apoptotic bodies containing intact 
organelles  and  nuclear  material.  These  bodies  are  rapidly  recognized  and 
engulfed  by p hagocytes.  The  process  occurs  without  the  induction  of 
inflammation and does not lead to scarring. 
Apoptosis  forms  an  important  mechanism  that  directs  the  development  and 
homeostasis in normal cell populations. It is considered to play an important role 
in an organ’s response to ischaemia and reperfusion. It is an energy consuming 
process and  can  only  proceed  when energy  rich substrates  are  available.  In 
their absence, cell death occurs by necrosis. Apoptosis has been found to be a 
key  determinant  of  the  immediate  post-transplant  function  after  islet 
transplantation [69]. 
The cellular machinery contains both pro-apoptotic and anti-apoptotic factors. 
The  ultimate  fate  of  the  cell  i.e.  apoptotic death  or  survival  depends  on  the 
balance of these two sets of factors. The major pro-apoptotic proteins are the 
caspases  and  the  pro-apoptotic  members  of  the  B  cell  lymphoma-2  (Bcl-2) 36
family. Caspases are a family of cysteine proteases that are closely involved in 
the initiation and execution of apoptosis[70, 71]. They are characterised by their 
very  specific  site  of  action- cleaving  their  substrates  after  the  aspartic  acid 
residues.  Caspases  have  been  classified  into  three  groups based  on  their 
function. Group 1 are the inflammatory caspases (caspase 1). Group 2 are the 
effector  caspases  (Caspase  3,  7)  and  group  3  are  the  initiator  caspases 
(caspase 2,8,9,10). Caspases are produced within the cell in a pro-enzyme form 
and undergo cleavage in suitable environments to form active units. The Bcl-2 
family  includes  several  proteins  involved  in  the  regulation  of c ellular 
apoptosis[72].  The  family i ncludes  pro-apoptotic  proteins  such  as  the  Bcl-2 
associated X protein (Bax)[73], Bcl-2 associated agonist of cell death (Bad) and 
anti-apoptotic proteins such as Bcl-2, Bcl-2 related protein A1 (Bcl2A1 or BFL-1) 
and  B-cell  lymphoma-2  like  1  (Bcl2L1 or  Bcl-xl).  They  affect  their  respective 
functions by altering the permeability of the mitochondrial membrane. The third 
group of proteins which includes the BH3 interacting domain death agonist (Bid) 
are also involved in the apoptotic process [74].
1.6.4 Pathways of apoptosis
The pathways of apoptosis have been largely conserved throughout the animal 
kingdom [75]. Apoptosis is activated by a cascade of reactions that lead to the 
proteolytic  activation  of  the  effector  caspases.  Initiation  of  apoptosis  occurs 37
primarily through two major pathways- extrinsic also called the death receptor 
mediated pathway and the intrinsic or mitochondrial pathway (Figure 4). 
Death receptor or extrinsic pathway
This pathway is activated by the binding of ligands to a family of transmembrane  
receptors. Binding of the ligands  activates the cytoplasmic domains of these 
receptors  to  form  a  death-inducing  signalling complex (DISC).  DISC  binds 
initiator  caspases  such  as  caspase  8  and  caspase  10  leading  to  their  auto-
activation. These activate downstream effector caspases (caspase 3) [76]. 
Mitochondrial or intrinsic pathway
Cellular stresses lead to the activation of pro-apoptotic Bcl-2 proteins such as 
Bad, Bax which are normally present in the cytoplasm [76]. Activation leads to 
their  localisation  to  the  outer  membrane  of t he  mitochondria.  They  bind  and 
inhibit  the  protective  function  of B cl-2  and  Bcl2L1   l eading  to i ncreased 
mitochondrial membrane permeability. This results in the leakage of cytochrome 
C from the inter-membrane space into the cytoplasm. Cytoplasmic cytochrome 
C  binds  with  the  apoptotic  protease  activator  factor  -1  (Apaf-1)  to  form  the 
apoptosome.  The  apoptosome  recruits  caspase  9  which  undergoes  auto-
activation in its vicinity. Caspase 9 activates caspase 3 leading to apoptosis. 
BID is a protein normally present in an inactive form in the cytoplasm. Activated 
Caspase 8 formed through the death receptor pathway converts it to truncated 
Bid (tBid). tBid moves to the mitochondrial membrane and activates Bax and 
Bad.  It  thus  serves  as  the  connecting  link  between  the  death  receptor  and 38
mitochondrial pathways of apoptosis.  Bcl-2 like protein 11 (Bcl2L11 or Bim) and 
the p53 up-regulated modulator of apoptosis (Puma) are two Bid-like proteins 
involved in the activation of Bax [77]. 
Execution of apoptosis
Effector caspases execute terminal processes involved in apoptotic cell death 
[71, 75]. They lyse a wide variety of cellular substrates including cytoskeletal 
proteins,  regulatory  proteins  and  nuclear  proteins.  Activated  caspase  3  is 
essential for the characteristic morphological features of apoptosis such as the 
formation of apoptotic bodies, DNA fragmentation and nuclear condensation. 39
Figure 4 Outline of the steps involved in apoptosis (adapted from MacFarlane et 
al[78])
Apoptosis is initiated by  a multitude of noxious stimuli. In the extrinsic or mitochondrial 
pathway, cell death stimulus directly acts on the mitochondria increasing outer 
membrane permeability and leakage of cytochrome c from the inter-membrane space 
into the cytoplasm. Cytoplasmic cytochrome c forms a complex with Apaf and caspase 9 
to form the apoptosome. Apoptosome activates the effector caspase 3. Apoptosis can 
also be initiated through activation of the TNF/Fas receptor complex present on the cell 
membrane. Receptor activation by TNFα and Fas ligand (FasL) leads to receptor 
trimerisation and formation of the death inducing signalling complex (DISC). DISC 
activates caspase 8. Caspase 8 can activate the effector caspase 3. Activated caspase 3 
acts on multiple cellular components to initiate the morphological features of apoptosis. 
Bcl2 family of proteins are usually present on the mitochondrial surface. Pro-apoptotic 
Bcl2 members (Bax) increase outer membrane permeability which is opposed by anti-
apoptotic members such as Bcl2. Net membrane permeability depends on the relative 
activities of these two types of proteins. Activated caspase 8 also lyses cytoplasmic Bid 
to form tBid. tBid moves to the mitochondrial outer membrane to increase membrane 
permeability and induce leakage of cytochrome c. Bid hence acts as the connecting link 
between the intrinsic and extrinsic pathways of apoptosis.40
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1.6.5 Anti-apoptotic mechanisms
Proteins of the Bcl-2 family have prominent roles in inhibiting the mitochondrial 
pathway of apoptosis[72]. Bcl-2, Bcl2L1 and Bcl2A1[73, 79] are normally present 
on  the  mitochondrial  surface.  They  interfere  with the  action  of B ax  and  Bad 
which increase mitochondrial membrane permeability. Several other intracellular 
proteins act to counteract apoptosis. Baculoviral IAP repeat-containing factors
(BIRC2,  BIRC3)  bind  to t umour  necrosis  factor  receptor-associated  factors 
(TRAF1  and  TRAF2)  and  block  the  death  receptor  pathway  of  apoptosis 
activation[80].  CASP8  and  FADD-like  apoptosis  regulator  (CFLAR)  has  been 
reported to block the death receptor pathway of apoptosis by inhibiting  the Fas-
associated death domain and caspase 8 activation. Phospho-protein enriched in 
astrocytes  15  (PEA15)[81],  pim-2  oncogene  (PIM2)[82] are  other  genes 
encoding proteins involved in the inhibition of apoptosis. PEA15 blocks TNFα
induced apoptosis by inhibiting caspase 8 activation by DISC. PIM2 blocks the 
function of the pro-apoptotic protein BAD.
Haemoxygenase-1  (HO-1  or  hsp32)  is a n  inducible  enzyme  which  is 
synthesised in large  quantities during periods of cellular stress. This enzyme 
catalyses the breakdown of haeme into biliverdin, carbon monoxide and ferrous 
iron. Carbon monoxide is postulated to inhibit apoptosis by multiple mechanisms 
[83]. 
Heat shock proteins are a group of proteins that are produced in large quantities 
during  periods  of  cellular  stress.  They  function  as  intracellular  chaperones 
preventing  the  accumulation  of  misfolded  proteins.  They  inhibit  apoptosis 42
through  the  death  receptor  and  mitochondrial  pathways  [84,  85].  They  have 
been  shown  to  block  TNFα receptor  mediated  activation  of  apoptosis  and 
disrupt  apoptosome  formation.  Several  signalling cascades  involved  in t he 
regulation of apoptosis are also subject to modulation by heat shock proteins. 
Clusterin  [86] and  Crystallin  α  have  chaperone  like  activity  and  inhibit 
mitochondrial apoptosis[87]. 
1.7 Oxidative stress and cellular anti-oxidant mechanisms 
Reactive  oxygen  species  (ROS)  are  free  radicals  such  as h ydroxyl  and 
superoxide ions or oxidants such as hydrogen  peroxide. Minute  quantities of 
reactive oxygen species are routinely produced during aerobic metabolism in all 
cells. Their activity is normally kept under check by a variety of anti-oxidative 
pathways  present  in t he  normal  cellular  milieu.  Small  amounts  of  reactive 
oxygen species are formed in the mitochondria during the ischaemia phase[88]. 
Reperfusion accelerates the production of reactive oxygen species through the 
xanthine  oxidase  pathway  and  from  damaged  mitochondria[89].  The 
uncontrolled  production  of R OS  and  their  secondary  products  such  as  the 
peroxynitrite anion leads to membrane damage, lipid peroxidation and cell death 
[90]. Inactivation of ROS is an energy dependent process and requires ATP. 
During  ischemia,  ATP  reserves  drop  precipitously  which  makes  the  cell  ill-
prepared to deal with the large  amounts of reactive oxygen species that are 
formed during the reperfusion phase. 43
Anti-oxidant  enzyme  systems  such  as  catalase,  peroxidase  and  super-oxide 
dismutase  directly  inactivate  ROS.  Catalase  and  peroxidase  breakdown 
hydrogen peroxide to form water and molecular oxygen. Superoxide dismutase 
is  an  enzyme  which  catalyses  the  breakdown  of t he  superoxide  ion  into 
molecular oxygen and hydrogen peroxide. 
Reduced glutathione is an important anti-oxidant mechanism. It is a tripeptide 
which is normally present in abundant quantities in the cytoplasm. Synthesis of 
glutathione occurs in t wo ATP dependent steps  by the enzymes  glutathione-
cysteine ligase (rate-limiting step) and glutathione synthetase[91]. It acts as a 
substrate for the enzyme Glutathione-s-transferase transferring a hydrogen ion 
to ROS. The oxidised glutathione then binds with another oxidised glutathione to 
form glutathione disulphide. Reduced glutathione is regenerated by the activity 
of the enzyme glutathione reductase.
Uncoupling protein 2 (UCP2) is an enzyme complex present in the mitochondrial 
inner membrane of all cells. It has been suggested that it uncouples electron 
transport from ATP production. Several studies have suggested a role for this 
protein in the neutralisation of mitochondrial ROS[92, 93]. 
Sestrins are a group of highly conserved proteins which act by regenerating over 
oxidized peroxiredoxins that deoxidize reactive oxygen species[94]. This leads 
to a decrease in intracellular ROS and confers resistance to oxidative stress.
Several transcription factors are induced by ROS. These include the Nuclear 
factor  Kappa  B  (NF-κB) pathway,  Mitogen  activated  protein  kinase  (MAPK) 
pathways and Nuclear Factor 2 (NRF2) pathway. The latter is a transcription 44
factor that is normally localised to the cytoplasm. During periods of oxidative 
stress it translocates to the  nucleus where it binds  with  other co-factors  and 
activates  the  transcription  of  multiple  cytoprotective  genes.  These  genes  are  
involved in increasing the anti-oxidant capacity of the cells and include those 
involved in glutathione synthesis and regeneration, aldehyde dehydrogenases, 
quinine oxido-reductases and haeme-oxygenase 1 [95-98]. 
1.8 Pathways involved in ischaemia reperfusion injury
Ischaemia reperfusion injury initiates multiple inter-linked biological pathways. 
These affect the inflammatory, immune and repair responses of cells. Toledo-
Pereyral and  co-workers  in  2004 identified  three  phases  of  ischaemia 
reperfusion injury with respect to the involved molecular pathways [62]. Phase I, 
which occurs seconds to minutes after the injury is characterized by leukocyte -
endothelial interactions and is dependent on the activation of phospholipases, 
intracellular  calcium  and  lipid  molecules.  Phase  II,  which  occurs  minutes  to 
hours after I/R injury is associated with the active transcription of inflammatory 
cytokines  such  as  TNFα and  IL-1β.  Initiation  of m ultiple  signalling pathways 
leads  to k inase  activation,  increased  transcription  and  progression  of t he 
inflammatory  process.  Phase  III,  which  occurs  several  hours  to  days  after 
ischaemia  reperfusion  is  associated  with  the  production  of a nti-inflammatory 
cytokines, adhesion molecules and growth factors. 
The second phase of ischaemia reperfusion is the most complex and critical with 
simultaneous  activation  of  both  pro-survival  and  pro-death  pathways. Innate45
immune responses are initiated by the activation of the cellular 'trinity of sensors' 
i.e. Toll-like receptor (TLR) family which are distributed in the cell membrane, 
Nod-like receptors (NLR) family and the RIG-like receptor (RLR) family which 
are cytoplasmic in distribution[99]. Activation of these receptors by bacterial and 
viral  products,  cellular  necrotic  debris  and  ROS  leads  to  activation  of  pro-
inflammatory  genes  and  NF-κB  activation.  TLR  activation  is  relevant  in  the 
setting  of  ischaemia  reperfusion  injury[100,  101].  Activation  of  pro-survival 
pathways  such  as  the  Extracellular  signal-regulated  kinases (ERK/MAPK), 
Protein kinase B (Akt/PKB) and NF-κB leads to the expression of genes involved 
in  anti-apoptosis,  anti-oxidant,  cell  repair  processes.  Activation  of p ro-death 
pathways  such  as p 38/MAPK  and  cJun  N-terminal  kinase  (JNK/MAPK) 
pathways leads to expression of genes involved in apoptotic and necrotic cell 
death. The net result depends on the cell state, its energy status, nature of the 
initiating stress and the balance between pro-death and pro-survival pathways. 
1.8.2 Mitogen Activated Protein Kinase pathway 
Mitogen activated protein kinases (MAPK) are a series of conserved metabolic 
pathways involved in the control of differentiation, proliferation and cell death
(Figure 5). MAPK pathways are characterised by the presence of at least three 
protein kinases in series which ultimately leads to the phosphorylation of a multi-
functional MAPK [102]. The setup allows for signal amplification and additional 
pathway regulation. Based on the initiating factors and the ultimate targets, three 
pathways  have  been  well-defined.  These  include  the  extracellular-signal 46
regulated kinases 1 and 2 pathways (ERK/ MAPK), the P38 MAPK pathway and 
the  c-Jun N -terminal  kinase  /Stress  activated  protein  kinase  pathway 
(SAPK/JNK pathway). Additional pathways like the ERK5 pathway have been 
described.
The ERK/MAPK pathway is primarily activated by growth factors binding to cell 
surface receptors. Receptor ligation leads to a  series  of events involving the 
proteins Growth factor receptor-bound protein 2 (GRB2) and son of sevenless 
homolog (SOS) leading to the activation of the G protein, Ras. Activated Ras
binds  and  activates  the  serine  threonine  specific  kinase,  Raf which  is  the 
Mitogen  activated  protein  kinase  kinase  kinase  (MAP3K) for  this  pathway. 
Activation  of  Raf also  occurs  through  the  diacyl  glycerol  (DAG)  pathway  via
protein kinase c (PKC) and the ras guanyl -releasing protein 1 (rasGRP) [103, 
104]. Raf phosphorylates the pathway specific mitogen-activated protein kinase 
kinases (MAP2K) which are MAP2K1 and MAP2K2. These phosphorylate the 
pathway  specific  MAPKs  (ERK1  or  ERK2).  Activated  ERK  activates  several 
transcription factors. It activates the p90 ribosomal s6 kinase (p90RSK) which is 
involved in translation. p90RSK also inhibits the pro-apoptotic Bcl-2 protein BAD 
through phosphorylation[105]. The ERK pathway is involved in cell proliferation 
and differentiation.
The  p38  MAPK  pathway  is  activated  by  cellular  stress  factors  such  as  heat 
shock,  reactive  oxygen  species,  lipopolysaccharide  and  by  the  inflammatory 
cytokines  tumour  necrosis  factor alpha (TNFα)  and  Interleukin  1 beta (IL1β) 
[106]. They act through a variety of protein kinases to activate multiple MAP3Ks 47
such as Tao 1/2, Tpl2, MEKK4, MEKK1. These activate the specific MAP2Ks, 
MAP2K3 and MAP2K6. The MAPK for this pathway is the p38 protein. Activated 
p38 induces a variety of transcription factors and inflammatory mediators. The 
net  result  is  the  progression  of  the  inflammatory  process  and  induction  of 
apoptosis. 
The  cJun  N-terminal  kinases (JNK)  pathway  is  activated  by  a  variety  of 
environmental stresses and inflammatory cytokines. Stress signals are delivered 
to this pathway by GTPases such as Rac and Rho.  These activate a member of 
the mixed lineage kinases (MLK) that phosphorylate and activate the MAP2Ks
for this pathway, MAP2K4 or MAP2K7. These activates JNK proteins 1-3 which 
translocate  to t he  nucleus  and  regulate  the  activity o f  multiple  transcription 
factors.
The activation of these pathways is kept under control by the dual specificity 
phosphatases  (DUSP)  and  protein  tyrosine  phosphatases  (Ptpn).  These 
pathways are also controlled by activity the protein phosphatases and activated 
Akt/PKB.48
Figure 5 Mitogen Activated Protein Kinase (MAPK) pathways
MAPK pathways contain a series of at least three protein kinases terminating at a 
multifunctional protein kinase (MAPK). The outline of the three major pathways is 
depicted along with their initiating stimuli and downstream role in cell survival.
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1.8.3 Phosphatidyl Inositol-3 kinase/ Protein kinase B pathway
Phosphatidyl Inositol-3 kinases (PI3K) are signal transduction enzymes that are 
involved in cell pathways promoting cell survival and proliferation [107]. Class 
1A PI3K phosphorylates phosphatidyl inositol and produces phosphatidyl inositol 
(3,4,5)-trisphosphate  (PIP3).  PIP3 is  a  key  second  messenger  in  the  cell.  It 
activates downstream serine-threonine protein kinases such as Protein kinase B 
(Akt/PKB) and protein kinase C (PKC). Class 1A PI3K enzyme is a heterodimer 
and  consists  of a  c atalytic  subunit  and  a  regulatory  subunit.  The  regulatory 
subunit  at h igh  concentrations has  an  inhibitory e ffect  on  the  activity  of  the 
enzyme by blocking the active site[108, 109].
Protein  Kinase  B  (Akt/PKB)  is  a  critical  regulator  of c ell  survival  and 
proliferation[110].  A  variety  of  growth  factors  and  insulin  activate  Akt/PKB
through  the  PI3Kinases.  Cellular  stress  has  also  been  reported  to  directly 
activate Akt/PKB pathway through heat shock proteins[111]. The activation of 
Akt is tightly regulated by the quantity of the second messenger Phosphatidyl 
inositol triphosphate (PIP3). Levels of PIP3 can be reduced by the activity of 
enzyme  phosphatidylinositol-3,4,5-trisphosphate  3-phosphatase  (PTEN).  Akt 
itself can be deactivated by the action of protein phosphatases[112].
Functions of Akt/PKB pathway
Akt/PKB contributes to several cellular functions including inhibition of apoptosis 
and cell survival, nutrient metabolism, cell growth, transcriptional regulation. Its 50
mechanism  of a ction  is t hrough  the  phosphorylation  of  serine  or  threonine 
residues in various proteins.
Akt inhibits apoptosis by multiple pathways. It phosphorylates the pro-apoptotic 
Bcl-2protein  BAD  and  induces  its  dissociation  from  the  mitochondrial 
membrane[113]. Akt mediated phosphorylation of caspase 9 has been reported 
to inhibit the catalytic activity of caspase 9. The forkhead group of transcription 
factors  have been identified as  another  target  of  Akt phosphorylation.  These 
transcription factors induce the transcription of pro-apoptotic genes including the 
Fas ligand (FasL) involved in death receptor pathway of apoptosis. Activated Akt 
prevents  the  nuclear  localisation  of  these  proteins  and  thus  blocks their 
activity[114].
Akt  acts  on  several  enzymes  involved  in c arbohydrate  metabolism.  It 
phosphorylates and inactivates the enzyme glycogen synthetase kinase 3. Akt 
phosphorylation has also been reported to activate the transcription of glucose 
transporter (GLUT 1) and the glycolytic enzyme Phospho-fructo-2-kinase. The 
net effect is to increase the uptake of glucose from the extracellular fluid and 
utilising it for the glycolytic pathway for generation of ATP[110]. AKT activation 
activates the NF-κB pathway by multiple mechanisms. 51
1.8.4 Nuclear Factor- Kappa B (NF-κB) pathway
Nuclear  factor- kappa  B (NF-κB) are  a  set o f  transcription  factors  which  are 
involved in the cellular response to stress. They were first identified as proteins 
which  bind  to t he  intronic  enhancer  region  of  the  κ chain  in  activated  B 
lymphocytes[115]. These enhancer sequences are now known to be ubiquitous 
in  distribution.  These  factors  act  to modify  the  expression  of m ultiple  target 
genes associated with the inflammatory response. 
Five different NF-κB elements (NF-κB 1, NF-κB 2, RelA, RelB, cRel) are known
[116]. These are usually present in the cytoplasm as homo or hetero-dimers. 
They are localised to the cytoplasm by being complexed to proteins called the 
Inhibitors of Kappa B (IκB). There are three types of IκB termed IκB -alpha, IκB -
beta and IκB -epsilon. Activation of the NF-κB pathway involves the breakdown 
of these complexes. This leads to the translocation of the NF-κB elements into 
the  nucleus  where  they  interact  with  other  transcription  factors  and  modify 
transcription. 
Hypoxia,  reactive  oxygen  species  and  cytokines  such a s  TNFα and  IL-1β
activate the NF-κB pathway through trans-membrane receptor complexes. The 
latter  include  the  tumour  necrosis  factor  receptor  (TNFR)  super-family,  IL-1β
receptor and TLR family[116, 117]. Activation of these receptor complexes leads 
to  a  cascade  of  events involving  several  adapter  proteins.  Tumour  necrosis 
factor  receptor  associated  factors  (TRAF)  family o f  proteins  are  important 
transducers  of s ignals  from t hese  receptor  complexes[118].  These  ultimately 52
activate protein kinases termed the inhibitors of kappa kinase (IKK) complex. 
Phosphorylated Akt activates the NF-κB pathway through direct activation of IKK
and  through  phosphorylation  of  the  MAP3kinase,  Tpl2[119,  120].  Three 
Inhibitors  of K appa  kinases  (IKK)  have  been  described.  These  include  two 
catalytic sub-units (α, β) and a regulatory subunit IKKγ. The latter is also called 
the NF-κB essential modifier (NEMO). The IKK complexes phosphorylate the 
IκB proteins which releases them from the NF-κB protein subunits. The released 
IκB proteins  undergo  proteosomal  degradation  leaving  the  NF-κB proteins  to 
translocate  to  the  nucleus.  Other  modes  of  both  IKK dependent and  IKK
independent activation of the NF-κB pathway in response to cellular stress have 
been described.
Functions of the NF-κB pathway
NF-κB pathway has been reported to have multiple roles in effecting the cellular 
response to stress. It has a primarily pro-inflammatory function. The list of target 
genes for NF-κB runs into hundreds in published literature[121-123]. It induces 
the  transcription  of  genes  related  to  cytokines,  cell  surface  receptors,  pro-
apoptotic and anti-apoptotic proteins, adhesion molecules and anti-oxidants. It is 
primarily considered to be anti-apoptotic, pro-survival though some studies have 
also reported a pro-apoptotic, pro-death role. The ultimate effect of the NF-κB
pathway depends  on  the  activity  of o ther  stress  induced  pathways  and  the 
cellular state[124].
NF-κB has been shown to inhibit TNFα induced apoptosis[125]. Activation of the 
NF-κB pathway leads to the transcription of factors involved in anti-apoptosis. 53
These  include  bfl-1/a1,  Bcl-XL,  Caspase  8/FADD  like  apoptosis  regulator 
(CFLAR), TRAF 2 and inhibitor of apoptosis proteins (BIRC2 and BIRC3, XIAP).
Activation of the NF-κB pathway has been found to control the accumulation of 
reactive oxygen species in response to TNFα. This is achieved primarily by the 
increased expression of ferritin heavy chain (FHC) and mitochondrial form of 
superoxide  dismutase[126,  127].  NF-κB activation  also  inhibits  the  JNK 
pathway[128]. Activation of the JNK cascade by TNFα is a recognised inducer of 
apoptotic cell death. It has been reported that activation of the NF-κB pathway 
blocks the JNK pathway at multiple steps. Gadd45β, a protein up-regulated by 
the NF-κB pathway is a prominent blocker of the JNK pathway[128, 129].
Regulation of the NF-κB pathway
NF-κB pathway  is  regulated  by  several  feedback  loops.  One  mechanism  of 
interest is the increased transcription of the IκBε gene in response to NF-κB
activation.  The  IκBε   p rotein  enters  the  IκB complexes  to d ecrease  NF-κB
protein  activation  thus  acting  as  a  feedback mechanism.  The  extent  of  IκBε 
transcription is hence an indicator of NF-κB pathway activity in the cell[130].
1.9 Microarrays- a primer
The full complement of genetic material present in an organism is called the 
genome. While a genome contains thousands of genes, only a fraction of these 
genes are expressed at any point in time. The set of genes expressed at any 
point in time is called the transcriptome. Measurement of the level of expression 
of these genes in a given clinical or experimental condition provides important 54
information regarding the response of the cell or tissue to these conditions at a 
molecular level. Technologies such as the polymerase chain reaction (PCR) can 
provide information regarding one or a handful of genes of interest. However it is 
now  known  that  expression  of  any  single  gene  can  be  modified  by m ultiple 
factors  due  to  the  extensive  redundancy  that  exists  in  the  cellular  response. 
Better  understanding  of  the  cellular  state  can  be  obtained  by  analysing  the 
expression  of  all  the  genes  in  a  genome. T his  gives  information  regarding 
thousands of genes in a single experiment. This information,  whilst complex, 
can  be  used  to  study  the  pattern of  global  gene  expression  and  provide 
information  regarding  the  biological  pathways  activated  or  suppressed. 
Microarrays are tools for analyzing expression of large number of genes in a 
single experiment[131].
1.9.1 Microarray techniques and analysis
The  technique  of D NA  microarray  analysis  is b ased  on  the  principle  of 
competitive binding of mRNA to complementary sequences attached to a glass 
slide or synthetic membrane. The procedure begins with extraction of RNA from 
cells  or  tissue.  The  RNA  is  labelled  with  a  fluorescent  dye.  The  RNA  is 
incubated on a glass slide containing thousands of spots-each containing oligo-
nucleotide  sequences  (a  short  fragment  of  a  single-stranded  DNA  that  is 
typically  5 to 50 nucleotides long) specific for different genes. After overnight 
incubation, the slides are washed to remove excess unbound RNA. The slide is 
then analysed by computerised laser equipment which detects the intensity of 55
fluorescence in each of the spots and converts it into a numerical value which is 
a  measure  of  the  amount  of  mRNA  specific  to  that  gene  in  the  RNA 
sample[132].  These  data  are  normalised by  correcting  for  experimental 
conditions.  After  further  statistical  analysis,  the  level  of  gene  expression  is 
presented as fold change, false discovery rate or P value.  
The data available from a microarray experiment usually consist of a data matrix 
which  includes  the  expression  levels  of  thousands  of  genes  in  each 
experimental condition. Analysis of gene expression data can be carried out in 
several ways. The simplest way to analyse these data is to compare the level of 
expression  of  specific  genes  which  have  been  identified  as  relevant  to  the 
nature of the investigation. This has limited utility and does not utilise the full 
potential of  microarrays.  Comparing  expression of  multiple genes  involved  in 
selected  relevant  biological  processes  can  give  a  better  idea regarding  the 
pattern of gene expression under various experimental conditions. This is best 
carried out by an ontological approach where the genes are grouped based on 
their  putative  function.  The  Gene  Ontology  (GO)  project  (accessible  at 
http://www.geneontology.org/)  is  a  worldwide  collaborative  effort  intended  to 
standardise  the  terminology  used  by  the  scientific  community  to  describe 
biological processes. Structured and controlled vocabularies (ontologies) have 
been  developed  that d escribe  gene  products  in  terms  of t heir  associated 
biological processes, cellular components and molecular functions in a species-
independent manner[133].  The  format  of Gene  Ontology is in the form of a 
directed acyclic graph, which is a hierarchical structure similar to a tree. Each of 56
the  three  ontologies  (biological  process,  cellular  component  and  molecular 
function) has been built with multiple levels of abstraction. Hence each general 
biological process has multiple child processes each of which can in turn have 
multiple  specific  child  processes.  Each  of  the  processes  has  an  assigned 
alphanumeric code, the 'GO term' which can ensure consistency in analysing, 
presenting and circulating information. 
Pathway  analysis  and  pictorial  visualisation  of  the  gene  expression  data  is 
another  powerful  tool  that  utilises  the  wealth  of  data  that  is p rovided  by 
microarrays. Here specific well studied biological pathways are represented with 
the expression of data of various involved genes highlighted in different colours 
to mark over and under-expressed genes. 
1.9.2 Utility of gene micro arrays in biology
DNA micro arrays have proven their utility in a multitude of biological research 
areas[134].  These  include  measurement  of g ene  expression  to  relate  it  to 
cellular physiology, detection of bio-markers for disease, detection of markers of 
disease  prognosis,  pathogen  detection  and  evaluation  of d efects  at t he 
transcriptional level of various genetic disorders. 
1.9.3 Limitations of gene microarrays
Microarray  technology  is  expensive  and  needs  specialised  equipment  and 
trained personnel. The risk of random errors entering the analysis is high due to 
the vast amount of data produced by microarrays. Strict statistical validation of 
expression data using novel statistical methods should therefore be carried out 57
before further analysis. Variation in gene expression could be due to multiple 
confounding  factors  especially  in  complicated  experiments.  Comparison  of 
results  from  different  microarray  experiments  is d ifficult  due  to  the  wide 
variability in the experimental protocols, and the actual microarray techniques. 
Attempts are now being made to standardise the form of data presentation and 
analysis a nd  establish  public  databases  to s tore  microarray  data[135]. 
Microarrays  only  provide  a  guide  to  the  relative  levels  of  gene  expression. 
Ideally  the  accuracy  of m icroarray  data  should  be  confirmed  by  quantitative 
polymerase  chain  reaction  (PCR)  analysis  of  selected  genes  from  the  same 
RNA sample. Finally, microarrays look at the first step in the ‘central dogma of 
life’ i.e. gene transcription. The effect of any physiological stimulus on the cell 
depends on multiple processes downstream of transcription. Gene microarrays 
provide no information regarding actual protein expression levels in the cells.
1.10 Ischaemia reperfusion injury in pancreas and islet 
transplantation
IRI  is  a  well  known  complication  after  pancreas  transplantation[136] and 
pancreatic  islet  transplantation[137].  It  presents  as  graft  pancreatitis  after 
pancreas transplantation and immediate blood mediated inflammatory response
(IBMIR) after islet transplantation. Both lead to graft dysfunction and graft loss. It 
has been reported that the exocrine component of the pancreas is much more 
susceptible  to  IRI  as  compared  to t he  endocrine  component  [138].  Exocrine 58
injury after pancreatic ischaemia reperfusion leads to extravasation of enzymes 
into  the  systemic  circulation.  These  enzymes  can  cause  auto-digestion  and 
progression  of t issue  injury.  Petersson and  co-workers  in  1998 [139]  
investigated  reperfusion  injury  in  cold p reserved  porcine  pancreases.  They 
reported   that  protease  activation  starts  during  the  cold  ischemia  phase  and 
increases several fold during the early reperfusion phase. This was decreased 
by  the  use  of f ree-radical  scavengers  suggesting  a  role  for  reactive  oxygen 
species  in p rotease  activation.  Garcia-gil  and  co-workers in 2 006 reported  a 
significant increase in the lipid peroxidation during the reperfusion phase after 
pancreas  preservation[89].  Mayer and  co-workers  in 1999  [140] identified 
significant  microcirculatory  disturbance  in  pancreas  with  prolonged  cold 
ischaemia.  Cold  ischemia  time o f  16  hours  significantly  reduced  functional 
capillary  density,  erythrocyte  velocity,  and  leukocyte-endothelium  interaction  
when compared to a cold ischemia time of 1.5 hours.
Ischaemia  reperfusion  injury  in  islet  transplantation  originates  before  the 
transplant procedure at the time of donor death. Induction of brain death is an 
activator  of  inflammation [141].  Contreras and  co-workers  in  2003 reported 
decreased islet yield and increased cytokine activation in pancreases retrieved 
from brain dead rats[142]. The severity of ischaemia reperfusion injury depends 
on the duration of warm ischaemia and subsequent cold ischaemia. Pileggi and 
co-workers in 2009 studied the effect of increasing duration of cold ischaemia on 
the yield and viability of rat islets. They reported that pancreases exposed to 
long  cold  ischaemia  times  yielded  lower  islet  numbers  and  showed  reduced 59
cellular viability. Islets from pancreases with prolonged cold ischaemia time also 
displayed increased activation of the p38/MAPK and JNK/MAPK pathways and 
lower  levels  of  pro-survival  factors[143].  The  process  of  re-warming  of  the 
pancreas  and  the  mechanical  stresses  involved  in i slet  isolation  lead to 
activation  of  multiple  inflammatory p athways.  Noguchi in  2007 reported 
activation  of  JNK  pathway  during  islet  isolation [144].  Production  of r eactive 
oxygen species during the islet isolation phase has been reported [145]. Armann
and co-workers in 2007 investigated the production of ROS in human pancreatic 
islets. They reported that the basal levels of ROS in human islets were higher 
than  in islets  isolated  from  rat  pancreases.  High  ROS  levels  were  also 
associated  with  increased  lipid  peroxidation  as  evidenced  by  islet 
malondialdehyde  levels.  Apoptosis  has  been  identified  as  an  important 
determinant  of p ost  transplant  islet  function[137].  Blockage  of  apoptotic 
mediators and increase in anti-apoptotic mediators has been shown to improve 
islet  function[69,  146].  Similarly i nhibition  of t he  p38MAPK  pathway  during 
pancreas  preservation  has  been  shown  to improve  post-transplant  islet 
function[147].
Improvement in the outcomes of islet transplantation can only be achieved by 
ameliorating  the  extent  of p ost-transplant  early  islet  loss  due  to i schaemia 
reperfusion injury[14]. It is hoped that improved quality of pancreas preservation 
which  can  provide  an  opportunity  for  the  commencement  of  reparative 
processes  during  the  cold  ischaemia  period  may  improve  the  viability  and 
function of these grafts. 60
1.11 Techniques of preservation of non-heart-beating-donor
pancreas 
1.11.1 Static cold storage
Static cold storage in UW solution is the preservation method currently used for 
transporting  human  pancreases.  It  is  cheap  and  does  not  need  specialised 
equipment or staff. In this technique, the pancreas is initially cooled by perfusion 
with cold UW solution through its arterial system. The pancreas is then placed in 
a  sterile  sealed  bag  containing  cold  UW s olution  and  stored in i ce.  The  low 
temperature slows metabolism and minimises continuing ischaemic damage in 
the tissues. 
Preservation  of h eart-beating-donor  pancreases  by  static  cold  storage  is 
sufficient  to  maintain  tissue  viability.  Improved  preservation  techniques  are 
required  for  non-heart-beating-donor  pancreases  that  have  sustained  warm 
ischaemia damage. Some new methods of organ preservation are already in 
clinical use while others are still at the experimental stage. 
1.11.2 Two Layer Method with oxygenated perfluorocarbon
Perfluorocarbons are biologically inert compounds with the capacity to dissolve 
20-25  times  their  own  weight  of  oxygen.  They  have  a  low  oxygen-binding 
capacity and can release oxygen easily at low oxygen partial pressures[148]. 61
The use of perfluorocarbons in pancreas preservation was first reported in 1988 
and  it  became  known  as  the  'two  layer  method'  (TLM)[149].  Here  the 
preservation container contained a bottom layer of perfluorocarbon which was 
continuously oxygenated with pure oxygen and a top layer of cold UW solution. 
The pancreas was suspended at the interface of the two layers with at least two-
thirds of the organ immersed in the perfluorocarbon layer[150] (Figure  6). Its 
superiority  over  static  cold  storage  has  been  demonstrated  in  experimental 
models  of p ancreas[19] and  small  bowel transplantation[151]. The  two  layer 
method has been shown to improve oxygen delivery[152], increase tissue ATP 
levels in the graft[153], decrease cellular apoptosis[154] and reduce ischaemia-
reperfusion injury[155] when compared to static cold storage. Kakinoki and co-
workers in 2005 [19] compared the islet yield and in vivo function of islets from 
non-heart-beating-donor rat pancreas preserved for 24 hrs by UW solution or 
two layer method. They reported better success rates of islet grafts from the two 
layer method group (80% vs. 0%). However several reports have queried the 
feasibility  of a dequate  oxygenation  of l arge  animal  pancreas  by s imple 
diffusion[156]. In a study of pig pancreas preservation, the two layer method did 
not improve islet yield compared to static cold storage[157]. Kin and co-workers 
in 2006 [20] reported a large scale clinical trial comparing the two layer method
with  static  cold  storage  for  preservation  of  pancreases  from  heart-beating 
donors. They reported no differences in tissue ATP content, islet yield, in vitro
function  or  transplant  success  rates  between  the  two  preservation  groups. 62
Another study reported that use of the two layer method did not improve the 
ischaemia tolerance of pancreatic grafts retrieved from elderly donors [158].
1.11.3 Hypothermic machine perfusion
Hypothermic machine perfusion involves the continued perfusion of the organ 
with preservation solution. The purported benefits of machine perfusion include 
better flush out of the organ, maintained patency of the vascular bed, provision 
of nutrients and removal of metabolites from the organ[159]. This technique was 
initially  reported  in c linical  kidney  transplantation  in t he  early  1970’s[160]. 
Increasing use of non-heart-beating-donor kidneys has revived interest in this 
technique of preservation[161]. Machine perfusion is now widely a ccepted as 
the  better  preservation  technique  for  non-heart-beating-donor  kidneys[162]
(Figure  7).  Machine  perfused  non-heart-beating-donor  kidneys  have  been 
shown  to h ave  shorter  periods  of d elayed  graft  function[163] and  better 
outcomes  than  static  cold  storage  kidneys  [164,  165].  A  recent  multicentre
randomised controlled trial compared static cold preservation and hypothermic 
machine  perfusion in d eceased  donor  kidney  transplantation.  This has 
confirmed the beneficial effect of machine perfusion in decreasing the duration 
of delayed graft function[166]. Several groups have also reported the utility of 
machine perfusion parameters in assessment of graft viability[167, 168].
Machine perfusion for the preservation of the pancreas for whole-organ or islet 
transplantation  has  been studied in e xperimental models  (Table  2).  However 
these studies have involved pancreases from heart-beating-donor models and 63
have not provided conclusive data. Most of these studies used plasma based 
perfusion fluids which are costly, have batch to batch variation in composition 
and have the theoretical risk of the transmission of blood borne infections. The 
high  perfusion  pressures  used  also  lead to  a  high incidence  of p ancreatic 
oedema  because  the  pancreas is a  low-flow o rgan  and  lacks  a well  defined 
capsule that can limit the development of oedema. 
More  recent  studies  using this modality  of o rgan  preservation  have  provided 
promising  results.  Leeser and  co-workers  in 2004  [169] reported  that  human 
pancreases  preserved  with  low-pressure  machine  perfusion  had  higher  islet 
yield and better in vitro function compared to static cold storage. Taylor and co-
workers  in  2008  [170] investigated  the  effect  of 2 4  hours  of l ow-pressure 
machine  perfusion  of p orcine  pancreases  on  islet  yield  and  function.  They 
reported higher islet yields in the machine perfusion group. They also reported 
more  uniform  digestion  and  fewer  entrapped  islets  in  the  machine  perfusion 
group. They postulated that the oedema which is a constant feature in machine 
perfused pancreases may aid pancreas digestion.64
Figure  6 Schematic  representation  of t he  'two-layer  method'  of  pancreas  preservation
(from Noguchi et al[150])
The two layer method involves the pancreas floating at the interface of two fluids in a 
sterile container. The bottom layer is perfluorocarbon solution which is continuously 
oxygenated by bubbling pure oxygen into the solution . The top layer is University of 
Wisconsin solution . The whole container is maintained at 4°C by keeping it in ice. The 
pancreas is suspended at the PFC-UW interface. Oxygen from the perfluorocarbon is 
hypothesised to diffuse into the pancreas and provide oxygen during the cold ischaemia 
period.
UW solution
Oxygenated 
perfluorocarbon 
solution65
Figure  7 Lifeport™  Renal hypothermic machine  perfusion  system  used  by t ransplant 
units for the preservation of non-heart-beating-donor kidneys66
Table 2 Summary of previous published reports investigating the potential role of machine perfusion as a 
method of pancreas preservation
Author Description of study
Details of animal model & machine 
perfusion model
Conclusion
Tersigni et 
al.[171]
Comparison of two 
perfusion fluids varying in 
electrolyte composition and 
osmolarity
Canine pancreas transplantation, 
Cryoprecipitate based fluids, 
pulsatile perfusion of 30-35 mmHg.
Pancreases perfused with high 
osmolarity fluid had better post-
transplant function
De Gruyl et 
al.[172]
Comparison of machine 
perfusion with static cold 
storage
Canine pancreas transplantation, 
Pulsatile machine perfusion with 
cryo-precipitated plasma
No difference in graft outcome 
between machine perfusion and 
static cold storage groups
Florack et 
al.[173]
Machine preservation 
compared with static 
storage for varying time 
periods
Canine segmental pancreas auto-
transplantation, Silica gel filtered 
plasma, perfusion at 30mmHg
Static cold storage better than 
machine perfusion67
Author Description of study
Details of animal model & machine 
perfusion model
Conclusion
Toledo-
Pereyra et 
al.[174]
Machine perfusion for 24 
and 48 hours compared with 
fresh pancreases
Canine islet auto-transplantation, 
Cryo-precipitate based pulsatile 
perfusion at 20-25 mmHg. 
Good success with 24 hour grafts, 
poor outcome with 48 hour grafts
Kenmochi et 
al. [175]
Non-heart-beating-donor 
pancreases preserved with 
machine perfusion for one 
hour
Canine segmental pancreas 
transplantation, Cryo-precipitated 
plasma, pulsatile perfusion for one 
hour, 50 mmHg
Tissue flow rate predicts super-
oxide dismutase levels in the 
pancreas and post-transplant 
function
Leeser et 
al.[169]
Pancreases preserved by 
machine perfusion or static 
cold storage 
Human pancreas- in vitro study, 
Pulsatile perfusion with UW solution, 
30-35mmHg pressure
Perfused pancreases had higher 
islet yields and in vitro function 
when compared to static storage. 
Taylor et al.
[170]
Porcine pancreases 
preserved for 24 hours by 
machine perfusion or static 
cold storage
Porcine pancreas-in vitro study, 
Pulsatile perfusion with KPS-1 
solution, 10mmHg pressure
Perfused pancreas had higher 
islet yields. They also had more 
uniform digestion and fewer 
entrapped islets.68
1.11.4 Venous oxygen persufflation
This method comprises the gaseous oxygenation of the graft through the venous 
side of the vascular system. The oxygen reaches all parts of the graft through 
the capillaries and escapes through small incisions or punctures made on the 
graft  surface.  During  this  process,  the  graft  is  placed  in o rgan  preservation 
solution maintained at 4°C. The technique of venous oxygen persufflation was 
described in early 1970’s by Isselhard and co-workers [176, 177]. Rolles and co-
workers in 1984 [178] studied the effectiveness of oxygen persufflation in the 
preservation of canine kidneys after 30 and 60 minutes of warm ischemia. They 
reported good post transplant function in grafts with 30 minutes warm ischemia 
and 48 hours preservation with oxygen persufflation. Persufflation with air was 
not as effective as pure oxygen and inert gases were completely ineffective in 
conferring any benefit. In a pilot clinical trial, the same group [179] reported data 
from  10  pairs  of  non-heart-beating-donor  kidneys, one  of e ach  pair  was 
preserved  by  oxygen  persufflation  and  the  other  by  static  cold  storage.  Two 
grafts from the persufflation group were lost  compared to one graft from the 
static group. Kidneys in the persufflation group had a shorter period of delayed 
graft function and lower creatinine levels. However, the numbers were too small 
to reach statistical significance.
There  is  a  now  a  large  amount  of e xperimental  data  supporting  the  role  of 
venous  oxygen  persufflation  in i mproving  preservation  of n on-heart-beating-
donor kidneys, livers[180] and heart[181]. The importance of using anti-oxidants 69
such as super-oxide dismutase or taurine during this method of preservation is 
well  documented  [182,  183].   M ultiple  mechanisms  have  been  postulated  to 
explain  the  beneficial effect  of oxygen  persufflation.  Minor and  co-workers  in 
2000 investigated  this  preservation  technique  in f atty  livers  of r ats.  They 
reported decreased hepatocyte damage, decreased Kupffer cell activation and 
better  preservation  of  mitochondria  and  endothelial  cells  with  oxygen 
persufflation[184]. Other researchers have reported reduced apoptosis[185] and 
increased intra-cellular ATP levels [186] with persufflation. Saad and co-workers 
in 2001 compared the post-transplant outcome of porcine livers exposed to 60 
minutes  of  warm  ischemia  and  preserved  with  static  cold  storage  or  oxygen 
persufflation.  They  reported  100%  5-day  survival  of  pigs  transplanted  with 
persufflated  grafts,  while  no  pigs  receiving  the  static  storage  grafts  survived 
[180].  Treckmann and  co-workers  in  2006 compared  post-transplant  graft 
outcomes  of p orcine  kidneys  exposed  to  60,  90  and  120  minutes  of  warm 
ischemia. Kidneys in each warm ischaemia group were preserved by static cold 
stored or by oxygen persufflation. They reported 100% graft survival beyond one 
week in the 60 minutes warm ischaemia + oxygen persufflation group while all 
other groups had early recipient deaths or high post-transplant creatinine levels 
[187]. Treckmann and co-workers in 2008 also reported a pilot clinical study in 
which five marginal livers rejected by three other centres were preserved for a 
short period (1-3 hours) with venous oxygen persufflation. All five livers were 
transplanted.  Pre  and  post  persufflation  biopsies  showed  higher  tissue  ATP 
levels after persufflation. All grafts had immediate function and were functioning 70
at two years. Bleeding from the puncture sites was a problem in two patients 
(peri-operative bleeding in one, subcapsular haematoma in one). One patient 
had hepatic artery thrombosis which was successfully thrombectomised.  The 
authors concluded that venous oxygen persufflation in the clinical liver transplant 
setting was feasible and that it improved aerobic metabolism and post-transplant 
graft function[188].
The utility of venous oxygen persufflation to preserve pancreas grafts has not 
been investigated. While the chief concern with this technique in solid organ 
transplantation was the risk of gas embolism after transplantation this is not an 
issue in islet transplantation. It is possible that the dissection of tissue planes 
that is caused by the persufflation may aid pancreas digestion. The anatomy of 
the pancreatic venous drainage involves multiple small venules draining into the 
splenic vein and proximal superior mesenteric vein. The latter two join to form 
the  portal  vein.  Oxygen  persufflation  through  the  portal  vein  should  hence 
oxygenate the pancreas, spleen and the duodenum. 
1.12 Summary of literature review
Pancreatic  islet  transplantation  is a  t herapeutic  option  in  carefully s elected 
patients with type 1 diabetes. Successful islet transplantation depends on the 
transplantation  of  sufficient  number of viable  islets and minimising  early  islet 
loss. Non-heart-beating-donors are not routinely  used for islet transplantation. 
Static cold storage is not optimum for the preservation of pancreases damaged 71
by warm ischaemia. The two layer method of preservation has shown promising 
results in the experimental setting, but its advantage over static cold storage in 
the clinical setting is still unclear. Hypothermic machine perfusion and venous 
oxygen persufflation both have theoretical benefits over static cold storage and
the two layer method. Their role in preservation of pancreases in the non-heart-
beating-donor setting has not been investigated in any detail. This project aims 
to bridge that gap.72
1.13 Research Hypothesis
The hypothesis tested in the present study is that ‘pancreatic damage caused by 
warm  ischaemia  can  be  ameliorated  by  improved  methods  of  pancreas 
preservation’.
1.14 Research aims
The main aims of the study defined for testing the research hypothesis were as 
follows.
 Develop a model of non-heart-beating-donor rat pancreas retrieval and 
preservation.
 Compare  the  yield  of  islets  isolated  from  non-heart-beating-donor  rat 
pancreases  preserved  with  static  cold  storage,  hypothermic  machine 
perfusion, and portal venous oxygen persufflation.
 Compare the severity of reperfusion injury after in vitro  warm reperfusion 
of n on-heart-beating-donor  rat  pancreases  preserved  by  static  cold 
storage and portal venous oxygen persufflation.
 Compare  the  gene  expression  profile  of  non-heart-beating-donor  rat 
pancreases preserved by static cold storage and portal venous oxygen 
persufflation after in vitro warm reperfusion. 73
2.1 Experimental design
The study was designed in two phases (Figure 8). 
Phase I of the study investigated the relative benefits of hypothermic machine 
perfusion, portal venous oxygen persufflation and two-layer method in improving 
islet yield from non-heart-beating-donor rat pancreases as compared to static 
cold storage. An additional group of pancreases with no warm ischaemia also 
underwent islet isolation and assessment to act as a positive control.
Phase II of the study compared the severity of reperfusion injury in non-heart-
beating-donor rat pancreases preserved by static cold storage or portal venous 
oxygen  persufflation  followed  by  in v itro warm  oxygenated  reperfusion. 
Pancreatic tissue removed from freshly killed rats was used as a control group. 
RNA  extracted  from t he  pancreases after  in v itro reperfusion was  used  for 
microarray analysis. The differential expression of genes in each preservation 
group  when  compared  with  control  pancreatic  tissue  was  used  to  identify 
differential activation of pathways pertaining to ischaemia reperfusion. 
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Figure 8 Flow-chart depicting the overall plan of study
Develop a non -heart-beating -donor rat 
pancreas preservation model
Compare the islet yield from pancreases 
preserved by hypothermic machine 
perfusion and portal venous oxygen 
persufflation with static cold storage
Choose the preservation method 
    with the best islet yield
Investigate the extent of ischaemia -
reperfusion injury in pancreases preserved 
by the chosen preservation method using 
an in vitro warm reperfusion model
Explore the gene expression profile in
rat pancreases preserved with the 
chosen preservation method75
2.2 Materials
General laboratory glassware and plastic-ware including pipettes, pipette tips, 
tubes, tissue culture flasks, multi-well plates, slides, cover slips, were supplied 
by Bibby Sterilin, unless otherwise stated.
Chemicals,  solvents,  reagents  were  of  Analytical  Reagent  (AR)  grade.  All 
chemicals were obtained from Sigma Aldrich (St.Louis, Mo) unless specified. 
Water was purified through a Milli Q ion exchange system (Millipore UK) for use 
in the preparation of aqueous solutions. Full list of reagents and equipment used 
is detailed in appendix 1
All tissue culture ware and consumables were sterilised by autoclaving at 121°C 
for 15 minutes. Reagents for islet culture media were already sterile and used 
directly or were filter-sterilised using a 0.2micron filter prior to use. University of 
Wisconsin  solution  was  stored  at  4°C.  Pancreas  recovery,  preservation  and 
digestion for islet isolation was carried out in clean but not sterile conditions. 76
2.3 Methods
2.3.1 Preparation of reagents and media
Wash medium for washing steps during islet isolation
To make 500 ml of wash solution, 50ml of 10X concentrated HBSS solution was 
added  to  450ml  of a utoclaved  de-ionised  water.  To t his  solution,  0.5g  of 
anhydrous  glucose,  175mg  of sodium  bicarbonate  and 2.5g  of bovine serum 
albumin were added and gently mixed. The pH was adjusted to 7.4. 
Collagenase solution for pancreas digestion
10mg of Collagenase P was weighed out carefully and transferred to a 20ml 
universal container. 10ml of HBSS solution (without bovine serum albumin) was 
added  and  mixed  gently. T he  solution  was  prepared  fresh  prior  to e ach 
pancreas  digestion.  The  prepared  solution  was  kept  on  ice and  used 
immediately.
Molar  glucose  solution  for  static  glucose  stimulated  insulin  secretion 
assay
7.2g of anhydrous glucose was weighed and transferred to a 50ml centrifuge 
tube. 40ml of autoclaved de-ionised water was added. The tube was warmed in 
a water bath to 37°C and mixed to ensure complete dissolution. The solution 
was sterilised by filtering through a 0.2µm syringe filter into a sterile centrifuge 
tube. The stock solution was stored at 4°C. 77
Islet culture medium
To make 500ml of sterile culture medium, 430ml of Dulbecco’s Modified Eagle 
medium was transferred aseptically to an autoclaved glass bottle. 50 ml of foetal 
calf serum, 5.5ml of 1M glucose, 10 ml of Penicillin-streptomycin solution, 5ml of 
Amphotericin B were added. The medium was prepared under an aseptic hood. 
It was stored at 4°C. 
Islet  incubation  medium  for  static  glucose  stimulated  insulin  secretion 
assay
Glucose free medium was prepared aseptically by adding 2.5g of bovine serum 
albumin,  5ml  of 1 M  Hepes,  and  L-Glutamine  (final  concentration  of 2 mM)  to 
500ml of Glucose free Dulbecco’s Modified Eagle Medium. The medium was 
stored at 4°C.
High glucose incubation medium (medium with 40mM glucose) was prepared by 
adding 830  microlitre of sterile 1M  glucose  solution to  20 ml of glucose free 
medium.  Low  glucose  incubation  medium  (medium  with  3mM  glucose)  was 
prepared  by  adding  4ml  of h igh  glucose  medium  to  50  ml  of g lucose  free 
medium.
Dithizone solution for staining islets
20mg  of d ithizone  powder  was  weighed  and  transferred  to  a  20ml  universal 
container. 2ml of dimethyl sulphoxide was pipetted into the container and mixed 78
well. 10ml of  wash medium was added and shaken vigorously. The mixture was 
filtered through a 20 micron syringe filter. The filtrate was stored at 4°C for up to 
one week.
Trypan blue solution for islet viability assessment
20 mg of trypan blue powder transferred to a 20ml universal container. 5ml of 
wash medium was added and mixed by shaking. The solution was stored at 
4°C.
Fluorescein  diacetate  /Propidium  iodide solutions  for  islet  viability 
assessment
Fluorescein  diacetate (FD) stock  solution  was  prepared  by  adding  5mg  of 
Fluorescein diacetate to 5ml of pure acetone and mixed well. This was stored in
a universal container away from light. Propidium iodide (PI) stock solution was 
prepared by adding 1ml of PI solution (1mg/ml) to 9ml of wash solution. The 
solution  was  stored  away  from  light. Working  solution  for  staining  islets  was 
prepared immediately before use. 1ml of the stock PI solution was transferred to 
a 1.5ml microcentrifuge tube. Ten microlitres of the stock FD solution was added 
and mixed well. 
Krebs- Henseleit solution for in vitro warm reperfusion experiment
450ml of autoclaved de-ionised water at room temperature was transferred to a 
1 litre sterile flask. 4.8 g of the reagent was weighed and added to the water 79
while stirring. To the solution 0.186g of calcium chloride dehydrate was added 
and stirred until dissolved. 1.05g of sodium bicarbonate was added and stirred 
until dissolved. 50ml of autoclaved water is added to the final solution and the 
pH adjusted to 7.4 with 1N hydrochloric acid or 1N Sodium hydroxide solutions. 
The  final  composition was NaCl  (118 mM), KCl (4.9mM),  KH2PO4 (1.2  mM), 
MgSO4.7H2O (1.2 mM), Glucose (11.1 mM), NaHCO3 (25mM), CaCl2 (2.5 mM). 
It was used immediately.
Radio-Immuno-Precipitation  Assay  buffer  for  homogenisation  of 
pancreatic tissue
180 ml of sterile de-ionised water was transferred to an autoclaved glass bottle. 
The  following  were  added  in  sequence  with  continuous  stirring : S odium 
chloride:  1755  mg,  NP-40  :  2  ml,  Sodium deoxycholate:  2  g, S odium  deoxy 
sulphate: 0.2g, 1.5 M Tris HCL (ph=7.6) : 3.3 ml. The solution was made to 
200ml by adding 15ml sterile de-ionised water. The solution was stored at 4°C. 
Phenyl Methyl Sulphonyl fluoride 
PMSF  is  unstable  in a queous  solution.  Hence  a  100mM  stock  solution  was 
prepared by adding 175 mg of PMSF to 10 ml of Isopropanol). The solution was 
stored in 0.5ml aliquots at -20°C. For homogenisation of pancreatic tissue, 0.1ml 
of 100mM stock solution was added to 10 ml of cold buffer just before its use for 
homogenisation.80
2.3.2 Choice of buffers in various experiments
Several different buffered solutions and media were used at various stages of 
the study. The choice of buffer for a particular step depended primarily on the 
literature review. Buffer solutions that have been repeatedly used for a specific 
purpose in the pancreas and islet literature were used in these experiments. 
University of Wisconsin solution (Viaspan™) was used for aortic flushing and 
preservation of the pancreas. This is a organ preservation solution with ionic 
composition similar to the intra-cellular fluid. This is the current standard of care 
in clinical pancreas preservation. 
Ringer's lactate solution has composition similar to extracellular fluid. It is cheap 
and easily prepared in the lab. It was  used for the irrigation of the pancreas 
during the retrieval procedure.
Hanks' buffered salt solution has been widely used for experimental and clinical 
islet isolation[189]. It is relatively cheap and was available as a concentrated 
solution that could be made up to the correct strength with sterile water.
Dulbecco’s Modified Eagle medium is a cell culture medium enriched with amino 
acids and vitamins. They provide essential nutrients needed for cells and tissues 
to remain viable. DMEM with additives was used for islet culture. It was also
used for the in vitro glucose stimulated insulin secretion assay as the glucose 
free version was commercially available. This enabled the preparation of DMEM 
with high and low glucose concentrations to be used for the assay.81
Krebs-Henseleit solution has been extensively reported in the literature for use 
in  in v itro reperfusion  experiments.  Hence this  was  used  in t he  oxygenated 
reperfusion experiments [190-192].
2.3.2 Techniques of pancreas preservation
Static cold storage of pancreas
The prepared pancreas was stored in a closed chamber containing ice-cold UW 
solution. The chamber was placed in a cold bath containing crushed ice.
Two layer method
50ml  of P erfluorocarbon  solution  was o xygenated  by b ubbling  pure  oxygen 
through it for at least 30 minutes prior to start of preservation. The retrieved 
pancreas was placed in the PFC. 100ml of cold UW solution was layered over 
the  pancreas.  The  pancreas  remains  at t he  interface  of  the  PFC  and  UW 
solution layers. Oxygenation of the PFC was continued during the preservation 
period.
Hypothermic Machine perfusion
UW solution was used as a perfusion fluid for machine perfusion. The pancreas 
was  placed in a chamber containing the preservation solution. This chamber 
was placed in crushed ice to maintain a temperature of around 4°C (Figure 9).
The perfusion circuit was powered by a peristaltic pump (Watson Marlow 323). A 
0.2µm filter was included in the circuit to trap and prevent particulate material 
from  entering  the  pancreatic  circulation. With  the  help of  a  Y  connector  the 82
circuit at the pancreas end was connected through high pressure tubing to a 
digital pressure monitoring device. After initial trials, the perfusion flow rate was 
fixed  at 3 rpm  which  gave  an  average  flow  rate  of 0 .27ml/min.  This  gave  an 
approximate  flow  rate  within  the  pancreas  of 0 .03ml/gram/min  (taking  the 
average weight of the retrieved pancreas-duodenum-spleen as 9 grams). This 
provided a perfusion pressure between 10-15mmHg.
Portal venous oxygen persufflation 
The pancreas was placed in a chamber containing ice-cold UW solution. This 
chamber was placed in crushed ice to maintain a temperature of around 4°C. 
Medical grade oxygen at low pressure was filtered through a 0.2µm syringe filter 
and  connected  to t he  portal  vein  cannula  for  controlled low  pressure 
persufflation  of  the  pancreas.  The  persufflation  pressure  was c onstantly 
monitored  by  a  digital  pressure  monitoring  device  using  a  Y  connector.  The 
initial oxygen flow rate was set to obtain a persufflation pressure between 10-15 
mmHg (Figure 10).
At the start of persufflation the oxygen entering the portal circulation was seen to 
gradually distend the capillaries on the surface of the pancreas, duodenum and 
spleen.
Using a hypodermic needle, punctures 1mm deep were made on the surface of 
the spleen to release the gas bubbles and partially decompress the circulation. 
The  oxygen  flow  was  then  adjusted  to  maintain t he  desired  persufflation 
pressure.83
Significant leaks  were  identified  at  the  start  of  persufflation  and  repaired  by 
suture ligation. If leaks could  not be repaired satisfactorily the pancreas  was 
discarded.
Figure 9 Schematic representation of the hypothermic machine perfusion circuit used for 
rat pancreas preservation84
Figure 10 Schematic diagram of the circuit used for rat pancreas portal venous oxygen 
persufflation85
Chapter 3 Method development & optimization
3.1 Development of the animal model
3.1.1 Background
Research in pancreas preservation using hypothermic machine perfusion and 
the two layer method has been carried out in the rat model[57, 193], canine 
model[174, 175, 194] and the pig model[195]. Surgical techniques to retrieve the 
rat  pancreas  have  been  previously  described[196].  These  reports  of t he 
procedure  have  involved  retrieval  from  anaesthetised  rats  under  controlled 
circumstances. In view of limitations due to Home Office license requirements;
this method could not be adapted directly for our purpose. Our group has gained 
experience of retrieving kidneys from schedule I killed non-heart-beating-donor 
rats. We aimed to extend these principles to retrieving rat pancreas.    
The aim of the following experiments was to develop a reproducible model of 
non-heart-beating-donor rat pancreas retrieval. This included standardization of 
the  durations  of  warm  ischaemia  and  the  total  retrieval  procedure.  The 
procedure should result in a pancreas with an intact vascular supply suitable for 
preservation  by  static  cold  storage,  hypothermic  machine  perfusion  or  portal 
venous oxygen persufflation. The technique aimed to simulate the temperature 
changes (initial warm ischaemia, rapid cooling by aortic flush, and maintenance 86
of cooling during the cold dissection phase) in a standard  non-heart-beating-
donor donor during the retrieval process. 
3.1.2 Evolution of pancreas preservation models
Male Wistar rats were used as pancreas donors. The weight range of the rats 
was limited to 350-400g as dissection and safe retrieval of the pancreas was 
difficult in smaller rats. Rats larger than 450g were avoided as excessive intra-
abdominal fat complicated pancreas retrieval. 
In-situ preservation model
The animal was killed by a Schedule 1 method (knock on the head or cervical 
distraction).  After  the  pre-defined  warm  ischaemia  time,  a  laparotomy  was 
carried  out.  The  abdominal  aorta  was c annulated  and  flushed  with  cold 
University of Wisconsin solution and vented through the intra-thoracic IVC. The 
whole animal was then submerged in a tub containing cold preservation solution 
and machine perfusion was instituted through the aorta.
This was technically simple and caused no trauma to the pancreas. However the 
problem  of f requent  blockage  of  the  perfusion  circuit  filter  with  debris  was 
difficult  to  manage.  Prolonged  perfusion  lead  to e xcessive  distension  and 
rupture  of t he  small  bowl  leading  to  faecal  contamination. This  model  also 
involved  the  use  of  large  volumes  of e xpensive  preservation  fluid  for  the 
immersion of the entire animal.87
Visceral block model
The  animal  was  killed  by a  S chedule  1  method.  After  the  pre-defined  warm 
ischaemia period, laparotomy was carried out and abdominal aorta was flushed 
with  University  of  Wisconsin  solution.  The  pancreas,  proximal  small  bowel, 
kidneys, liver and stomach was retrieved along with the abdominal aorta, portal 
vein  and  inferior  vena  cava  (Figure  11).  This  was  then  immersed  in c old 
preservation solution and preserved. 
This model had the advantage of being technically simple and less traumatic for 
the pancreas itself. However the problem with excessive small bowel distension 
persisted.  Leakage  of p reservation  fluid  from s mall  arteries  was  inevitable.  
Perfusion/  persufflation  of m ultiple  organs  along  with  the  pancreas  made 
measurement  of  the  actual  perfusion/  persufflation  pressure  in t he  pancreas 
inaccurate.
Isolated pancreas model 
In view of these problems, an isolated pancreas+ duodenum+ spleen model was 
developed.  This  was  an  adaptation  of a  p reviously  published  method  of r at 
pancreas recovery  with  minimal circulatory impairment [196]. This model has 
several advantages. Changes in vascular resistance during preservation would 
primarily be due to changes in the pancreatic vascular bed itself. This model 
best approximated the clinical situation where the pancreas is retrieved along 
with the duodenum and spleen. The model provided reliable access to both the 
arterial  (aorta)  and  venous  (portal  vein)  sides  of t he  pancreas  for  machine 
perfusion and gaseous persufflation respectively (Figure 14).88
The problems  with the isolated pancreas  model w ere  essentially technical. It 
involved prolonged dissection which increased the risk of rewarming. Capsular 
tears and leaks from the vascular system were common due to the fragile nature 
of the rat pancreas, leading to wastage of organs.89
Figure 11 Visceral block model of pancreas retrieval
The  visceral  block  model  of  pancreas  retrieval  involved  removal  of the  liver, 
stomach, duodenum and proximal jejunum, pancreas and spleen. together. The 
photograph  shows  the  prepared  block  with  the  aortic(1)  and  portal  vein  (2) 
cannulas. A silastic catheter in the bile duct(3) is also seen. 
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Figure 12 Technique of Non-heart-beating-donor rat pancreas retrieval-initial dissection
The initial dissection of mobilising the stomach (1) by dividing its peritoneal 
attachments is shown. Gauze swabs soaked in warm Ringer's lactate solution (2) are 
used to cover the pancreas (3) during the dissection phase to maintain its temperature 
close to 37°C to simulate warm ischaemia. 
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Figure 13 Technique of non-heart-beating-donor rat pancreas retrieval- in situ aortic flush 
with cold university of Wisconsin solution
The pancreas and spleen (A) has been fully exposed by removing the stomach and 
ligating the proximal duodenum (B). The common bile duct has been cannulated by a 
fine silastic cannula (C). The aortic cannula (D) is connected to a perfusion pump and is 
flushed with cold University of Wisconsin solution. The pale pancreas following cold 
flush is clearly seen.
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Figure 14 The retrieved non-heart-beating-donor rat pancreas with adjoining duodenum 
and spleen in the preservation chamber
The prepared rat pancreas is placed in the preservation chamber (A) containing cold 
university of Wisconsin solution. The chamber is placed in a box containing crushed ice 
(B) to maintain the temperature at 4°C. The aortic cannula (C), portal vein catheter (D) 
and bile duct catheter (E) are seen. The pancreas is being persufflated through the 
portal vein cannula. Gas bubbles escaping through the spleen surface can be seen (F).
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3.1.3 Technique of isolated pancreas retrieval
The retrieval process lasted about 65 minutes. The procedure was divided into 
four phases.
The first phase (warm ischaemia period) lasted 35 minutes. This started with 
cardiac  arrest  and  lasted  until  start  of a ortic  flush  with  cold  University  of 
Wisconsin solution. During this period, the peritoneal cavity and  organs were 
kept warm by regular irrigation with warm Ringer’s lactate solution (37°C) and 
the pancreas, duodenum and spleen were kept covered with swabs soaked in 
warm  saline.  Five  minutes  before  completion  of  this  phase,  10,000  units  of 
streptokinase dissolved in 1ml of Ringer’s lactate solution was injected into the 
aortic  cannula.  Streptokinase  stimulates  thrombolysis.  This  was u sed  in  the 
model as an initial flush to lyse clots formed during the warm ischaemia period 
and improve the quality of perfusion. The benefit of using thrombolytic agents in 
non-heart-beating-donor has been proven [197]. The dose used in the study was 
calculated by using data from non-heart-beating-donor kidney preservation. 
The second phase lasted 5 minutes. This started with aortic flush with cold UW 
solution  and  simultaneous  external  cooling  of  the  pancreas  by  flooding  the 
peritoneal cavity with ice cold Ringer’s lactate solution. Twenty millilitres of UW 
solution was injected into the aorta at a rate of 200ml/hr using a syringe pump. 
The third phase lasted 15 minutes. During this period dissection of the pancreas 
was completed. Aortic perfusion with cold UW solution continued at a slower 94
rate of 20ml/hr during this phase. Swabs soaked in cold Ringer’s lactate solution 
were used to keep the pancreas cold during this period.
The  fourth  phase  lasted  5-10  minutes.  The  pancreas  was  transferred  to  a 
petridish. It was gently flushed with cold UW solution to identify any leaks. Any 
identified leaks were sutured. The pancreas was flushed finally with 2ml UW 
solution containing 1000U of superoxide dismutase. Super-oxide dismutase is a 
free-radical  scavenger.  Its  benefit  in  preventing  free-radical  injury  in  livers 
preserved by venous oxygen persufflation has been reported in  experimental 
studies[198].  We i ncluded  it  as  a  step  in  all  preservation  arms  to  ensure 
uniformity.  The  dose  used  was  calculated  from the  dose  used  in  published 
studies of liver  preservation [180].
3.1.4 Procedure of non-heart-beating-donor rat pancreas retrieval
 The animal was killed by a Schedule I method (blow on the head and 
cervical distraction). It was placed on the dissecting table supine with its
tail end towards the operator. 
 70% ethanol was sprayed on the abdomen and thorax. A midline vertical 
incision was made with transverse extensions at the level of the costal 
margins to improve exposure.
 Dissection  was  started  by  separating  the  colon  and  caecum  from  the 
pancreas and the duodenum. The middle colic and right colic pedicles 
were ligated and cut.95
 The proximal jejunum was mobilised by dividing the mesenteric vessels 
after ligation. 
 The root of mesentery with the SMA and the SMV was suture ligated and 
divided.
 Mobilisation was continued  by  dividing the gastro-splenic ligament and 
greater  omentum.  The  short  gastric  and  the  left  gastric  pedicles  were 
ligated and cut close to the fundus (Figure 12).
 The stomach was divided at the pyloro-duodenal junction after closing the 
duodenum  with  a  heavy  suture.  The  stomach  was  removed  from  the 
abdomen by dividing at the gastro-oesophageal junction to fully expose 
the pancreas. 
 The animal was turned 90° i.e. head towards the surgeon's left.
 The  duodenum  was  retracted  to  the  left  of  the  animal  to  expose  the 
common bile duct and portal vein at the hepatic hilum.
 A fine cut was made in the duct with micro-scissors distally (towards liver) 
and a fine cannula was passed through the incision towards the pancreas 
and secured with fine ties.
 The portal vein at hilum was cut partly to insert a short & wide silastic 
cannula  towards  the  pancreas.  Care  was  taken  not  to o cclude  the 
junction  of  splenic  vein  into  the  portal  vein.  The  cannula  was  fixed  in 
position with ties.96
 The portal structures were sutured ligated with prolene suture to secure 
the  cannula in p osition and  also  ligate  the  hepatic  artery  which  would 
otherwise leak during machine perfusion.
 The infra-renal aorta was dissected and cannulated. 
 The supra-coeliac aorta at the diaphragm was looped and ligated.
 After completion of warm ischaemia period, 10000 U of streptokinase in 
1ml normal saline was injected into the aortic cannula. 
 This was followed after 2minutes with cold UW  flush (20 ml) through the 
aortic cannula. The flush was done using a syringe driver pump initially 
set to deliver UW solution at a rate of 100ml/hr for the first 10ml and then 
reduced to 20ml/hr for the next 10 ml.
 Good perfusion was confirmed with the efflux of blood through the portal 
vein  cannula  and the pancreas  and  duodenum becoming  pale (Figure 
13).
 Simultaneous  external  cooling  of  the  pancreas  and  duodenum  was 
started by irrigation with cold saline and swabs soaked in ice-cold saline.
 The  portal  structures  were  divided  close  to  the  liver  and  above  the 
ligatures for the bile duct and portal vein to separate the pancreas block 
from the liver.
 The pancreas was immediately rinsed in a petri-dish containing ice-cold 
Ringer's lactate solution and transferred to another petridish containing 
cold UW solution. 97
 Using 5ml of cold UW solution to flush the aortic cannula, the pancreas 
was examined for leaks which if present were ligated.
 Super-oxide dismutase (1000units in 2ml of University of Wisconsin) was 
flushed through the aortic cannula as the final step.
 The weight of the pancreas was recorded.
3.1.5 Temperature control during pancreas retrieval
The period of warm ischemia was simulated by keeping the pancreas moist and 
warm  at  37°C  during  the  initial  30  minutes  of  the  dissection.  This w as  then 
changed to external cooling from the time of the aortic flush. 
To  evaluate  the  temperature  control  during  the  entire  dissection  period, 
continuous  temperature  monitoring  was  carried  out  in t hree  animals.  Three 
temperature probes were placed in the duodenal lumen, spleen and in the neck 
close to the carotid vessels immediately after laparotomy. One probe was left 
outside to record the ambient lab temperature. The temperature readings in the 
four  probes  were  recorded  continuously.  This  showed  a  gradual  fall  in  the 
pancreas temperature to 30°C during the warm phase followed by a sharp fall 
during aortic flush to around 8°C. The temperature remained around 10°C -15°C 
during the remaining duration of the retrieval procedure (Figure 15). 98
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Figure 15 Line chart demonstrating the trend in temperature recordings in four probes 
during one rat pancreas retrieval procedure
Three temperature probes were placed in the rat immediately after laparotomy. Probes 
1 and 2 were placed in the duodenum and in the spleen respectively. Probe 3 was placed 
in the neck to monitor temperature changes in the rat away from the operative zone. 
Probe 4 was left exposed to measure ambient lab temperature. Temperature recordings 
were made automatically at 2 minute intervals throughout the retrieval procedure. 
Recordings were started 10 minutes before start of dissection and stopped when the 
pancreas was removed from the rat abdomen (end of phase 3 of the retrieval)
Channel 1: Duodenum Channel 2: Spleen
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3.2 Batch testing of collagenase
Collagenase is a proteolytic enzyme that is used extensively for islet isolation 
from pancreas. Batch to batch variability is a well known problem with the use of 
this enzyme. Gradual decline in the potency of the enzyme during storage has 
also  been  reported.  Variation  in  potency  may a ffect  the  completeness  of 
digestion of pancreases. 
In an  attempt to overcome this problem, periodic assessment of collagenase
activity was done to adjust the duration of pancreas digestion.
Collagenase P was stored at 4°C in a sealed container. The collagenase activity
was  assessed  at  approximately  2  monthly  intervals.  Freshly  retrieved  rat 
pancreas was distended with 10 ml of collagenase solution in HBSS (1mg/ml). 
The  distended  pancreas  was  bluntly  divided  into  two  parts  and  incubated  in 
universal containers in a water bath at 37°C. After 30 minutes of incubation, the 
tubes  were  gently  shaken  to  disrupt  the  pancreas.  Intermittent  sampling  of 
digest from the two tubes was done every 4 minutes. The sampling was done 
alternately so that one tube was sampled every 2 minutes. In between sampling 
the  tubes  were  incubated  in  the  water  bath.  The  samples  were  immediately 
stained with dithizone. The time point when free islets were present in the digest 
was noted. This was used as the guide for the optimum duration of pancreas 
digestion.  In  practice  the  actual  time  was  2-3  minutes  longer  than  the  time 
identified from these experiments.  The duration of incubation of the pancreas 100
for optimum digestion increased from 40 minutes immediately after purchase of 
the collagenase preparation to 52 minutes towards the end of its shelf-life.101
3.3 Effect of increasing warm ischaemia time on total islet yield 
and viability
3.3.1 Background 
Increasing warm ischaemia times are associated with decreasing islet yield and 
poor  islet  viability[199].  Previous  studies  have  reported  that  warm  ischaemia 
periods of 30 minutes or more are associated with a significant decrease in islet 
yield[46]. This experiment was planned to study the effect of increasing warm 
ischaemia duration on islet yield. The aim of these experiments was to identify a 
warm ischaemia duration that would lead to 50% decrease in islet yield. This 
would  provide  a  useful  point  from  where  to  compare  various  preservation 
techniques for their ability to improve islet yield.
3.3.2 Methods
Male Wistar rats were used as pancreas donors. The animal was killed by a 
schedule I method. Laparotomy was carried out after various durations of warm 
ischaemia (0, 15, 30, 45 or 60 minutes). The pancreas and the common bile 
duct  were  identified.  The  common  bile  duct  was  cannulated and 10mg 
collagenase (1mg/ml) was injected into the common bile duct. The distended 
pancreas was bluntly dissected out and transferred to a universal container. The 
pancreas digestion technique is described in detail elsewhere (section 4.2.2). 
The crude islet yield was calculated by counting dithizone stained islets in the 
digest. Density gradient separation was not used for this experiment. Islets from 102
the  digest were hand-picked  under the microscope and cultured overnight at 
37°C. Islet viability was assessed with trypan blue exclusion staining. The crude 
islet count and viability were compared using the analysis of variance (ANOVA) 
test.  
3.3.3 Results
The crude islet counts ranged from 140 to 1600 islets per pancreas. Pancreases 
with no warm ischaemia produced the largest number of islets. There was a 
significant decrease in crude islet yield with increasing warm ischemia period 
(ANOVA, p<0.001). A warm ischaemia of 30 minutes lead to a 65% fall in crude 
islet  count  (Figure  16).  Viability  was  lower  following  longer  periods  of w arm 
ischaemia; however the difference was not significant (ANOVA, p=0.163).  Islets 
isolated from pancreases with 60 minutes warm ischemia were misshapen and 
irregular as compared to islets from pancreases with shorter warm ischaemia 
times (Figure 16).
3.3.4 Discussion
The  experiment  showed  that  increasing  warm  ischaemia  time  decreased the 
crude  islet  count.  The  decrease  was  most  significant  with  warm  ischaemia 
periods of more than 15 minutes. Very few islets were obtained after 60 minutes 
of warm ischaemia. The decrease in islet viability with longer ischaemia times 
did not reach levels of statistical significance. Hand picking islets from the digest 
for culture would have introduced a confounding factor in viability assessment. 
Hand-picking depends on the identification of islets based on morphology. It is 103
possible  that  non-viable  islets  (which  have  deformed  morphology)  may  have 
been picked less often. 
Based on these data it was decided to develop a non-heart-beating-donor rat 
pancreas model with warm ischaemia duration of 30 minutes. This experiment 
also  demonstrated  the  inherent  problem  with  crude  islet  counts  and  hand-
picking of islets. Density gradient purification of pancreatic digest was used for 
the rest of the islet experiments to obtain good numbers of representative islets 
to enable viability and in vitro function testing.104
Figure 16 Effect of increasing warm ischaemia duration on islet yield and islet viability
Each point of the graph denotes islet isolated from a single rat pancreas. Graph A 
shows a linear decrease in crude islet yield with increasing warm ischaemia. Warm 
ischaemia of 30 minutes produced a 65% decrease in crude islet yield. Graph B shows a 
decrease  in  islet  viability  with  increasing  warm  ischaemia  times.  The  decrease  in 
viability was however not consistent (discussed in text)
Graph A
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3.4 Optimisation of Static Glucose Stimulated Insulin Secretion 
assay
3.4.1 Background
Numerous  techniques  exist  for  the  assessment  of i slet  function.  The  most 
accurate  method  is  their  ability t o  correct  hyperglycaemia  following 
transplantation  into  immuno-deficient  diabetic  mice.  Routine  utilisation  of  this 
technique is expensive and time-consuming. The test is irrelevant in the clinical 
setting as results from these experiments will be available long after the islets 
had been transplanted. In vitro methods of testing for islet function have been 
based  on  the  ability  of  functional  islets  to s ecrete  insulin  in r esponse  to 
glycaemic  stress,  measurement  of  oxygen  consumption  of  the  islets[200], 
ADP/ATP ratio[201] and the levels of stimulated and basal ROS levels in an islet 
isolate[145]. 
The Static Glucose Stimulated Insulin Secretion test was used to assess the in 
vitro
function of  the  islets  in  our  study.  It  was  based  on  the  principle  that  viable 
functioning islets produce insulin when exposed to glucose[202]. The amount of 
insulin produced depends on the concentration of glucose in the islet medium. 
Thus by exposing aliquots of islets to serial high and low glucose concentrations 
it  was  expected  that  viable  islets  will  produce  more  insulin  in  high glucose 
containing  medium.  Non-viable  islets  on  the  other  hand  do  not  show  a 
differential  response  in  insulin  production  to  different  glucose  concentrations. 
The ratio of insulin secreted at high glucose to the insulin at low glucose is the 106
stimulation  index[28,  203].  Studies  have  shown  that  the  results  from  GSIS 
assays have poor correlation with post-transplant function. Documentation of a 
biphasic response of islets to a glucose challenge with a return to baseline was
suggested  as  an essential  criteria for  suitability f or  transplantation[204].
Stimulation indices of clinically transplanted islets ranges from 2-4[28].
3.4.2 Initial protocol of static glucose stimulated insulin secretion 
test
Dulbecco’s Modified Eagle Medium with low or high Glucose (2.5mM or 20mM) 
concentrations was used as the incubation media in initial trials. Purified islets in 
islet culture medium were transferred to a petridish. A 12 chamber culture plate 
was  pre-filled  with  2ml  of  low  glucose i ncubation  medium.  10  islets  were 
transferred  to e ach  well.  The  contents  of e ach  well  were  mixed  by  gentle 
pipetting using a sterile Pasteur’s pipette. The islets were allowed to settle for 5 
minutes. The top 1.5ml of the incubation medium was removed and replaced by 
fresh low glucose incubation medium twice. The  islets were  incubated in the 
wells for one hour. At the end of this period, the contents of each well were 
again  gently  mixed  and  the  supernatant  pipetted  off  after  5  minutes.  The 
procedure  was  repeated  except  that  either  high or  low  glucose  containing 
incubation medium was added to alternate wells. Three repeats of each isolate 
under high and low glucose incubation were done. The islets were placed in a 
shaker set at 50 rpm in a walk-in incubator at 37°C. At the end of two hours the 
contents  of  each  well  were  transferred  to  1.5ml  micro-centrifuge  tubes  and 107
centrifuged at 17500g for 2 minutes. The supernatant was collected in labelled 
micro-centrifuge tubes and stored at -80°C for future analysis.  
This technique was used for the initial 16 isolates. These included 7 control, 3 
machine perfusion, 3 cold storage and 3 oxygen persufflation pancreases. This 
technique however caused a wide variation in the insulin levels and stimulation 
index of individual sets (Figure 17).
In view of the poor consistency of results the technique was reviewed to identify 
areas  of  improvement.  Three  major  areas  were  identified  and  corrective 
modifications were made to the procedure. 
1. Picking islets under the microscope using a pipette was time-consuming. It 
was difficult the keep track of the individual sizes of the islets in individual wells. 
The number of islets left in each well after the washes were found to be highly 
variable.  It  was  felt  that  the  process  of  repeated  pipetting  to p ick  islets  was 
traumatic to the islets. 
We attempted to improve the consistency by using the same set of islets for 
serial low  and high glucose incubations. However this led to very low insulin 
secretions in the high glucose phase. Viability staining of islets after 5 hours in 
the incubation medium showed that the majority of islets were non-viable. 
The  technique  was  modified  so  that  50%  of  the  islets  isolated  from  each 
pancreas  were  used  for  the  assay  after  overnight  culture.  The  islets  were 
washed in low glucose medium twice by centrifugation at 100g for 1 minute. The 
pellet was uniformly suspended in 2ml of low glucose medium and 200µl of the 108
suspension was used in each well instead of picking up individual islets. This 
provided more consistency in the number of islets in each well.
Figure 17 Bar graph showing the variation in the stimulation indices of the replicates in 
an initial series of 16 static glucose stimulated insulin secretion assays
Bar chart summarizing the results of the initial glucose stimulated insulin secretion test. 
Sixteen isolates were assessed. The individual replicates for each isolate are represented 
by the different coloured bars in each isolate on the horizontal axis. The stimulation 
index is shown on the vertical axis. There was wide variation in the stimulation indices 
of the replicates for each isolate.109
2. The use of the walk-in incubator led to excessive evaporation of the medium 
from the wells. This was evident as condensation on the inside of the cover. This 
had the potential of changing the concentration of various components in the 
incubation fluid. This was evident by the change of the colour of the ph indicator 
in  the  medium  to  a  very  bright  pink.  10mM  Hepes buffer was  added  to  the 
incubation medium to counteract the change in pH on incubation. Attempts at 
incubating the plates in a closed water bath did not completely correct these 
problems and was prone to mishaps. The most consistent results were obtained 
by placing the incubation plate in a table top incubator containing 5% CO2 along 
with intermittent manual shaking of the plate.
3. The insulin production remained low even in the control islets using the above 
mentioned  medium.  Following  further  review  of  the  literature,  additives  were 
added to the incubation medium to improve the insulin secretion from the islets. 
Addition of 0.5% Bovine serum albumin and 2mM Glutamine improved insulin 
secretion. 110
3.4.3 Final protocol for static glucose stimulated insulin secretion 
assay
Incubation medium (Glucose free DMEM supplemented with 0.5% Bovine serum
albumin, 10mM Hepes, 2mM Glutamine) was used for the stimulation studies. 
High glucose medium (with 40 mM glucose) and low glucose medium (with 3 
mM glucose) were prepared from the sterile incubation medium and warmed to 
37°C in a water bath.
Islets after overnight incubation were washed twice in low glucose medium by
centrifugation (100g for 1 minute). The islet pellet was re-suspended in 2 ml of 
low glucose medium. 200μl of islet suspension  were added to 800 μl of low 
glucose medium  placed  in s ix  wells  in  a  24  well  plate  and  mixed  by g entle 
aspiration. The islets were incubated at 37°C for one hour. After the incubation 
period, the islets were  washed thrice  with  low glucose medium. 500μl of the 
supernatant medium was aspirated from each well and replaced by the same 
volume of either low or high glucose medium (3 wells each)  and  mixed with 
gentle aspiration. This gave a final glucose concentration of 3mM and 21.5mM
in the low and high glucose medium wells. The islets were re-incubated at 37°C 
for 3 hours. The plate was gently shaken every 30 minutes. At the end of the 
incubation period the contents of each well were transferred to labelled tubes 
taking care to collect all the islets from the wells. The tubes were centrifuged at 
17500g for  2 minutes.  The  supernatant  was  collected  in l abelled  tubes  and 
stored  at  -80°C.  Insulin  concentration  in  the  fluid  was  assayed  using 111
commercially available kit (Mercodia High range Rat Insulin Elisa kit) according 
to the manufacturer’s instructions.
3.4.4 Evaluation of intra-replicate covariance using the modified 
static glucose stimulated insulin secretion assay
There  was  significant  reduction  in  the  covariance  between  individual  sets  of 
GSIS after the above protocol modifications (Figure 18). This was more evident 
for the non-heart-beating-pancreases compared to the control pancreases. This 
is expected as islets isolated from non-heart-beating-donor pancreases would 
have endured greater stress in the form of warm and cold ischaemia compared 
to  the  control  pancreas  islets.  That  makes  them  more  susceptible  to  poor 
function  in c hallenging  environments.  Improvement  of  the  quality  of  the 
incubation  medium  with  additives  and  decreased  handling of  the  islets 
contributed to more consistent islet function.112
Figure 18 Bar charts comparing the covariance of stimulation indices of replicates for 
islet isolates assessed before and after protocol modifications of the glucose stimulated 
insulin secretion assay.
Figure 18A: Overall comparison, Figure18 B: Differential effect in various preservation 
groups 
18A
18B113
3.5 Determination of activated Caspase 3 levels in islet extracts 
and pancreatic tissue as a measure of the extent of apoptosis
3.5.1 Background
Caspases  (Cysteine-requiring  aspartate  proteases)  are  a  family o f  proteases 
that mediate cell death by apoptosis. Caspase 3 is an effector caspase and is a 
critical enzyme involved in apoptosis.  
Rationale for methodology
The  caspase  3  colorimetric  assay  is  based  on  the  hydrolysis  of  the  peptide 
substrate  acetyl-Asp-Glu-Val-Asp  p-nitroanilide  (Ac-DEVD-pNA)  by  activated 
caspase  3,  resulting  in  the  release  of t he  p- nitroaniline  (pNA)  moiety.  p-
Nitroaniline  has  a  high  absorbance  at  405  nm.  The  concentration  of p NA 
released from the substrate is calculated from the absorbance values at 405 nm 
or from a calibration curve prepared with defined pNA controls. Samples with 
selective caspase-3 inhibitor are included in the assay protocol to identify non-
specific cleavage of the substrate that produces false positive results.
Basic assay protocol
The assay buffer, lysis buffer, substrate and inhibitor and caspase 3 enzyme 
were prepared using the assay kit according to manufacturer’s instructions.
The  micro-plate  assay  method  was  used  for  all  experiments (Table  3).  All 
assays  were  carried  out  in  duplicate.  Test s amples  or  caspase  3  positive 
controls were added to wells. Caspase 3 inhibitor was added to selected wells to 
identify false positive results. The contents in each well were made up to 90µl
with assay buffer. 10µl of caspase 3 substrate was added and the plate was 114
incubated  overnight  at  37°C.  A  p-nitroaniline (pNA) calibration  curve  was 
prepared according to manufacturer’s instructions. The plate was then read in a 
micro-plate spectrophotometer at 405nm.
Table 3 Reaction scheme for the caspase 3 assay using the micro-plate assay method
Standard calibration curve and calculation of test results
The standard calibration curve was prepared by using increasing concentrations 
of pNA (10µM to 200µM). 100µl of each dilution was added to duplicate wells in 
a  96  well  microtitre  plate.  100µl of a ssay  buffer  is  added  as  a  blank.  The 
absorbance was read at 405nm. A calibration curve was prepared by plotting the 
mean absorbances against the amount of pNA (in µmol) in each well (Figure 
19). The amount of pNA released by individual test samples was calculated on 
the basis of the calibration curve using curve fitting software (CurveExpert™). 115
The caspase 3 activity was then calculated in terms of µmol pNA released per 
minute per ml of cell extract.
Activated Caspase 3 activity = pNA x D/ T x V
pNA=p-Nitroaniline in µmoles present in the well at the end of incubation period
V=volume of test sample used in the well (in ml)
D= dilution factor of the test sample
T= reaction time in minutes
The protein  content  in t he  cell  extract/  tissue  extracts  was  assayed.  The 
Caspase 3 activity in terms of µmoles of pNA released per min per mg of tissue 
protein extract was then calculated. 
Figure  19 Sample  calibration  curve  for  µmoles  of  p-nitroaniline  in e ach  well  plotted 
against the absorbance at 405nm116
3.5.2 Determination of apoptosis in human peripheral blood 
mononuclear cells
Initial  work  to  standardize  utilization  of t he  kit  was  done  using  lymphocytes 
separated from blood of human volunteers (informed consent and University of 
Sunderland ethics committee approval obtained). These experiments were used 
to  confirm  that  sensitivity  of t he  assay  could  be  increased  by i ncreasing the 
volume of the test sample and by increasing the duration of incubation.
Preparation of peripheral blood mononuclear cells (PBMC)
5  ml  of b lood  was  collected  and  mixed  with  100  units  of  preservative  free 
heparin to prevent clotting. The blood was diluted 1:1 with RPMI and carefully 
underlaid with 10 ml of Nycoprep™ (1.077g/L). This was centrifuged at 400g for 
25 minutes. An interface layer of PBMC developed between the Nycoprep™ and 
plasma columns. This layer was carefully removed using a Pasteur pipette. This 
was added to phosphate buffered saline (PBS) and centrifuged for 10 minutes at 
400g. The sedimented PBMC were collected and transferred to fresh PBS for 
culture.
Induction of apoptosis 
PBMC  were  incubated  in  5  ml  phosphate  buffered  saline  at  37°C  in  an 
environment  of 5 %  carbon  dioxide.  After  overnight  incubation,  PBMC were 
washed  twice  with  fresh  PBS  by c entrifugation  at  400g  for  5  minutes.  The 
washed  pellet was  resuspended  in 1  m l  of  cold  PBS and sonicated  for  15 117
seconds. The contents were centrifuged at 5000g for 5  minutes at 4°C. The 
supernatant was collected and used for caspase 3 assay.
Caspase 3 assay 
Samples of the PBMC extract were assayed in duplicate. To confirm the dose-
effect relationship,  10µl and 25µl of the extract was used in duplicate wells. To 
assess the incubation time-effect relationship on the caspase 3 activity in the 
wells the plate was read twice, once after 4 hours of incubation and then again 
after overnight (16 hours) incubation. Measurable caspase 3 activity was seen in 
the PBMC extract. A proportional relationship was noted between the caspase 3 
activity in the extract as measured by the absorbance and the volume of extract 
in each well. There was also an increased caspase 3 activity after overnight 
incubation (Figure 20). 118
Figure 20 Effect of volume of PBMC extract and duration of incubation on the measured 
caspase 3 activity
Extract from apoptotic PBMC was prepared as described in the text. Two reaction 
volumes of the extract (10µl and 25 µl) were used to confirm dose-reaction relationship. 
The plate was read twice (after 4 hours and 16 hours of incubation) to confirm 
incubation time-reaction relationship.119
3.5.3 Determination of activated caspase 3 levels in rat pancreatic 
digest
Background
Pancreatic islets isolated from non-heart-beating-donor rat pancreases are likely 
to have undergone significant stress. We attempted to estimate the extent of 
caspase 3 activation in aliquots of islet samples from control pancreases and 
from  non-heart-beating-donor  pancreases  preserved  by  various  preservation 
techniques. Estimation of caspase levels in islet isolates has been reported as a 
means of investigating apoptosis [154].
Rationale for use of pancreatic digest instead of islet isolates for caspase 
3 assay
In an initial series of experiments an aliquot of the islet isolate was lysed in the 
lysis buffer and  used for  the  caspase-3  assay.  However  only  100-200IEQ  of 
islets were available for the assay after their use for viability testing and glucose 
stimulated  insulin  secretion  assay.  The  levels  of e xpected  caspase  3  in  the 
samples were below the sensitivity of the colorimetric assay  and no increased 
absorbance  at  405nm  was  seen  over  the  blank  controls.  To  overcome  this 
problem,  whole  pancreas  digest  at t he  end  of  the  washing  step  and  before 
density  gradient  separation  was  used  for  the  assay.  It  was  assumed  that a 
similar  level  of a poptotic  change  would be  noted  in  both  islet  and  exocrine 
components of the pancreatic digest. Briefly at the end of the washing step the 
digest was suspended in 5 ml of wash medium. 0.5ml of the suspension was 120
transferred to a microcentrifuge tube while the rest of the digest proceeded to 
islet  purification.  The  microcentrifuge  tube  was  centrifuged  at  5000g  for  2 
minutes.  The  supernatant  was r emoved  and  the  tube  was  snap  frozen  by 
immersing it in liquid nitrogen. The tubes were stored at -80°C until analysis.
Protocols for preparation of cell extract
Two techniques were evaluated for lysis of the pancreatic digest. In  the first 
method (freeze-thaw  technique),  the  pellet  was  suspended  in 1 00µl of l ysis 
buffer. It was then snap frozen by immersing in liquid nitrogen and then thawed 
in a water bath at 37°C. The micro-centrifuge tube was vigorously agitated for 5 
seconds. The steps were repeated twice. At the end of three cycles the tube 
was  centrifuged  at  4°C  and  15,000g  for  5 minutes.  The  supernatant  was 
collected and transferred to labelled tubes and stored at -80°C for analysis. In 
the second method (sonification technique), the pellet was suspended in 100µl
of lysis buffer. It was subjected to sonication for three periods of 5 seconds each 
with  10  second  cooling  down  interval  in a n  ice  bath.  The  tube  was  then 
centrifuged  at  15,000g  for  5  minutes.  The  supernatant  was  transferred  to 
labelled tubes and stored at -80°C for analysis.
The two methods were compared for three different pancreatic digest samples. 
For  each  pancreas,  aliquots  were  processed  by  both  methods.  The  protein 
concentration  and  caspase  3  activity  in t he  extracts  were  assayed.  Protein 
concentration  in t he  extracts  was  calculated  using  the  Invitrogen  Quant-iT 
protein  assay  kit.  Caspase  3  activity w as a ssayed  using  the  Caspase  3 121
colorimetric assay kit. The manufacturer’s instructions were modified and 20µl of 
extract was used for each well with a concomitant reduction in the volume of 
assay  buffer  per  well.  The  plate  was  incubated  overnight  and  analysed  in  a 
micro-titre plate reader at 405nm.
Sonication protocol gave better results for both total protein concentration and 
activated caspase 3 activity for all three samples (Figure 21&Figure 22). The 
sonication technique was hence utilized for pancreatic digest caspase assays.
Figure 21 Bar chart comparing the sonication and freeze-thaw technique for tissue lysis 
from three rat pancreatic digest samples- total protein concentration
Duplicate aliquots of the three rat pancreas digest samples (1,2,3) were subjected to 
either sonication  or  freeze-thaw  methods  of  tissue  lysis  (protocol  in  text).  The 
concentration  of  protein  in  the  supernatant after  centrifugation  of  the  extract  was 
assayed  using  the  Qubit  Quant-iT  protein  assay  kit.  Data  is  presented  as  protein 
concentration in mg/ml of extract. The sonication technique provided better tissue lysis 
and higher total protein concentration for all three samples.122
Figure 22 Bar chart comparing the sonication and freeze-thaw techniques for tissue lysis 
from three rat pancreatic digest samples- Caspase 3 assay
Duplicate aliquots of the three rat pancreas digest samples (1,2,3) were subjected to 
either sonication  or  freeze-thaw  methods  of  tissue  lysis  (protocol  in  text).  The 
concentration  of  activated  caspase  3  in  the  supernatant  after  centrifugation  of  the 
extract  was  assayed  using  the  Caspase-3 colorimetric  assay.  The  caspase  3 level  is 
represented as absorbance at 405 nm. The sonication technique provided better tissue 
lysis and higher absorbance  for all three samples.123
3.5.4 Activated Caspase 3 levels in rat pancreas tissue extracts after 
warm oxygenated perfusion
Background
A comparison of the degree of apoptotic activation in non-heart-beating-donor 
pancreases which underwent prolonged cold ischaemia and oxygenated warm 
reperfusion in vitro was attempted. 
Pancreatic  tissue is a  r ich  source  of p roteolytic  enzymes  that  are  released 
during exocrine tissue injury. These enzymes can break down cellular proteins 
and enzymes during homogenisation. There is therefore a risk of spuriously low 
results from caspase 3 assay of the pancreas digests due to proteolysis. Use of 
pan-protease  inhibitors  during  sample  preparation  will  affect  the  cysteine 
protease activity of caspase 3 making its estimation using a substrate based 
assay  inaccurate.  The  following  measures  were  taken  to  limit  the extent  of 
proteolysis  during  the  homogenization  phase. The  entire  storage  and 
homogenization process was completed at low temperatures to inhibit enzyme 
activity.  Radio-Immuno-Precipitation  Assay  (RIPA)  buffer  supplemented  with 
phenyl methyl sulfonyl fluoride (PMSF) (1mM) was used as the vehicle during 
homogenisation. RIPA buffer is commonly used for the lysis of mammalian cells 
and tissues. It does not contain any protease inhibitors of its own. Pancreatic 
enzymes  are  serine  proteases.  Phenyl  methyl  sulfonyl  fluoride  irreversibly 
inhibits serine proteases such as trypsin and chymotrypsin but does not inhibit 124
cysteine proteases such as caspase 3.  Hence it was chosen as the protease 
inhibitor during homogenisation.
Preparation of tissue extracts
RIPA buffer with 1 mM PMSF (0.1ml of 100mM stock solution added to every 10 
ml  of  RIPA  buffer  just  before  homogenization)  was  used.  The  frozen  biopsy 
(approximately 0.5-1 gm) was transferred into a universal container containing 
3ml of the prepared RIPA buffer. The contents were transferred to a clean glass 
tube  and  homogenized  with  a  motorised  glass-Teflon  homogeniser  in  an  ice 
bath. The extract was then transferred to micro centrifuge tubes and centrifuged 
at 1 2000g  for  5  minutes. The  supernatant  was  collected  in  labelled  micro 
centrifuge tubes and stored at -80°C.
Caspase 3 assay procedure
Caspase 3 assay using the tissue extracts was initially attempted according to 
the manufacturer’s instructions. Using the 96 microtitre plate assay and 5µl of 
tissue extract per well, the absorbance at 405nm after overnight incubation was 
very low. To increase the sensitivity, the volume of tissue extract per well was 
increased along with a decrease in the volume of assay buffer per well. This 
increased the sensitivity of the test. However the problem with this was the high 
background  non-specific  absorbance  in  some  specimens.  In  an  attempt  to 
account for this variable, the tests were run in triplicates with a negative control 
for every test sample. This involved adding a caspase 3 specific inhibitor that is 
included in the kit to one well containing the test samples. The absorbance was 
read at 405nm after overnight incubation. The true absorbance for each sample 125
was  calculated  by s ubtracting  the  excess  absorbance  in t he  test  well with 
caspase  3  inhibitor from  the  mean  absorbance  in t he  test  wells  (Figure 23). 
Caspase 3 levels were calculated in terms of µmol pNA released after overnight 
incubation per mg of protein in the extract.
Figure 23 Schematic  representation  of  the  method  for  calculating  true  absorbance  of 
study samples with high non-specific absorbance126
3.5 Extraction of pancreatic RNA for microarray analysis
The quality of information obtained from microarray analysis depends to a large 
extent on the quality of RNA used [205]. RNA quantity can be adversely affected 
by degradation or by contamination  with genomic  DNA, proteins and solvents 
used during the extraction process. RNA extraction from pancreas is specifically 
complicated  by  the  high  concentration  of  ribonuclease  enzyme  present  in 
pancreatic tissue[206, 207]. Background noise from degraded RNA adversely 
affects the ability of RNA microarrays to identify differential expression. TRIzol
reagent  was  used  for  the  extraction  of  pancreatic  RNA  in  our  study.  This 
extraction  is  based  on  the  Guanidinium  thiocyanate-phenol-chloroform 
extraction method that was developed by Chomczynski and co-workers in 1987 
[208].
3.5.1 RNA extraction protocol
TRIzol  reagent was  used  for  immediate  RNA  isolation  according  to 
manufacturer’s instructions. Briefly the steps in RNA extraction were as follows.
Homogenisation: The  pancreas  biopsy  was  immediately chopped  into  small 
pieces (2mm) and placed in a universal container containing approximately 10 
times  the  amount  of T RIzol  (approximately  5ml).  The  contents  were  then 
homogenised  in a  g lass  and  Teflon  electrical  homogeniser  which  had  been 
cleaned  with  RNAzap  and  rinsed  with  autoclaved  water.  The  homogenised 
mixture was allowed to stand at room temperature for 5 minutes. The mixture 
was  then  transferred  to  six  sterile  1.5ml  microcentrifuge  tubes.  These  were 127
centrifuged  at  12000g  for  10  minutes  to  precipitate insoluble  remnants.  The 
supernatant was transferred to fresh tubes.
Phase  separation: To  each  tube,  100  µl  of 1 -bromo-2  chloropropane  was 
added. The  mixture  was  shaken  vigorously  for  15  seconds  and  incubated  at 
room temperature for 2-3 min. The samples were centrifuged for 15 minutes at 
12000g. The top aqueous phase was collected and transferred to fresh tubes.
RNA precipitation : To the aqueous phase in each tube, 500 µl of isopropanol 
was added. After gently mixing the contents by inverting the capped tube 4-5 
times,  it  was  allowed  to  stand  for  10  minutes.  The  samples  were  then 
centrifuged at 12000g for 10 minutes. This precipitates the RNA at the bottom 
and sides of the microcentrifuge tube. The isopropanol was pipetted out.
RNA purification: To each tube, 1ml of 75% ethanol was added and mixed by 
gentle inversion of the capped tube. The tubes were then centrifuged at 7500g 
for 5minutes. The ethanol was then pipetted off leaving the RNA pellet dry at the 
bottom of the tube.
RNA  storage:  The  pellet  was  air-dried.  It  was  then  dissolved  in  100µl  (per 
microcentrifuge tube) of RNA secure. This was then stored at -80°C.
3.5.2  Assessment of quality of RNA
Assessment and further purification of RNA was carried out by Dr Noel Carter. 
RNA samples from each pancreas were run on an agarose gel. Three samples 
from  each  preservation  group with  the  best  electrophoretic  pattern  were 
identified.  These  samples  were  re-precipitated using  3.5N  lithium  chloride 128
according  to  manufacturer's  instructions  and  resuspended  in  RNAsecure. 
Samples were run on a gel again to confirm RNA integrity. The samples were 
quantified using a Qubit assay. The selected samples within each preservation 
group and control group were mixed in equimolar ratios for a final concentration 
of 1µg/ml. 20µl aliquots of the three pooled samples were supplied to Dr Heiko 
Peters, Department of Human Genetics, Centre for Life, Newcastle university for 
microarray  analysis.  Quality  of  RNA  was  assessed  in  terms  of  rRNA   r atio 
(28s/18s) and RNA integrity number (RIN) using Agilent 2100 bioanalyser. The 
rRNA ratio was 1.1 for the three samples. The RIN was 6.2 for the control and 
the portal venous oxygen persufflation groups and 6.6 for the static cold storage 
group (Figure 47). 
3.5.4 Modifications to RNA extraction method
Samples  of R NA  extracted  during  the  initial  part  of  the  study  using  the 
manufacturer's  instructions  were  significantly  degraded.  Following  literature 
review [207, 209], protocol modifications were made. The amount of pancreas 
tissue  used  for  extraction  was  decreased.  Approximately  0.2g  of  tissue  was 
homogenised with 5ml of the reagent. The tissue sample was snap frozen in 
liquid  nitrogen  to m inimise  RNA  degradation  while  being  taken  to  the 
homogeniser station.  
These modifications improved the quality of RNA extracted from samples in the 
later part of the study. Li and co-workers in 2009[210] attempting to improve the 
quality  of p ancreatic  RNA  extracted using  TRIzol  reagent  arrived  at  similar 129
conclusions. Despite our modifications, the 28s/18s ratio of the samples was 1.1 
and the RNA integrity number (RIN) of the analysed samples ranged between 
6.1-6.6. This was sub-optimal as the recommended 28s/18s ratio and RIN levels 
for microarray analysis are greater than 1.63 and 7.8 respectively [205]. 130
Figure 24 in opposite page. 
The two methods of RNA assessment used in our experiments were the rRNA ratio and 
the RNA integrity number. The gel images of the three RNA samples are shown on the 
right side of the picture. The gel shows the prominent 18S and 28S bands representing 
rRNA in the sample. The electropherogram on the left is a graphical representation of 
the gel. The numerical representation of RNA quality in terms of rRNA ratio (28s/18s) 
and the RNA integrity number is depicted at the lower end of the figure. Sample key 
(Control  group:  Sample  4;  Static  cold  storage:  Sample  5;  Portal  venous  oxygen 
persufflation: Sample 6)131
  
Figure 24 Assessment of RNA quality for microarray analysis
Control group
Portal venous oxygen 
persufflation
Static cold storage132
3.6 Discussion
This chapter describes some of the optimisation work carried out for this study. 
Developing the rat model of pancreas preservation was by far the most time-
consuming part of the study. After multiple attempts with en bloc models, the 
isolated  pancreas  model  was a dapted.  The  retrieval  procedure  as  described 
could be repeated consistently. Technical problems leading to organ wastage 
and some degree of rewarming injury during the prolonged dissection process 
were some of the problems identified. The temperature during the third phase of 
the  dissection  stayed  around  10-15°C, which  can  be  considered  to  be  sub-
optimal. Hence the effective warm ischaemia time experienced by the pancreas 
could have been longer than 35 minutes.
The work described previously,  investigating the effect of warm ischaemia time 
on  islet  yield, highlighted  the  problems  with  hand-picking  of i slets  for 
assessment. Representative samples of the islet yield cannot be obtained by 
hand-picking and hence the density gradient separation technique was used for 
further islet work (Chapter 4). Numerous protocols for  glucose stimulated insulin 
secretion  assay  are  described  in  the  literature.  The  consistency of  the  final 
protocol  used  in  this  study  was shown  to  be  better  than  the  initial  protocol. 
However  the  biphasic  function of t he  islets was  not  evaluated.  The  cellular 
insulin levels in the islets were also not estimated.  
Assessment  of  apoptosis  can  be  carried  out  in  multiple ways.  Various 
techniques exploit the characteristic features of apoptosis such as the ladder 133
pattern  of D NA  breakdown  on  DNA  electrophoresis,  tdT  annexin  assay  to 
identify specific breakpoints of DNA strands, assays of apoptotic enzymes such 
as caspases and the expression of genes involved in apoptosis. The caspase 3 
assay was used in the study. It is well described and inexpensive. It could be 
used  with  both  tissue  and  cell  extracts  and  hence  could  be  used  for  both 
pancreatic tissue and islet cell extracts. The same tissue extracts could also be 
used for assessment of lipid peroxidation in our experiment. The chief drawback 
of the chosen assay was that it was not sensitive enough for the requirements of 
our  study. The  optimisation  steps  described in  this  chapter  improved  its 
sensitivity. The assay also looked at a single step in the complicated process of 
apoptosis. All these increase the risk of false positive and false negative results. 
Hence levels  of c aspase  3  measured  in  the  test  samples  would only  be 
estimates of the extent of apoptosis. 
RNA  microarrays  are  being  increasingly  used  as  a  screening  tool  to  identify 
relevant underlying biological processes in experimental studies. Portal venous 
oxygen  persufflation  is  a  novel  preservation  technique  which  has  been 
investigated in the setting of experimental and clinical organ preservation. The 
effects of portal venous oxygen persufflation on global gene expression in the 
pancreas have not been previously reported. 
The control RNA for the study was obtained from pancreases of freshly killed 
rats.  This  should  provide  the  gene  expression  set  in a  m etabolically  active 
pancreas. Since it is not  possible to completely flush the control pancreases 
before  RNA  extraction,  this t issue  would  contain  leukocytes  which  have  a 134
different  gene  expression  signature  to  pancreatic  tissue.  This  makes  it  an 
imperfect control. Both preservation groups were compared to the same control 
group independently to identify  differential expression of genes and pathways 
separately. 135
4.1 Background
Successful islet transplantation is predicted by  the mass of viable islets or β
cells transplanted in the recipient[211]. Studies have shown that approximately 
9,000-12,000 islet equivalents per kg body weight of the recipient are required to 
achieve insulin independence[28, 29]. Pancreases retrieved from donors  with 
significant periods of warm ischaemia have poor islet yields[46]. The currently 
used methods of pancreas preservation are static cold storage and two layer 
method. Static cold storage is not ideal for these organs. Experimental studies of 
two-layer method have been promising though the benefit in the clinical setting 
has been unclear[20, 150, 158]. The relative benefits of hypothermic machine 
perfusion and portal venous oxygen persufflation in preserving pancreases that 
have suffered significant warm ischaemia was investigated in this chapter. 
Early attempts to isolate islets involved meticulous dissection of islets from the 
pancreases.  Lacy  and  Kostianovsky   w ere  the  first  to  describe  large  scale 
isolation  of  islets  from  pancreases  of  rats  and  mice[212].  Their  technique 
involved initial disruption  of pancreatic parenchyma  by intraductal injection of 
Hanks' buffered salt solution (HBSS). The pancreas was then finely chopped 
and incubated in Krebs-Henseleit solution containing collagenase. Intra-ductal 
injection of collagenase solution and digestion at 37° C in a shaking water bath
Chapter 4 Comparison of islet yield from non-heart-
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was described by Noel and co-workers in 1982 [213]. The method used in our 
experiments was based on the static digestion technique described by Gray and 
co-workers in 1984 [214].
Several methods to purify the islet fraction from the pancreatic digest have been 
described. Methods such as hand-picking under a low power microscope are 
still  utilised  when  a  small  number  of p ure  islets  are  required.  Density b ased 
separation methods are the most commonly utilised to separate large numbers 
of relatively pure islets. They exploit the fact that digested exocrine tissue has a 
higher  density  compared to  islets.  Sucrose,  Percoll™,  Ficol™,  Histopaque™ 
have  all  been  used  to p repare  density g radients  for  islet  purification.  Both 
continuous and discontinuous density gradients have been used. Discontinuous 
gradients are commonly used for rat or mouse pancreas isolation[202]. 
Assessment  of i slet  yield  includes  the  counting  of  islets,  calculation  of  islet 
equivalents,  viability and  estimation  of in  vitro and  in v ivo function[203]. 
Dithizone  (Diphenylthiocarbazine)  intensely  stains  the  proinsulin/insulin 
complexes of β cells giving a deep red colour. It is a helpful guide in identifying 
islets from exocrine tissue (Figures 25, 26). 
Islet Equivalent is the term used to estimate the actual volume of the islet. This 
measurement  has  better  correlation  with  post-transplant  outcome  when 
compared to islet count. To calculate islet equivalents each islet is considered to 
be 150µm in diameter. Islets of different sizes are converted to this standard 
size and expressed as IEQ [203].  Viability of islets is an essential criterion for 
assessing the quality of islet yield. Exclusion staining with propidium iodide[215]137
or  trypan  blue  are  commonly  used  techniques to  assess  viability.  Cell 
membranes of live cells are impermeable to these dyes. Uptake of these stains 
by  islets  indicates  ineffective  cell  membrane function  and cell  death[216]. 
Morphology  of i solated  islets  is  a  strong  predictor  of i slet  function  and  post-
transplantation success. Studies have shown that healthy and functional islets 
are  larger,  more  globular  and  have  a  regular  outline.  Small,  irregular  and 
fragmented islets reflect damage and predict poor post transplant function[217, 
218].  Islet  index  or  islet  isolation  index  is  calculated  from  the  ratio  of  islet 
equivalents to the islet number. It is a measure of the average size of the islets 
and is a guide to the degree of fragmentation of the islets. Islet isolation index 
less than 1 indicates extensive fragmentation. Studies have shown better results 
with islets with isolation index  greater than 1.0[31, 217, 218]. However it has 
also been suggested that smaller islets have a better chance of surviving the 
hypoxic conditions after transplantation. These studies have claimed that larger 
islets develop a central core of hypoxic cell death leading to graft failure [219].     
The  most  accurate  method  to  assess  islet  function  is  their  ability  to  correct 
hyperglycaemia  following  transplantation  into  immuno-deficient  diabetic  mice. 
However routine utilisation of this technique is expensive and time-consuming.
The test is also irrelevant in the clinical setting as results from these experiments 
will be available long after the islets had been transplanted. In vitro methods of 
testing  islet  function  are based  on  the  ability  of  islets  to  secrete  insulin  in 
response  to  glycaemic  stress[202,  220].  Static  glucose  stimulated  insulin 
secretion test is the simplest and most commonly used test to assess in vitro138
islet  function.  This  is  based  on  the  principle  that  viable  islets  secrete  more 
insulin  in  high  glucose  environments.  The  ratio  of i nsulin  produced  at  high 
glucose environment and low glucose environment (basal insulin production) is 
called stimulation index. The stimulation index of viable islets is usually greater 
than one [203]. 139
Figure 25 Injection of collagenase into the common bile duct
The duodenum at the insertion of the bile duct is clamped. This ensures retrograde 
filling of the pancreatic duct and pancreas distension.140
Figure 26 Distension of pancreas with collagenase solution
The pancreas was distended with collagenase solution by injecting it into the pancreatic 
duct through the common bile duct cannula. The distended pancreas is pink in colour 
due to the use of Hanks' buffered salt solution to prepare the collagenase solution. 
Phenol red used as the indicator in the solution gives it the pink colour.141
Figure 27 Completion of discontinuous density gradient islet purification step
The density gradients and separated components of the pancreatic digest are clearly 
seen. The exocrine tissue has settled at the bottom of the tube (A). Above this is the high 
density Histopaque column (B). The low density Hanks' buffered salt solution forms the 
top layer(C). Purified islets can be seen at the interface between the low and the high 
density columns (D).
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Figure 28 Pancreatic digest stained with dithizone to demonstrate the staining 
characteristics of exocrine tissue and islets
An aliquot of the pancreatic digest has been stained with dithizone solution and 
examined under the low power microscope. The large amount of exocrine tissue which is 
not stained by dithizone is yellow in colour. The single islet in the centre of  the field 
stains red.143
Figure 29 Purified islets stained with dithizone
Purified islets after overnight culture were stained with dithizone and examined under a 
low power microscope.  Islets are identified as globular structures with characteristic 
red staining with dithizone (A). Clumps of irregular exocrine tissue are also seen in the 
picture (B). These do not stain with dithizone.
B
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Figure 30 Viability testing of islets-Staining with trypan blue and dithizone
The  islets  after  overnight culture  were  stained  with  dithizone  and  trypan  blue  and 
examined  under  a  low  power  microscope.  Dithizone  stains  all  islets  red  in  colour. 
Trypan blue stains dead cells blue in colour. These are predominantly viable islets (A)
with only a few blue staining cells. Larger islets show a central area of staining with 
trypan blue (B). This represents core necrosis of islets due to ischaemia. 
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Figure 31 Viability testing of islets-Staining with Fluorescein diacetate and Propidium 
iodide
Islets after overnight culture were stained with Fluorescein diacetate and propidium 
iodide and examined under blue light using a fluorescent microscope. The bright green 
fluorescence of islet clusters is clearly seen in the top image. The bottom image shows a 
single islet with red fluorescence in the central part of the islet suggestive of dead cells. 146
4.2 Methods
4.2.1 Study plan and positive control group
The study plan is depicted in figure 31. The null hypothesis formulated for this 
phase of the study was that 'change in technique of pancreas preservation does 
not alter the islet equivalent yield and the stimulation index of the islets isolated 
from  the  pancreas'.   R etrieval  of n on-heart-beating-donor  rat  pancreas was 
described previously (section 3.3.1 The duration of warm ischaemia was set at 
35 minutes as previous experiments had shown that a warm ischaemia of 30 
minutes lead to a greater than 50% reduction in crude islet yield. The techniques 
of static  cold  storage,  two-layer  method,  hypothermic  machine perfusion  and 
portal  venous  oxygen  persufflation  have  been  previously  described (section 
2.3.2). The  perfusion  pressure  and  persufflation  pressure  was  continuously 
recorded during the preservation period. At the end of the preservation period 
the  pancreas  was  weighed  and  the  change  in  weight  after  preservation  was 
calculated. The pancreas then underwent islet isolation. 
Pancreases retrieved from rats without significant warm ischaemia served as 
positive controls.  Here  the  rat  was k illed  by a  s chedule  I  method  and  an 
immediate  laparotomy  was  carried  out.  The  animal  was  exsanguinated  by 
dividing the inferior vena cava. The bile duct was identified and cannulated. Cold 
collagenase solution (10mg of collagenase P in 10 ml of HBSS) was injected 
into the  pancreatic  duct after  clamping  the  insertion  of  the  bile duct  into  the 
duodenum (Figures 25, 26). The distended pancreas was bluntly excised and 147
processed for islet isolation. Assessment of islet yield in terms of islet count, 
viability and in vitro function were carried out. 
Figure 32 Flow chart depicting the plan of study (Phase I)148
4.2.2 Procedure of rat pancreas islet isolation
The  pancreas  was  transferred  to  a  petridish  containing  cold  University  of 
Wisconsin solution. The duodenum was clamped at the point of insertion of the 
common bile duct (CBD). 10ml of 1mg/ml Collagenase P solution (in ice cold 
Hanks'  buffered  salt  solution)  was  injected  through  the  CBD  cannula  slowly. 
Care was taken to ensure that the collagenase solution was not leaking out or 
into the duodenum.  The  uniformly  distended  pancreas  was  bluntly  separated 
from  the  duodenum  taking  care  not  to t ear  the  duodenum  or  the  pancreatic 
capsule. Pancreas was separated from the spleen and placed in a sterile 20ml 
centrifuge tube. It was incubated in a static water bath at 37°C for 50 minutes. 
After completion of the incubation period the tube was shaken for 10 seconds to 
homogenize the pancreas.
The digest was washed thrice with the wash solution by centrifugation at 300g 
for  one  minute.  The  digest  was  then  passed  through  a  400  micron  sieve  to 
remove  the  undigested  pancreatic  tissue,  lymph  nodes  and  fibro-fatty tissue. 
The filtrate was centrifuged at 300g for 1 minute with brakes off. The precipitate 
was  suspended  in 2 0  ml  of s terile  Histopaque  1.083.  The  digest-Histopaque 
suspension  was  divided into  four  aliquots  and  carefully layered  over  2  ml of 
Histopaque 1.083 in each of four centrifuge tubes. 4ml of Hanks' buffered salt 
solution was layered over the digest-Histopaque suspension in each centrifuge 
tube using a Pasteur pipette.149
The  tubes  were  centrifuged  at 8 00g  for  10  minutes  with  brakes  off  in  a 
refrigerated  centrifuge  (4°C).  Islets  concentrate  at  the  Histopaque-HBSS 
interface (Figure 27). This was aspirated with a Pasteur pipette and transferred 
into  sterile  centrifuge  tubes.  This w as  washed  twice  with  wash  solution  by 
centrifugation at 300g for 1 minute. The precipitate was suspended in 10 ml of 
sterile  culture  medium  previously  warmed  to  37°C  and  transferred  to a  g as-
permeable  culture  flask.  The  flask  was  incubated  overnight  at 3 7°C  in a n 
incubator with 5% carbon dioxide.
Discussion
Discontinuous density gradient separation is the preferred method of purification 
of i slets  from  the  rat  pancreas.  This  is b ased  on  the  differential  density  of 
digested  exocrine  tissue  and  separated  islets.  Exocrine  tissue  has  a  higher 
density and hence is precipitated. By using suitable density medium the islets 
form a column separate from the precipitated exocrine tissue. Various studies 
have  reported  the  use  of  sucrose,  percoll,  iodine  based  medium  of v arious 
densities  to  purify  the i slets.  After  several  attempts,  the  best  results  were 
obtained  by u sing  Histopaque  which  is  an  iodine  contrast  medium.  This  is 
available in various density preparations. Histopaque 1.083 provided the best 
separation of islets from the digest with minimal loss of islets in the exocrine 
precipitate. 
Several measures  were  found  to i mprove  the  purification  process. The 
Histopaque was warmed to room temperature before use. The bottom column of 
pure Histopaque improved the delineation of the exocrine tissue pellet at the end 150
of purification. Dividing the digest into 4 aliquots minimized the clumping of all 
the islets together in too small a space at the interface. The centrifuge was pre-
cooled. The centrifuge was used with the breaks off to prevent disruption of the 
density  columns  due  to  rapid  deceleration.  After  separation,  the  islet  rich 
interfaces were collected and washed thrice with wash medium as Histopaque 
has been reported to be toxic to the islets on prolonged contact.
4.2.3 Staining islets with dithizone and islet count
All counts and size estimations were done by a single observer who was not 
blinded to the type of pancreas preservation.
1 ml of islet suspension was transferred to a 10 ml universal container. An equal 
volume of prepared dithizone solution was added to the suspension and mixed 
by  shaking  gently. T he  mixture  was i ncubated  at r oom  temperature  for  5 
minutes.  The  islets  were  rinsed  twice  with  the  wash  solution.  They w ere 
suspended in 2 ml of the wash solution and transferred to multiple wells of a 96 
well  micro-titre  plate  using  a  Pasteur  pipette.  Islets  were  counted  under  low 
power microscope (4X objective). Islets stain bright red while exocrine tissue 
does not stain (Figures 28,29)
4.2.4 Calculation of islet equivalents (IEQ) and islet isolation index
Islet suspension was stained with dithizone as described above. The number of 
islets and the size of each islet were noted. Size of each islet was estimated 
using an eye-piece graticule fixed in the microscope. The graticule provided a 
scale in the visual field of the microscope where 1mm is divided into 100 sub-151
divisions by 99 lines. The diameter of each islet was measured using this scale 
in  two  perpendicular  directions. T he  mean  of  the  two  observations  was 
documented as the islet diameter. The islet yield in IEQ was then calculated 
using the following formula[203].
Islet equivalents (IEQ) = (n50-100* / 6 ) + (n100-150 /1.5) + (n150-200 X 1.6) + (n200-
250 X 3.5) + (n250-300 X 6.3) + (n300-350 X 10.4) + (n350-400 X 15.8) + (n>400 X 22.8) 
* n50-100 is the number of islets with diameter from 50µ to 100µ and so on
The islet isolation index is a measure of the extent of fragmentation of the islets. 
It was calculated for each isolate by dividing the islet yield in Islet equivalents by 
the actual islet count. Islet isolation index was low (<1) in isolates where the 
islets are highly fragmented. Well preserved islets will have an index greater 
than one. 
4.2.5 Assessment of islet viability
Viability assessment by propidium iodide staining
25-50 islets suspended in 0.5 ml of culture medium were transferred to a 1 ml 
microcentrifuge  tube.  An  equal  volume  of t he  fluorescein  diacetate/propidium 
iodide working solution was added. The tube was gently inverted several times 
to  ensure  mixing  and  incubated  at r oom  temperature  for  one  minute. 
Supernatant  fluid w as  aspirated  and  the  islets  were  washed  twice  by 
sedimentation  with  wash  solution.  They  were  transferred  to  a  custom  made 
glass  slide  with  central d epression and  examined under  blue light  in a  152
fluorescent  microscope.  Non-viable  islets stained  red  while  viable  islets  were 
stained fluorescent green (Figure 31).
Islet viability testing by trypan blue staining
25-50 islets suspended in 0.5 ml of culture medium were transferred to a 1 ml 
micro-centrifuge tube. 100 µl of 0.4% trypan blue solution was added to the islet 
suspension  and  mixed  by  inverting  the  tube.  After  incubation  at  room
temperature  for  five  minutes  the  islets  were  washed  twice  by  sedimentation 
using the medium solution. The suspension was transferred to a custom-made 
slide and examined under low power microscope. Dead islets were blue and 
viable  islets  were  cream  coloured.  Pale  islets  with  central  blue  staining 
suggested viable with central necrosis. Pale islets with peripheral blue staining 
suggested viable islet with mantle of non-viable exocrine tissue. Simultaneous 
counterstaining with dithizone helped differentiation of viable islets from viable 
clumps of exocrine tissue (Figure 30).
4.2.6 Assessment of islet in vitro function
The  static glucose  stimulated  insulin  secretion  test  was  used  in  the  study  to 
assess the in vitro function of islets. The rationale for the use of this assay and 
the optimisation of the assay procedure was previously detailed. Briefly, islets 
after overnight incubation were washed twice in low glucose medium. Aliquots of 
the  islet  suspension  were  transferred  to  six  wells  containing  low  glucose 
medium. The islets were incubated at 37°C for one hour. The islets were rinsed 153
with fresh low glucose medium. To each well, either low or high glucose medium 
(3 wells each) was added and mixed with gentle aspiration. The islets were re-
incubated at 37°C for 3 hours. At the end of the incubation period the contents 
of each well were transferred to labelled tubes taking care to collect all the islets 
from  the  wells.   T he  tubes  were  centrifuged  at  17500g  for  3  minutes.  The 
supernatant  was  collected  in  separate  labelled  tubes  and  stored  at  -80°C. 
Insulin concentration in fluid was assayed using Mercodia High range Rat Insulin 
Elisa  kit  according  to m anufacturer’s  instructions.  Stimulation  index  was 
calculated as previously described.
4.2.7 Statistical analysis
Minitab™ was  used  to  calculate  the  sample  size  required  to r eject  the  null 
hypothesis. A sample size of 10 animals per treatment group was required to 
reject  the  hypothesis  with  a  power  of 8 0%  at a  5 %  level  of  significance. 
Comparison  of  islet  yield  and  insulin  stimulation  index  between  the  various 
groups was done using analysis of variance (ANOVA). The relation between 
perfusion  or  persufflation  pressures  and  islet  yield  and  in  vitro function  was 
analysed  by  Pearson's  correlation  coefficient.  154
4.3 Results
4.3.1 Laboratory animal usage and number of successful isolations
For the control arm, 15 rats killed by schedule I method were used. Islet isolation 
was not satisfactory for one pancreas and it was excluded from further analysis. 
Fourteen pancreases underwent successful islet isolation and assessment. Fifty 
eight non-heart-beating-donor pancreases were retrieved after standardisation 
of the pancreas retrieval procedure. All these pancreases were exposed to 35 
minutes of warm ischemia. The pancreases were then preserved by any of the 
four preservation techniques. Problems in preservation or islet isolation led to 11 
pancreases being excluded from the further analysis (table 4). The reasons for 
not using 11 pancreases were as follows.
1. L eaks  identified  during  back-table  preparation  which  could  not  be 
satisfactorily repaired (Total=5, HMP=3, PVOP=2)
2, P oor  distension  of p ancreas  with  collagenase  injection  due  to  leakage 
(Total=3, SCS=2, PVOP=1
3. Loss of significant portion of pancreatic digest during the purification process 
(Total=2, SCS=1, PVOP=1)
Hand-picking of islets was used to collect islets for viability assessment in the 
initial phase of the project. This was changed to discontinuous density gradient 
separation once the technique was standardised. A total of fifty one pancreases 
(control group=12, study groups=39) underwent density gradient purification
(Table 4).155
Table 4 Table showing the number of animals and the number of 
successive islet isolations in various preservation groups.
Control 
group 
pancreas
es
Non-heart beating pancreases
Total SCS HMP PVOP TLM
Total  number of  rats 
used
15 58 20 16 17 5
Number of pancreases 
discarded
1 11 4 3 4 0
Number  of s uccessful 
preservation- islet 
isolations
14 47 16 13 13 5
Isolates  which 
underwent  density 
gradient separation
12 39 12 11 11 5
SCS: Static cold storage, HMP: Hypothermic machine perfusion, PVOP: Portal venous 
oxygen persufflation, 
TLM: Two layer method  156
4.3.2 Quality of pancreas distension
Distension with intra-ductal collagenase injection was good and uniform in the 
control pancreases. The quality of pancreas distension was poor in non-heart-
beating-donor pancreases preserved by static cold storage. It was non-uniform 
with small parts in the  tail remaining un-distended. Resistance to intra-ductal 
injection was high and it was difficult to inject the entire 10ml of collagenase 
solution into the pancreas.  The quality of distension was better in the machine 
perfused  and  oxygen  persufflated  pancreases  with  lower  resistance  to 
collagenase injection. 10 ml of the collagenase solution could be injected without 
difficulty. 
4.3.3 Comparison of islet yield parameters in control group 
pancreases and non-heart-beating-donor group pancreases
Pancreases which underwent islet isolation immediately without any warm 
ischaemia yielded more islets. Control group islets also had improved viability 
and higher islet isolation index as compared to non-heart-beating-donor 
pancreases (Table 5).  157
Table 5 Comparison of islet parameters between islets isolated from control group and all non-heart-beating-
donor group rat pancreases
Islet  assessment 
parameter
Control g roup  pancreas 
(n=12)
Non-heart-beating-donor 
pancreas (n=39)
Mann  Whitney  U 
test statistic
p value
Median IQR Median IQR
Crude islet count 1200.0 830.0 920.0 445.0 213.0 0.047
Crude  islet 
equivalents
2360.7 949.0 1708.0 746.0 231.0 0.093
Pure islet count 400.0 275.0 200.0 130.0 197.5 0.024
Pure islet equivalents 1042.5 639.0 481.7 411.0 167.0 0.005
Islet isolation index 2.8 2.3 2.4 1.0 107.0 0.012
Islet viability (%) 89.7 8.9 76.0 10.3 47.0 0.0001
IQR: Inter quartile range158
4.3.4 Comparison of islet yield parameters within the non-heart-
beating-donor groups
Islet count and islet equivalents
Post-purification data was available for 39 non-heart-beating-donor pancreas 
isolates. Static cold storage group had the lowest crude islet count and islet 
equivalents.  Two  layer  method  and  Portal  venous  oxygen  persufflation 
groups  had  better  islet  yields  There  was  no  significant  difference  in  islet 
count or IEQ between the four groups (ANOVA p=0.863 and 0.403). Portal 
venous oxygen persufflation group had the highest purified islet count and 
equivalents.  Differences  in  purified  islet  equivalents  was  statistically 
significant (ANOVA, p=0.018) though there  was no statistical difference in 
purified islet counts (ANOVA, p=0.121) (Figures 33,34)
Islet isolation index & islet morphology
The  islet  isolation  index  was  lowest  for  static  cold  storage  group.  The 
difference  in  the index  between  the  four  preservation  groups  was  not 
statistically s ignificant  (p=0.080).  Within  the  non-heart-beating-donor 
preservation  groups islet morphology showed prominent differences. Islets 
isolated from static cold storage group were small, irregular and fragmented. 
This was much improved in the portal venous oxygen persufflation group and 
the two-layer method groups where the islets were more rounded and larger
(figures 35.37).
Islet viability
Islet viability based on trypan blue exclusion staining and propidium iodide 
staining gave comparable results with good correlation (Pearson’s correlation 
coefficient= 0.757) Portal venous oxygen persufflation and two-layer method 159
group had improved viability as compared to machine perfusion and static 
cold  storage.  The  difference  was  not statistically s ignificant  (ANOVA, 
p=0.151) (Figure 36).160
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Figure 33 Bar graph comparing crude islet count & islet equivalents within the four 
non-heart-beating-preservation groups.
Crude  (pre-density  gradient  purification)  islet  count  and  islet  equivalent  yield 
recovered  per  non-heart-beating-donor  rat  pancreas  preserved  by the  static  cold 
storage  (n=16),  hypothermic  machine  perfusion  (n=13),  portal  venous  oxygen 
persufflation  (n=13)  or  two  layer  method  (n=5)  were  compared.  Bars  represent 
mean while the error bar represents one standard error of mean. The differences in 
both  crude  islet  count  and  islet  equivalents  were  not  statistically  significant 
(ANOVA).161
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Figure 34 Bar graph comparing the purified islet count and islet equivalents within the 
four non-heart-beating-donor pancreas preservation groups. 
Post-density gradient purification islet count and islet equivalent yield recovered per 
non-heart-beating-donor rat pancreas preserved by the static cold storage (n=12), 
hypothermic machine perfusion (n=11), portal venous oxygen persufflation (n=11) 
or two layer method (n=5) were compared. Bars represent mean while the error bar 
represents one standard error of mean. The differences in purified islet equivalents 
was statistically significant (ANOVA; p=0.018).162
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Figure 35 Bar graph comparing the isolation index of islets within the four non-heart-
beating-donor rat pancreas groups.
Islet isolation index for islets recovered from non-heart-beating-donor rat pancreas 
preserved by the static cold storage (n=12), hypothermic machine perfusion (n=11), 
portal  venous  oxygen  persufflation  (n=11)  or  two  layer  method  (n=5)  were 
compared. Bars represent mean while the error bar represents one standard error of 
mean. The isolation index is a marker of islet fragmentation during the isolation 
process. Within the four groups static cold storage had the lowest isolation index. 
The differences in isolation indices between the four groups was not statistically 
significant (ANOVA; p=0.080).163
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Figure 36 Bar graph comparing the viability of islets retrieved from four non-heart-
beating-donor rat pancreases preservation groups.
Viability of islets recovered from non-heart-beating-donor rat pancreas preserved by
the static cold storage (n=12), hypothermic machine perfusion (n=11), portal venous 
oxygen  persufflation  (n=11)  or  two  layer  method  (n=5)  was  compared.  Bars 
represent  mean while the error  bar represents one  standard  error  of  mean. The 
viability represented in the graph as a percentage was the average of the viabilities 
measured by trypan blue staining and propidium iodide staining of two separate 
aliquots of islets from each isolate. Within the four groups static cold storage and 
hypothermic machine perfusion had the lowest viability. The differences in viabilities 
between  the  four  preservation  groups  was   n ot  statistically  significant  (ANOVA; 
p=0.151).164
Figure 37 Morphology of islets retrieved from positive control and non-heart-beating-
donor pancreases
The islets were double stained with dithizone and trypan blue. Islets isolated from 
positive control  pancreas  (A)  are  globular  with  smooth  margins  and  minimal 
staining with trypan blue. Islets from static cold storage pancreas (B) are small, 
irregular and frequently fragmented. They also have increased staining with trypan 
blue suggestive of poor viability. Islets isolated from hypothermic machine perfusion 
(C) and portal venous oxygen persufflation (D) are less fragmented as compared to 
static  cold  storage  group.  The  margins  are  not  smooth  and  there  is  evidence  of 
trypan blue staining of the larger islets. This is more prominent in the islets from 
pancreases preserved by hypothermic machine perfusion (C).165
4.3.5 Comparison of in vitro function by static glucose stimulated 
insulin secretion test
The mean stimulation index for the control group pancreases was 2.99. This 
was significantly higher than the stimulation indices for the non-heart-beating-
donor  pancreas  groups  irrespective  of  the type  of  preservation  (ANOVA, 
p=0.035). Within the non-heart-beating-donor preservation groups, static cold 
storage  group  had  the  lowest  mean  stimulation  index.  There  was  no 
significant difference in the stimulation indices of the three non-heart-beating-
donor  preservation  groups  (ANOVA,  p=0.311).  The  percentage  of isolates 
from each preservation group which had a stimulation index greater than 1.0 
was evaluated. Static cold storage group had the lowest percentage of islet 
isolates with stimulation index lesser than 1.0 (Figures 38,39). 166
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Figure 38 Bar chart comparing the stimulation indices of islets isolated from positive 
control and non-heart-beating-donor rat pancreases
The bars represent the mean stimulation index for the control/ preservation group. 
Error  bar  represents  one  standard  error  of  mean.  The  stimulation  index  of  the 
positive control  group  pancreases  was  significantly  higher  than  the  non-heart-
beating-donor pancreases (ANOVA, p=0.035). Within the three preservation groups 
static  cold  storage  had  the  lowest  stimulation index.  The  stimulation indices  of 
hypothermic machine perfusion and portal venous oxygen persufflation were similar. 
The  difference  in  stimulation  indices  in  the  three  preservation  groups  were  not 
statically significant (ANOVA, p=0.311)167
Figure 39 Bar chart comparing the percentage of islet isolates with confirmed in vitro
function in various preservation groups
Islet isolates with a mean stimulation index greater than one by static glucose 
stimulated insulin secretion test were considered to have confirmed in vitro function. 
The graph depicts the comparative percentage of isolates from the positive control 
and non-heart-beating-donor pancreas preservation groups that have a stimulation 
index greater than 1. The actual number of isolates assessed for each group is shown 
in the graph. Islets from positive control group and hypothermic machine perfusion 
group were 100% functional. 88% of islets isolates from portal venous oxygen 
persufflation group were functional. Only 55% of islet isolates from static cold 
storage were functional. The differences were not statistically significant168
4.3.6 Perfusion parameters during hypothermic machine perfusion 
and their correlation with islet yield
Eleven  non-heart-beating-donor  rat  pancreases  underwent  hypothermic 
machine perfusion followed by islet isolation and assessment. The median 
duration of perfusion was 252 min (Inter-quartile range, 240 -285 min). The 
mean  starting  pressure  was  16.2 mmHg  (13 mmHg-18 mmHg).  The 
perfusion pressure decreased during the perfusion period in 7 pancreases 
(63.6%). Averaged perfusion pressure during the entire perfusion period was
14.3mmHg.  The  pre-preservation  weight  of  the  pancreas  (including 
duodenum  and  spleen)  was  8.5g  (8.0-9.3).  All  pancreases  increased  in 
weight at the end of machine perfusion. The median percentage weight gain 
at the end of the perfusion period was 14.3% (7.8-17.9%). 
Relation between pancreas perfusion parameters and islet yield
There  was  significant  positive  correlation  between  the initial  perfusion 
pressure and crude islet count (p=0.028). There was no correlation between 
the  perfusion  pressure  and  purified  islet  yield.   T here  was  a  significant 
negative  correlation  between  the averaged  perfusion  pressure  and  the 
viability o f  isolated  islets  (p=0.026).  Pancreases  with  perfusion  pressure 
greater than 15mmHg had decreased viability (78% vs. 60%, p=0.012). 
4.3.7 Persufflation parameters during portal venous oxygen 
persufflation of non-heart-beating-donor pancreases
Eleven  pancreases  underwent  portal  venous  oxygen  persufflation  for  a 
median of 250 minutes (240-300 minutes). There was no consistent change 
in the weight of the pancreas following persufflation (median weight loss of 169
0.3%).  The  initial  persufflation  pressure  was  15.2mmHg  (7.3-16.8mmHg). 
Averaged  persufflation  pressure  during  the entire  persufflation  period  was
12.3mmHg.  A  decrease  in  persufflation  pressure  was  noted  in  all 
pancreases. There was no correlation between persufflation parameters and 
islet isolation variables.
4.4 Discussion
The  yield  and  in  vitro function  of  islets  from  pancreas  damaged  by  35 
minutes  of  warm  ischaemia  was  significantly w orse  than  control  group 
pancreases.  Within  the   n on-heart-beating-donor  preservation  groups,  the 
purified islet equivalent yield was highest in pancreases preserved by venous 
oxygen persufflation and was similar to the yield from two layer method. This 
was significantly higher than the purified IEQ from static cold storage. Islets 
from persufflation group also had higher viability, lesser fragmentation and 
better  morphology  when  compared  to  static  cold  storage  and  machine 
perfusion  groups.  The  difference  in  these  parameters  was  not  statistically 
significant.
The  technique  of  islet  isolation  and  purification  itself  can  influence  islet 
numbers and viability as damaged islets are more likely to be lost during islet 
isolation.  The  islet  yield  obtained  from  damaged  pancreases  may  hence 
exclude  the  poor  quality i slets  lost  in  the  process. This  can  explain  the 
significant differences in islet numbers between various preservation groups 
but broadly insignificant differences in other islet parameters. 170
The  in  vitro function  test  did  not show  any  significant  difference  in  the 
stimulation indices of the three preservation groups. There was an however a 
tendency  for  islets  isolated  from  static  cold  storage  pancreases  to  have 
stimulation index less than 1.0.  
The decrease in islet yield after significant duration of warm ischaemia is well 
described  in  the literature[46].  Static  cold  storage  had  the worst  islet 
parameters  amongst  all  the  preservation  techniques  studied.  This 
demonstrates the potential room for improvement that exists in non-heart-
beating-donor pancreas preservation. Improved distension of the pancreas 
with  intraductal  collagenase  after  preservation  with  portal  venous  oxygen 
persufflation  and  two  layer  method  was  seen.  This  could  partly   e xplain 
improved  islet  yield  from each  pancreas  because  a  greater  portion  of the 
pancreas  is  exposed  to  collagenase  and  is  available  for  digestion.  
Improvement  in islet  yield  with  these  methods  could  also  be  due  to  the 
improved oxygenation during the cold ischaemia period. Both methods would 
be expected to act in similar ways i.e. by improving the energy status of the 
grafts  and  providing  an  opportunity f or  tissue  repair.  The  evidence  of 
preserved  islet  architecture  seen  with  these  preservation  techniques  also 
suggest improved quality of the isolated islets. 
There was no significant difference in the stimulation indices for the three 
preservation  groups.  It  is  possible  that  the significant  warm  ischaemic 
damage has lead to a period of islet dysfunction that could improve over a 
period  of time. This is very  common in clinical practice and delayed  graft 
function  is  a  universal  occurrence  in  non-heart-beating-donor  kidney 
transplantation.  Hence  glucose  stimulated  insulin  secretion  after  overnight 171
incubation  may  not be  a  reliable  test  to  compare  function  in  non-heart-
beating-donor  islets.  Another  explanation  is  that  the  assay  as  being 
performed  is  not  sensitive  enough  to detect  small  difference  in  function 
between  the  groups.  Techniques  such  as  islet  perifusion  to  confirm  a 
biphasic response[220] and islet oxygen consumption  rate[221]  are more 
sensitive methods to assess islet response to glycaemic stress.
Analysis of perfusion pressure  data in the hypothermic machine  perfusion 
group  showed that higher perfusion pressures correlated with poorer viability 
of islets. The machine perfusion circuit used in our experiment was volume 
controlled.  High  perfusion  pressure  indicates  increased  intravascular 
resistance  and  could  be  a  marker  of  severe  micro-vascular  injury.  A pilot 
study  to  investigate  the feasibility o f  hypothermic  machine  perfusion  of 
porcine  pancreases was  carried  out  (Appendix  1).  It  was  found  that  the 
perfusion parameters correlated with the levels of activated caspase 3 levels 
in the  pancreatic tissues. This once  again suggests that  organs with  high 
intravascular resistance are pre-damaged. It corroborates the data from the 
rat  study  suggesting  a  possible  role  of  this  preservation  technique  in 
identifying grafts that are not suitable for islet isolation.
The  portal  vein  was  used  as  the  inflow  for  oxygen  persufflation  in  the 
experiments. This enables oxygen to reach the entire vascular network in the 
pancreas, spleen and the duodenum. Small punctures on the surface of the 
spleen were made to decompress the system and allow for the oxygen to 
escape. There is a theoretical risk of oxygen bypassing the venules of the 
pancreas and duodenum by directly escaping through the spleen. However 
because the punctures are very superficial, there would still be a pressure 172
gradient within the vascular system that would improve diffusion of oxygen to 
the pancreas. While persufflation studies of liver and kidneys have involved 
decompression through punctures directly on the surface of the preserved 
organ  we  avoided  it  in  the  pancreas  for  risk  of  creating  leaks  into  the 
pancreatic  duct  system  which  might  compromise  ductal  collagenase 
injection.
The objective of this phase of the study was to investigate whether islet yield 
from non-heart-beating-donor rat pancreas could be improved by alternate 
means  of  preservation.  We h ave  shown  that  portal  venous  oxygen 
persufflation improves islet yield in terms of islet numbers and equivalents. 
Islets from this preservation group also had improved viability, morphology, 
decreased fragmentation and improved in vitro function as compared to static 
cold storage. Both portal venous oxygen persufflation and two layer method 
improve  tissue  oxygenation.  The  advantage  of  portal  venous  oxygen 
persufflation is that it does not depend entirely on the ability of oxygen to 
diffuse  into  the  pancreas.  Studies  have  shown  that  two-layer  method 
oxygenates only the outer part of the pancreas leaving the core parenchyma 
ischaemic[156]. While this may not be important in the rat pancreas which is 
very  thin, it  would  be  particularly r elevant  for  large  animal  and  human 
pancreases. Hypothermic machine perfusion also improved islet parameters 
as compared to static cold storage in our study. The study did not identify 
significant differences between these two groups, but there was a trend for 
improved preservation with persufflation. In view of these results we feel that 
portal  venous  oxygen  persufflation  has  greater  potential  for  clinical 
application and have chosen this technique for further investigation.173
5.1 Background
Phase  I  of  the  study  (Chapter  4)  showed  that  portal  venous  oxygen 
persufflation  provided  the  best chance  of  improved  pancreas  preservation 
and islet yield. It resulted in a significant increase in purified islet equivalent 
yield. Islets from pancreases preserved by portal venous oxygen persufflation 
also had better viability, morphology and in vitro functionality as compared to 
static cold storage. 
The  mode  of  action  of  portal  venous  oxygen  persufflation  has  been 
investigated in the area of liver preservation. Reports have suggested that 
portal  venous  oxygen  persufflation  leads to  increased  cellular  ATP 
levels[186,  222] and  decreases the extent  of  apoptosis  in  the  graft[185]. 
Pancreas  preservation is complicated because the  exocrine component  of 
the pancreas produces multiple lytic enzymes. Warm and cold ischaemia and 
subsequent  reperfusion  can  lead  to  extravasation  of  these  enzymes[223]. 
The extravasated enzymes can cause breakdown of cellular components and 
exacerbate tissue injury. This is one of the causes of post transplant graft 
pancreatitis in whole organ pancreas transplantation. Reperfusion injury is 
also  relevant  in  islet  transplantation.  Increased  levels  of  amylase  in 
preservation fluid around a pancreas graft has been reported to correlate with 
low islet yield and poor in vitro islet function[224]. It can also occur during the 
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digestion of pancreas, islet purification and after transplantation. Reperfusion 
injury is an important component of the IBMIR which is responsible for the 
loss of transplanted islets that  occurs  within  hours of islet transplantation. 
Measures  to  reduce  the  severity o f  reperfusion  injury  in  the non-heart-
beating-donor  pancreas  can  improve  outcomes  after  both islet  and  whole 
organ  pancreas  transplantation.  This  phase  of  the  study w as  aimed  at 
evaluating the effect of portal venous oxygen persufflation on the severity of 
reperfusion injury in the non-heart-beating-donor rat pancreas compared to 
static cold storage. 
5.2 Methods
5.2.1 Overview of the study
The plan of the study is depicted in the flow chart (Figure 40). The study 
included two experimental arms and one control arm. Male Wistar rats (350-
400g) were  used  for  the  study.  The  retrieval  of  the  pancreas  and  the 
techniques  of  pancreas  preservation  have  been  described  previously
(Sections 3.1 & 2.3.2). In the experimental arm, 14 non-heart-beating-donor 
rat pancreases were preserved by static cold storage (n=6) or portal venous 
oxygen persufflation (n=8). The duration of warm ischaemia was 35 minutes. 
The duration of cold preservation was extended to 16 hours in an attempt to 
induce  a  severe  ischaemic  injury. The  pancreases  then  underwent 
oxygenated warm reperfusion for 60 minutes. In the control arm, four animals 
were killed by cervical dislocation and underwent an immediate laparotomy. 
They were rapidly exsanguinated and pancreatic tissue was collected. Tissue 
was processed for caspase 3 activity, TBARS assay and RNA extraction.175
Figure 40 Flow chart depicting the plan of study for Phase 2 (opposite page)
Comparison of the severity of reperfusion injury after oxygenated warm reperfusion 
of non-heart-beating-donor pancreases preserved with static cold storage and portal 
venous  oxygen persufflation.  Rat  pancreases  retrieved  after  35  minutes  of  warm 
ischaemia  were  preserved  by  either  static  cold  storage  or  portal  venous  oxygen 
persufflation  for  16  hours.  After  cold  preservation  they  were  re-warmed  and 
subjected  to  60  minutes  of  oxygenated  warm  reperfusion  using  Krebs-Henseleit 
buffer through the aortic cannula at 37°C. Portal venous effluent was collected at 
timed  intervals  from  the  portal  vein  catheter.  These  samples  were  analyzed  for 
exocrine enzymes (amylase, lipase), glycerol, lactate, pyruvate and nitrates. After 
completion of reperfusion, biopsies of the pancreas were collected and processed for 
estimation of malondialdehyde levels (lipid peroxidation), activated caspase 3 levels 
(apoptosis). RNA was extracted immediately from pancreas biopsies and stored at -
80°C for microarray analysis. A control arm (not shown) was also included. Here 
pancreas  biopsies  were  taken  from  freshly  killed  rats  and  were immediately 
processed for malondialdehyde and activated caspase 3 level estimation and for RNA 
extraction.176177
5.2.2 In vitro warm oxygenated reperfusion of rat pancreas
Preparation of the perfusion medium
The perfusion fluid used for the reperfusion experiments was Krebs-Henseleit 
solution. 500ml of the solution was made fresh for each experiment using the 
commercially available powder and sterile de-ionised water (section 2.3.1). 
The pH of the solution was adjusted to 7.4±0.1. The fluid was warmed to 
37°C in a water bath and maintained at that temperature. The mouth of the 
sterile beaker containing the solution was covered with aluminium foil. The 
solution was oxygenated with a mixture of oxygen and carbon dioxide (95% 
and 5% respectively) bubbled into the perfusion fluid for at least 15 minutes 
before  the start  of  reperfusion  and  continued  throughout  the reperfusion 
period.  This  ensured  that  the partial  pressure  of  dissolved  oxygen  in  the 
solution was at least 450-500mmHg. The pH of the solution was monitored 
and  maintained  at  7.4±0.1  by  addition  of  small  quantities  of  0.1N 
Hydrochloric acid or 0.1N Sodium hydroxide.
Procedure of warm oxygenated reperfusion
After  16  hours  of  static  cold  storage  or  venous  oxygen  persufflation,  the 
pancreas was allowed to re-warm to room temperature in UW solution over 
20 minutes. This is to simulate the gradual re-warming of the organ during 
implantation[225].  It  was  then  placed  in  the perfusion  chamber  containing 
approximately 50ml of warm oxygenated Krebs-Henseleit solution. The aortic 
cannula was connected to the reperfusion circuit. A bubble trap was used in 
the inflow to prevent air bubbles from entering the pancreas. Re-perfusion 
was started at the slowest rate (3 cycles per minute) and gradually increased 178
over the next 4-5 minutes to achieve an initial perfusion pressure of 60±2 
mmHg. The perfusion pressure of 60mmHg was chosen because it is closer 
to  the  physiological  blood  pressure  (80-90mmHg)  and  can  thus  ensure 
uniform perfusion and oxygenation of the tissues.  This flow rate was then 
fixed  for  the  entire  re-perfusion  duration.  The  perfusion  pressure  was 
continuously m onitored  and  recorded  as  a  surrogate  measure  for  the 
vascular  resistance  during  the reperfusion  period.  The  pancreas  was  re-
perfused  for  a  maximum  duration of  60  minutes.  Venous  effluent was 
collected  directly f rom  the  portal  vein  catheter  in  labelled  cryovials  (1ml  
each) at pre-determined time points (5, 20, 40 and 60 minutes) and stored at 
-20°C  for  later  analysis.  The  remaining  venous  effluent drained  into  the 
perfusion chamber. This was transferred intermittently using a clean 20 ml 
syringe back into the main reservoir.
At the end of warm reperfusion, pancreas was biopsied with scissors. One 
biopsy was held with a forceps and kept immersed in a flask containing liquid 
nitrogen until the bubbling had stopped. The biopsy was then transferred into 
a  labelled  cryovial  and  stored  at  -80°C.  Another  biopsy  was  immediately 
processed for RNA extraction. 
5.2.3 Measurement of  amylase and lipase levels
Amylase and lipase are enzymes produced in the pancreatic acini. They are 
only released into the blood circulation by injured exocrine tissue. Levels of 
these enzymes in the portal venous effluent give a measure of  tissue injury 
during reperfusion. Effluent samples were collected at specific time periods 
and stored at -20°C.They were analysed for amylase and lipase levels using 179
a commercially available radioimmunoassay kit. These assays were kindly 
carried out by Dr Peaston, Department of Biochemistry, Freeman Hospital, 
Newcastle upon Tyne.
5.2.4 Measurement of fluid glycerol, lactate and pyruvate levels 
Portal  venous  effluent samples  collected  at  timed  intervals  during  the 
reperfusion period were stored at -20°C until analysis. These were batched 
analysed  using  the  CMA600  Micro  dialysis  analyser  according  to 
manufacturer's  instructions.  All  three  assays  were  based  on  the  ultimate 
production of the red-violet coloured quinoneimine. The rate of formation of 
this product was measured photometrically at 530 nm and was proportional 
to the substrate concentration. Detailed reactions involved in these assays 
are included in appendix 2 of this thesis. 
5.2.4 Estimation of fluid Nitrite levels
Estimation of nitrite levels in the fluid was used as a marker of nitric oxide 
production during reperfusion. Griess reagent kit for Nitrite determination was 
used with minor modifications to manufacturer’s instructions. Briefly, Griess 
reagent was freshly prepared according to manufacturer's instructions. In a 
microtitre plate, 20 µl of Griess reagent was added to wells containing 280 µl
of  the  test  fluid samples  in  duplicate.  The  plate  was  incubated  at  room 
temperature  for  30  minutes.  The  plate  was  then  read  at  548nm  in  a 
spectrophotometric plate reader. A calibration curve was prepared by using 
sodium  nitrite  solutions  at  concentrations  ranging  from  1-100µM.  Nitrite 180
concentrations in the test samples were then calculated using the standard 
calibration curve. 
5.2.5 Preparation of tissue extracts
Lytic enzymes  (trypsin,  chymotrypsin,  DNA  and  RNA  nucleases)  released 
from  the  pancreas  can  breakdown  cellular  proteins,  enzymes  and  nucleic 
acids. The extent of proteolysis can be limited by storing the specimens at -
80°C,  homogenisation on  ice  and  addition  of  protease  inhibitors  to  the 
homogenisation buffer. RIPA buffer with PMSF was used for homogenisation 
of  the  pancreatic  tissues.  The  rationale  and  actual  technique  of 
homogenisation  has  been described  in  the  method  development  chapter 
(section 3.5.4).
5.2.6 Estimation of thio-barbituric acid reactive substances 
(TBARS) in tissue extracts
The protocol used was modified from the original protocol by Okhawa and 
co-workers in 1979 [226] (available at http://www.mccullylab.org.tbarsassay , 
retrieved on 25 June 2009).
Malondialdehyde (MDA) standards  were  prepared  by  diluting  pure  1,1,3,3 
Tetra-methoxy propane (6M) with 1.15% potassium chloride solution. Initially 
a  100  mM  stock   s olution  of  malondialdehyde  was  prepared.  The  stock 
solution was further diluted to make a 100 µM solution. This was used to 
make  50µM,20µM,10µM,  7.5µM,  5µM,  4µM,  2µM,  1µM  and  0.5µM 
concentrations using 1.15% potassium chloride solution.
For the assay, 500µl of standards (0.5µM to 50µM) in duplicate were added 
to labelled 15ml centrifuge tubes. 500µl  aliquots of tissue extract were also 181
added in duplicates to labelled tubes. 0.2 ml of 8.1% sodium docyl sulphate 
and 1.5ml of 20% acetic acid were added in sequence to all samples and 
standards with vigorous mixing after each step. The pH was adjusted to 3.5 
with 10 M sodium hydroxide. 1.5 ml of 0.8% aqueous thio-barbituric acid was 
added to the mixture. The volume was made up to 4 ml by adding 250 µl of 
distilled water. The tubes were capped and placed in standing position in a 
boiling water bath for 60 minutes. The tubes were then cooled in a cold water 
bath. To each tube 3 ml of N-butanol/pyridine (15:1 volume by volume) was 
added. The tubes were shaken to mix well and then centrifuged at 800g for 
10 minutes. The upper organic layer from each tube was carefully removed 
and  transferred  to  numbered  glass  cuvettes.  The  absorbance  of  the 
supernatant was read at 532 nm in a spectrophotometer. Thio-barbituric acid 
reactive  substances  (TBARS  in  µM)  in  the  test  samples  were  calculated 
using the following formula.
TBARS = At/As x Cs x 14 where,
At was absorbance of test sample
As was absorbance of the standard closest to the range of results  
Cs was the MDA concentration with absorbance of As
14 was for the dilution used (when 500 uL of test tissue extract was assayed 
in a final total volume of 7 mL) 
The protein content in the tissue extracts was assayed using the Quant-iT 
protein assay kit according to manufacturer’s instructions. The extent of lipid 
peroxidation was reported as µmoles of TBARS per mg protein.182
5.2.7 Microarray analysis
RNA was extracted from pancreatic biopsies taken at the completion of warm 
reperfusion. The technique of RNA extraction is described in chapter 3. 
Analysis of microarray data is described in chapter 6. The expression of 
genes associated with apoptosis, oxidative stress and anti-oxidant 
mechanisms are presented here.
5.2.8 Sample size estimation
Sample size calculations were not carried out for this phase of the study as it 
was primarily exploratory.183
5.3 Results
Persufflation  pressure  data  was  not  recorded  in  one  pancreas  due  to 
technical problems. In the remaining seven pancreases, the mean starting 
persufflation pressure was 14.8 mmHg. The general trend was a decrease in 
the  persufflation  pressure  over  the duration  of  preservation.  The  average 
persufflation pressure decreased by 25% in the first 3 hours of persufflation. 
5.3.1 Reperfusion parameters
The  mean  initial  flow  rate  was  50cycles/minute  (4.5  ml/min)  in  both 
preservation  groups.  This  resulted  in  an  initial  perfusion  pressure  of 
60.5mmHg  for  the cold  storage  group  and  59.6mmHg  for  the  oxygen 
persufflation  group.  The  pressure  gradually  decreased  to  50.1mmHg  and 
46.6mmHg respectively after one hour of re-perfusion. The pressures were 
not significantly different between the two study groups (Figure 41).
Re-perfusion for 60 minutes was completed in 12 pancreases. Re-perfusion 
was stopped in two cases at 45 and 52 minutes respectively due to leakage 
of  duodenal  contents in  one  pancreas  and  tipping  over  of  the perfusion 
chamber in another. In both cases the pancreas was immediately biopsied 
and tissue processed for analysis. 
In three cases (all preserved with portal venous oxygen persufflation) visible 
duodenal peristalsis was documented during reperfusion. This started at 15, 
20 & 15 minutes after the start of reperfusion and continued throughout the 
reperfusion period.  The increased intra-duodenal pressure due to peristalsis 
in one pancreas led to release of duodenal contents (video clips in attached 184
CD). There was no visible peristalsis seen in any pancreases from the static 
cold storage group.
Figure 41 Mean perfusion pressures in the two preservation groups during warm re-
perfusion
Line chart showing the comparative perfusion pressures during the reperfusion 
period. The truncated Y axis shows the perfusion pressure in mm of mercury. The X 
axis shows the time points during the reperfusion. The data points indicate the mean 
pressure in the preservation group at each time point. The error bars represent one 
standard error of mean. There was no significant difference in the perfusion 
pressures between the two study groups.185
5.3.2 Analysis of portal venous effluent
There was a steady increase in the concentrations of amylase and lipase in 
the portal venous effluent over the duration of reperfusion. The increase was 
not uniform throughout the preservation period. It was mainly restricted to the 
time  interval  between  20  - 40  minutes  for  amylase  and  between  40-60 
minutes for lipase. This trend was similar in both preservation groups. There 
was  no  significant  difference  in  the enzyme  concentrations  in  pancreases 
preserved by static cold storage or venous oxygen persufflation at any of the 
time points (Figures 42,43).
There was a serial increase in the glycerol levels in the effluent during warm 
reperfusion.  The  glycerol  levels  in  the  portal  venous  oxygen  persufflation 
group were higher than the static cold storage group though the difference 
was  not statistically s ignificant  (Figure  44).  The  lactate:pyruvate  ratio  was 
higher  in  the  venous  oxygen  persufflation  group  after  5  minutes  but the 
difference was not statistically different (Mann Whitney U, p=0.093). There 
was an initial dip in the ratio at 20 minutes which was more prominent in the 
venous oxygen persufflation group followed by a progressive increase in the 
lactate  pyruvate  ratio  during  the remaining  duration  of reperfusion  (Figure 
45).
The fluid nitrite levels could not be assayed as the Griess reagent kit was not 
sensitive enough for the low nitrite concentrations in the effluent samples. 186
Figure 42 Effluent amylase concentrations during warm re-perfusion
The amylase concentration in the portal effluent collected at each time point during 
warm reperfusion was  compared between static cold storage and venous oxygen 
persufflation groups. The time point during reperfusion is denoted on the X axis. The 
amylase concentration in international units is denoted on the Y axis. The data points 
denote the mean amylase concentration. The error bars denote one standard error of 
mean. A serial increase in amylase levels throughout the reperfusion was noted (5-10 
fold,  median  increase  6.7  fold).  The  increase  was  maximal  between  20  and  40 
minutes of reperfusion. There was no statistically significant difference in amylase 
concentrations between the two preservation groups at any time point.187
Figure 43 Effluent lipase concentration during  warm re-perfusion
The lipase concentration in the portal effluent collected at each time point during 
warm reperfusion was  compared between static cold storage and venous oxygen 
persufflation groups. The time point during reperfusion is denoted on the X axis. The 
lipase concentration in international units is denoted on the Y axis. The data points 
denote the mean lipase concentration. The error bars denote one standard error of 
mean. A serial increase in lipase levels throughout the reperfusion was noted (5-75
fold,  median  increase  9.8  fold)  The  increase  was  maximal  between  40  and  60 
minutes  of  reperfusion.  There  was  no  statistically  significant  difference  in  lipase 
concentrations between the two preservation groups at any time point.188
Figure 44 Glycerol concentration in the venous effluent during warm re-perfusion
The glycerol concentration in the portal effluent at each time point during warm 
reperfusion was compared between the static cold storage and the venous oxygen 
persufflation groups. The glycerol concentration is denoted on the Y-axis. The time 
points during reperfusion was denoted on the X axis. The bars represent the mean 
glycerol concentration. There was a gradual increase in the glycerol levels during 
the  reperfusion  period.  The  increase  was  more  prominent  between  20  and 40 
minutes. There was a tendency towards increased levels in the portal venous oxygen 
persufflation group. The difference was not statistically significant. 189
Figure 45 Lactate:pyruvate ratio in the venous effluent during warm re-perfusion
The lactate pyruvate ratio in the portal effluent at each time point during warm 
reperfusion was compared between the static cold storage and the venous oxygen 
persufflation groups. Both lactate and pyruvate levels were presented as µM. The 
ratio is denoted on the Y-axis. The time points during reperfusion were denoted on 
the X axis. The bars represent the mean lactate pyruvate ratio. There was a tendency 
towards  increased  levels  in  the  portal  venous  oxygen  persufflation  group.  The 
difference was not statistically significant. The lactate:pyruvate ratio in blood at rest 
is  about  10.  Levels  greater  than  20  indicate  an  oxygen  debt  i.e.  anaerobic 
respiration[48].190
5.3.3 Estimation of lipid peroxidation
Thio-barbituric acid reactive substances (TBARS) in the tissue extracts were 
determined to estimate the extent of lipid peroxidation (Figure 46). The levels 
of TBARS in the non-heart-beating-donor pancreas group were significantly 
higher than the control group pancreas. (19.6 nmoles/mg protein in NHBD
group and 6.7 nmoles/mg protein in control group, T test, p=0.008). Within 
the  two  non-heart-beating-donor  preservation  groups,  levels  in  the  portal 
venous  oxygen  persufflation  group  were  higher.  The  difference  was  not 
statistically significant (17.2 nmoles/mg protein in static cold storage group 
and 22.3 nmoles/mg protein in the portal venous oxygen persufflation group. 
(t test, p=0.206).
5.3.4 Estimation of activated caspase 3
The activated caspase 3 levels in the tissue extracts were measured using a 
modification of the manufacturer's protocol as previously discussed (section 
3.5.4 ). It was not significantly different between the control group and NHBD
group  (0.215  µmoles pNA/mg  protein  and  0.109  µmoles pNA/mg  protein 
respectively; t test, p=0.379). There was no significant difference in caspase 
3 activity between the two preservation groups (Figure 47). 191
Figure 46 Comparison of TBARS in tissue extracts of control and two preservation 
groups.
Bar graph showing the thio-barbituric acid reactive substances (TBARS) levels in 
tissue extracts from pancreases preserved by  the static cold storage (n=6), portal 
venous oxygen persufflation group (n=8) and control pancreas group (n=4). 192
Figure 47 Comparison of activated caspase 3 levels in the tissue extracts of control 
group and two preservation groups.
Activated caspase 3 was measured as the amount of p-nitroaniline  (pNA) released 
from the sample tissue extract after overnight incubation with the peptide substrate 
Ac-DEVD-pNA. The assay procedure was modified as described in section 3.5.4  to 
account for the non-specific background absorbance.  Bar graph showing the mean 
pNA levels in tissue extracts from the static cold storage (n=6), portal venous oxygen 
persufflation group (n=8) and control pancreas group (n=4). 193
5.3.8 Apoptosis and anti-apoptosis- Microarray data
General description of apoptotic pathways is given in chapter 1. The following 
MAPP diagram represents the interactions between the various gene 
products involved in apoptosis (Figure 50).
Apoptosis can be initiated through the death receptor pathway or the 
mitochondrial pathway. Apoptosis by the death receptor pathway is initiated 
by the binding of ligands such as TNFα to the cell surface receptors of the 
tumor necrosis factor receptor family. This leads to receptor aggregation and 
recruitment of procaspase 8 and the adapter molecule FADD to form the 
death inducing signalling 
complex  (DISC).  This  complex  leads  to  the  cleavage  and  activation  of 
caspase 8. This activates the effector caspases 3,7 and 2. It also cleaves Bid 
to  tBid.  Bid  is  a  pro-apoptotic  protein  residing  in  the  cytoplasm  which  on 
cleavage moves to the mitochondria to activate the mitochondrial pathway of 
apoptosis.  The  mitochondrial  pathway  is  activated  by  intracellular  stress 
signals.  These  activate  the  pro-apoptotic  bcl2  proteins  such  as  Bax  to 
increase the permeability of the outer membrane of the mitochondria. This 
leads to the leakage of cytochrome c from the inter-membrane space into the 
cytoplasm. The leaked cytochrome c forms the apoptosome in combination 
with Apaf1 and Caspase 9. This complex cleaves the effector caspases 3 
and 7. Action of the effector caspases on a multitude of intracellular proteins 
leads to cell death and the characteristic features of apoptosis. Anti-apoptotic 
proteins are primarily the bcl2 proteins that stabilize the mitochondrial outer 
membrane  and  prevent  cytochrome  c  leakage,  inhibitors  of  apoptosis 
proteins  which  inhibit  the caspases,  CFLAR  (FLIP)  which  regulates  the 194
activation  of  caspase  8  by  the death  receptor  complex.  Activation  of  the 
TNFΑ receptor family can also lead to activation of the NF-κB pathway and 
the  JNK/MAPK  pathways.  Both   t hese  pathways  lead  to  the  increased 
transcription  of  inflammatory  cytokines.  NF-κB  has  a  cyto-protective,  anti-
apoptotic  function  by  inducing  the production  of  multiple  anti-apoptotic 
proteins. JNK/MAPK has a pro-apoptotic
Differential expression in pancreas preservation groups
Initiators  of  apoptosis  such  as  Tumour  necrosis  factor  alpha  (TNFα)  and 
proteins involved in the transduction of apoptotic signals from TNFR and TLR 
were differentially expressed in both preservation groups when compared to 
control group. Caspase 8 was over-expressed in the portal venous oxygen 
persufflation group while Caspase 1 was under-expressed in the static cold 
storage group. Death receptor pathway was significantly over-represented in 
the  portal  venous  oxygen  persufflation  group.  Genes  coding  for  the  pro-
apoptotic BH3 proteins, BID and PUMA were differentially expressed in static 
cold storage. Bid was under-expressed and PUMA was over-expressed (fold 
change 3.4). Other pro-apoptotic Bcl-2proteins involved in the mitochondrial 
pathway of apoptosis were not differentially expressed in either preservation 
group (Figures 48,50).
The  effector  pathway  of  apoptosis  including  terminal  caspases  was  not 
differentially e xpressed  in  either  preservation  group  in  comparison  to  the 
control  group.  Inter-group  comparison  revealed  a  2.0 fold  increased 
expression of caspase 3 in the portal venous oxygen persufflation group as 
compared to the static cold storage group. 195
Figure 48 Bar diagram comparing the fold change of differentially expressed genes 
involved in the initiation and transduction of apoptosis.
Figure  in  opposite  page.  The  vertical  axis  indicates the  symbols  of  relevant 
differentially expressed genes. The fold change is denoted on the horizontal axis. 
Both over-expression (to the right) and under-expression (to the left) are depicted. 
By  definition,  fold  changes  between  -1.0  and  +1.0  cannot  exist.  The  cut  off  for 
significant differential expression used in the analysis was 2.0. Hence genes with fold 
change changes between -2.0 and -1.0 or between +1.0 and +2.0 are not shown. If a 
gene is differentially expressed in one group only, then it is represented with the 
correct fold change for that group and an arbitrary fold change value set at 0.2 for 
the second group.
The genes shown are inducers of apoptosis (TNFα, IL1β), components of the TNF 
receptor complex and proteins involved in transduction of apoptotic signals through 
the  death  receptor  pathway  (TNFRSF1A  and  TNFRSF21,  TANK,  RIPK1,  RELA, 
MYD88,  IRAK2),  caspase  proteins  (CASP1,  CASP8)  and  BH3  domain  protein 
linking the death receptor and mitochondrial pathways of apoptosis (BID)196
Figure 48: Legend in opposite page197
Genes coding for 20 proteins with anti- apoptotic properties were differentially 
expressed in the two preservation groups when compared to control group 
(17 in PVOP group and 16 in SCS group). 
This was more prominent in the portal venous oxygen persufflation group. 
Inter-group comparison (PVOP vs SCS, fold change ≥2.0) showed that nine 
genes  were  significantly o ver-expressed  in t he  portal  venous oxygen 
persufflation  group  as  compared  to  the static  cold  storage  group.  These 
included Bcl2a1, inhibitor of apoptosis proteins (BIRC2, BIRC3), PIM2 and 
PEA15. Three  genes  were  significantly o ver-expressed  in  the static  cold 
storage  group  when  compared  to the  portal  venous  oxygen  persufflation 
group.  These  included  the enzyme m itochondrial  superoxide  dismutase
(SOD2) (Figure 49,50).198
Figure 49 Bar-chart comparing the differential expression of genes encoding proteins 
with anti-apoptotic functions between the two preservation groups.
Figure in next page. The vertical axis indicates the symbols of relevant differentially 
expressed  genes.  The  fold  change  is  denoted  on  the  horizontal  axis.  Both  over-
expression  (to  the  right)  and  under-expression  (to  the  left)  are  depicted.  By 
definition,  fold  changes  between  -1.0  and  +1.0  cannot  exist.   T he  cut  off  for 
significant differential expression was 2.0. Hence genes with fold change changes 
between  -2.0  and  -1.0  or  between  +1.0  and  +2.0  are not  shown.  If  a  gene  is 
differentially expressed in one group only, then it is represented with the correct fold 
change for that group and an arbitrary fold change value set at 0.2 for the second 
group.
Genes  differentially  expressed  included  chaperone  proteins  such  as  heat  shock 
proteins  (HSPB1,  HSPB1,  DNAjB9),  haeme-oxygenase  1  (HMOX),  inhibitors  of 
apoptosis (BIRC2, BIRC3), anti-apoptotic Bcl2 proteins (Bcl2a1), inhibitor of death 
receptor pathway (CFLAR, PEA15), inhibitors of pro-apoptotic BAD (PIM2) and the 
mitochondrial  form  of  super-oxide  dismutase.  There  was  increased  expression  of 
anti-apoptosis related genes in the portal venous oxygen persufflation group.199
Figure 49 : legend in opposite page200
Figure 50 Pathway diagram of apoptosis demonstrating the differential expression of 
genes in the static cold storage (SCS) and portal venous oxygen persufflation (PVOP) 
groups
Figure in opposite page.
MAPP demonstrating  apoptotic and anti-apoptotic mechanisms. This MAPP was 
modified from the version available at GenMAPP version 2.1. Genes are denoted by 
rectangles with arrows  showing the  relation between  individual genes. Red  lines 
connecting genes indicate pro-apoptotic action, blue  lines indicate anti-apoptotic 
mechanisms. The rectangle for each gene is split into two parts to show the nature of 
differential  expression  of  that  particular  gene  for  each  of  the  two  preservation 
groups.  The  colour  codes  for  over-expression  and  under-expression  for  each 
preservation group are noted in the diagram legend.201
Detailed legend in previous page202
5.3.9 Oxidative stress and anti-oxidant mechanisms- Microarray data
Genes  whose  expression  is k nown  to  be  modified  by o xidative  stress  were 
differentially  expressed  in b oth  preservation  groups.  Twenty  genes  were 
differentially expressed in the Portal venous oxygen persufflation preservation 
group as compared to 14 genes in the static cold storage group. Inter-group 
comparison identified six genes which were differentially expressed between the 
two preservation groups. Five of these genes were over expressed in the portal 
venous oxygen persufflation group while one gene was over-expressed in the 
static  cold  storage  group  (mitochondrial  super-oxide  dismutase). G enes  over 
expressed  in  the  portal  venous  oxygen  persufflation  group  included  pro-
inflammatory genes (VCAM and CCL5) and genes coding for proteins with anti-
oxidant  functions  i.e. NAD(P)H  dehydrogenase  (NQO1),  NRF2  and  NF-κB1 
(Figures 51 & 52).203
Figure 51 Bar-chart comparing the differential expression of genes coding proteins with 
anti-oxidant roles in the two preservation groups
Bar chart comparing differential expression of genes involved in the cellular response to 
oxidative stress between the two preservation groups. Nuclear factor 2 is a transcription 
factor that induces the expression of several proteins with anti-oxidant functions such as 
thioredoxin (TXNRD1), glutathione-cysteine ligase (GCLC) and NAD(P)H 
dehydrogenase. They were all preferentially over-expressed in the portal venous oxygen 
persufflation group. Haemoxygenase 1 (HMOX1) was over-expressed in both groups. 
Mitochondrial superoxide dismutase was over-expressed exclusively in the static cold 
storage group while the extracellular form of super-oxide dismutase (SOD3) was under-
expressed in portal venous oxygen persufflation group alone. Sestrin1 and 3 which have 
a role in regeneration of oxidized peroxiredoxins were suppressed in both groups.204
Figure  52 MAPP  diagram  depicting  the  cellular  response  to  oxidative s tress  and  the 
differential expression of involved genes in the two preservation groups
MAPP demonstrating  cellular antioxidant mechanisms. This MAPP was modified from 
the version available at GenMAPP version 2.1. Genes are denoted by rectangles with 
arrows showing the relation between individual genes. The rectangle for each gene is 
split into two parts to show the nature of differential expression of that particular gene 
for each of the two preservation groups. The colour codes for over-expression and 
under-expression for each preservation group are noted in the diagram legend. 
Oxidative stress occurs due to an excess formation of reactive oxygen species. Reactive 
oxygen species activate the JNK/MAPK pathways and also stimulate the production of 
immediate early genes such as cFos and Junb. Multiple transcription factors including 
NRF2 and NF-ΚB are activated leading to the production of anti-oxidant proteins such 
as enzymes involved in glutathione metabolism, super-oxide dismutase, thioredoxin. 
Reactive oxygen species causes repression of multiple genes including oxidases such as 
xanthine oxidase which are involved in ROS generation and transcription factors such 
as Nuclear factor 1 (NFIX) and cytochrome p450 system[227]. 205
5.4 Discussion
These experiments have shown no improvement in the markers of reperfusion 
injury with portal venous oxygen persufflation of the non-heart-beating-donor rat 
pancreas compared to static cold storage. 
In vitro warm reperfusion is a well established technique to assess reperfusion 
injury in cells, tissues and organs. The technique of in vitro reperfusion used in 
the  study  has  been  described previously  for  the  liver, kidneys  and  pancreas 
[184,  190,  222,  228].  The  technique  provides  preliminary  data  regarding  the
severity  of  reperfusion injury  in  the  graft  without  the  need  for  actual 
transplantation.  It  also  has  the  advantage  of  not  utilizing  blood  products  or 
protein solutions. Krebs-Henseleit buffer is widely used in this technique[190]. It 
contains glucose as a source of energy and bicarbonate as the buffer.  Krebs-
Henseleit  buffer  was  used  without  addition  of  colloids in t hese  experiments. 
Some authors have however advocated the addition of albumin to the buffer as 
a  means  of i mproving  the  quality  of w arm  reperfusion[229].  Maintenance  of 
perfusate pH within the physiological range, close monitoring of temperature and 
adequate oxygenation of the perfusate are other important aspects that have 
been  reported  to a ffect  experimental  results.  The  perfusate  temperature  was 
maintained at 37°C and the pH was monitored and maintained close to 7.4. A 
mixture  of o xygen  and  carbon  dioxide   ( 95%  and  5%)  was  used  to  provide 
oxygenation.  This  has  been  shown  to p rovide  sufficient  oxygen levels  in  the 
perfusate. The carbon dioxide improves the buffering capacity of bicarbonate in 206
the Krebs-Henseleit solution. The perfusion flow rate is another key factor in this 
technique. The rate of perfusion should be enough to provide sufficient oxygen 
to  the  tissues  and  low  enough  to  avoid  baro-trauma.  Studies using warm 
reperfusion of the isolated rat liver have suggested a flow rate of 3.0ml/gram 
tissue/minute[190]. The average weight of the rat pancreas with duodenum and 
spleen as used in our experiment was 9 grams. This would indicate an ideal flow 
rate of 27 ml/minute. Such high flow rates could be not achieved during initial 
trials. This could be due to the small capacity of the pancreatic vascular bed in 
comparison to the liver. The injury to the microvasculature from warm and cold 
ischaemia  would  also  be  expected  to  increase  vascular  resistance  in t he 
pancreas.  Other  researchers have  used  isolated pancreas  perfusion at  lower 
flow  rates[230].  The perfusion  flow r ate  was  hence  adjusted  to  simulate 
physiological perfusion pressures. It is possible that the resultant flow rate (4.5 
ml/minute)  in  the  circuit  was  not  sufficient  to o xygenate  the  pancreas.  The 
experimental  setup  therefore had  the  potential  to  drive  the  warm  ischaemia 
injury during the reperfusion phase.
Studies  have  shown  that  the  exocrine  component  of t he  pancreas  is m ore 
susceptible to reperfusion injury than the endocrine component [138]. Pancreatic 
exocrine enzymes are released into the circulation following acinar damage as 
in pancreatitis and pancreatic reperfusion injury[231]. We measured the levels of 
amylase  and  lipase  in the portal effluent as a  marker  of pancreatic  exocrine 
injury. Cell  membrane  damage  is  an  important  component  of  ischaemia  and 
reperfusion injury.  This is caused during both warm and cold ischaemia due to 207
depletion of ATP reserves and during reperfusion due to production of reactive 
oxygen species. Glycerol is a component of cell membranes. Increased serum 
and  interstitial  glycerol  levels  have  been  reported  to  predict  cell  membrane 
injury[232,  233].  Studies  have  shown  increased  interstitial  levels  of g lycerol 
during  cold  ischaemia[233].  The  impact  of  reperfusion  on  interstitial  glycerol 
levels depends on several factors. In cases where the ischaemic injury is small 
and  reperfusion  is s atisfactory t here  is a  p rompt  decrease  in  the  interstitial 
glycerol  concentrations suggestive  of a n  arrest  of  further  cell  membrane 
damage. In cases where ischaemia is prolonged, glycerol concentrations remain 
high due to severe ongoing reperfusion injury[233]. 
The lactate:pyruvate ratio has been reported as a surrogate marker for oxygen 
debt[48]. The normal lactate:pyruvate ratio in the blood is approximately 10. In 
instances  of  anaerobic  respiration  and  lactic  acidosis  the  ratio  can  go  up  to 
40[48].  Studies of experimental and clinical liver transplantation have identified 
characteristic  changes in t his  ratio during  the  phases  of donor  retrieval,  cold 
ischaemia, re-warming and reperfusion [234-236]. The ratio is low during cold 
ischaemia with low levels of both lactate and pyruvate, increases during anoxic 
re-warming and decreases sharply after reperfusion with a decrease in lactate 
and  increase  in  pyruvate  concentrations  as  aerobic  respiration  ensues. 
Increased lactate:pyruvate ratio following reperfusion indicates 'no-reflow' i.e., 
insufficient  delivery  of  oxygen  or  disruption  of c ellular  apparatus  for  aerobic 
respiration. 208
Analysis of timed effluent samples in our study showed interesting trends. The 
levels of exocrine enzymes and glycerol were similar in both groups at 5minutes 
and at 20 minute time points. There was a decrease in the lactate:pyruvate ratio 
between the two time points. The later was more prominent in the portal venous 
oxygen  persufflation group. After 20 minutes the levels of exocrine enzymes, 
glycerol and lactate:pyruvate ratio increased in both preservation groups. 
There  could  be  several  factors  contributing  to  these  findings.  The  prolonged 
warm and cold ischaemia duration mean that all pancreases irrespective of the 
type  of p reservation  have  endured  extensive preservation injury.  Sub-optimal 
oxygenation during the reperfusion phase due to insufficient perfusion or no-
reflow  phenomenon   c an  cause  continued  ischaemic  damage. T his  could 
explain the continued release of exocrine enzymes and glycerol seen throughout
the reperfusion period. 
The reperfusion phase was preceded by a period of gradual re-warming of the 
pancreas to room temperature over 15 minutes. The pancreas is anoxic during 
this period. The higher lactate:pyruvate ratio seen in the portal venous oxygen 
persufflation group at the start of reperfusion indicates a speedier restoration of 
metabolic activity and anaerobic glycolysis and the build up of an oxygen debt. 
The prompt decrease in the lactate:pyruvate ratio during the first 20 minutes of 
reperfusion  could  also  indicate  better  clearance  of t he  oxygen  debt  by  the 
resumption of  aerobic  respiration.  The  low  initial  lactate:pyruvate  ratio  and 
minimal change in the initial 20 minutes of reperfusion seen in the static cold 
storage  group  indicates  a  more  delayed  return  to a ctive  metabolism.  It  is 209
interesting to note that the ratio in b oth groups  was less than 10 at  all time 
points.
An additional explanation for the prominent increase of exocrine enzymes and 
glycerol in effluent concentrations after 20 minutes may reside in the design of 
the  experiment itself.  The  warmed,  oxygenated  Krebs-Henseleit  solution  was 
pumped  through  the  pancreas  from  a  separate  reservoir.  Venous  effluent 
collected in the pancreas chamber during reperfusion. Intermittently when the 
chamber  was  full,  the  effluent  was  transferred  back  into t he  Krebs-Henseleit 
reservoir. This could have contributed to the steep increase in effluent enzyme 
and cellular injury marker levels after 20 minutes of reperfusion. To avoid this 
confounding  factor, we  suggest  that  future  studies  with  reperfusion  circuits 
should be either continuously recycling or entirely non-recycling. 
The TBARS assay was used to estimate the extent of lipid peroxidation. It is 
based  on  the  reactivity  of  thio-barbituric  acid  (TBA)  toward  malondialdehyde  
which  is a  p roduct  of  oxidative  lipid d egradation. TBA  reacts  with 
malondialdehyde to yield a fluorescent red adduct. TBARS assay is not specific 
for lipid peroxidation and other proteins, nucleic acids and bilirubin can produce 
an  MDA like  adduct.  MDA  is  also  not  produced  stochiometrically  during lipid 
peroxidation  and  hence  is n ot  quantitatively  related  to  the  extent  of l ipid 
peroxidation [237]. The advantage of the assay is its ease of use and low cost.
Hence a number of studies have used it as a measure of lipid peroxidation [89, 
238,  239].  Since  the  assay  was  used  here  to  compare  lipid p eroxidation 
between groups and not as an absolute measure of lipid peroxidation we felt 210
that it was reasonable to use it. As expected, tissue from control pancreas had 
significantly lower levels of TBARS as compared to the non-heart-beating-donor 
pancreas  samples.  There  was  a  tendency  for  higher  TBARS  levels  in t he 
oxygen persufflation group though the difference was not statistically significant. 
One pancreas from the persufflation group had TBARS levels nearly three times 
higher than the median level in that group (sample G, TBARS=67.8 nmoles/mg). 
Review  of t his  pancreas  identified  no  specific  issues  during  persufflation  or 
warm reperfusion. Duodenal peristalsis was identified in this pancreas during 
warm  reperfusion  and  there  was  no  corroborating  evidence  of  excessive 
reperfusion injury such as elevated glycerol or caspase 3 levels.
Caspase 3 activation is the definitive step in apoptosis and can occur through 
both the death receptor and mitochondrial pathways. Its presence indicates cells 
that have irreversibly entered the apoptotic pathway. The levels of caspase 3 
activation in the control and preservation groups were low, needing modification 
of the  assay methods  to  increase  its  sensitivity.  Surprisingly, w e  have found 
increased levels of caspase 3 activity in the control pancreases as compared to 
the preservation groups. One possibility is that the levels seen in the control 
group are the normal level of apoptotic activity seen in the pancreas. Apoptosis 
and measurable caspase 3 levels have been reported in healthy liver tissue[240, 
241]. It is expected that metabolically active pancreatic tissue would have some 
basal caspase 3 activity.  The damage secondary to warm and cold ischemia in 
the  study  group  pancreases  should  activate  both  the  apoptotic and  necrotic 
pathways  of c ell  death.  The  apparent  low  levels  seen  in  the  reperfused 211
pancreases  could  be  due  to b reakdown  of  caspase  3  by  autolytic  enzymes 
activated during this period. 
We believe that the phenomenon of duodenal peristalsis observed in some of 
the  pancreases  during  reperfusion  is a  s ignificant  finding.  Peristalsis  is a n 
energy  dependent process.  It indicates  availability o f energy  rich  phosphates 
such as ATP in the tissues. It also signifies viable duodenal smooth muscle and 
maintenance  of t he  necessary  inter-myocyte  communications  to  produce 
coordinated  contractions.  Several studies  have  reported  onset  of d uodenal 
peristalsis  after  reperfusion  in e xperimental  pancreato-duodenal 
transplantation[242]. Development of peristalsis has also been considered as a 
marker  of  viability  of s mall  bowel i n  studies  of  isolated  small  bowel 
perfusion[243].  The  fact  that  all  the  three  pancreases  showing  peristalsis 
belonged  to t he  persufflation  group  further  strengthens  the  idea  that  these 
organs are more metabolically active.   
To  summarise,  these  experiments  were  planned  to  evaluate  the  efficacy  of 
prolonged  portal  venous  oxygen  persufflation  in a meliorating the s everity o f 
reperfusion injury in the non-heart-beating-donor rat pancreas. Our results did 
not show significant improvement in markers of reperfusion injury after portal 
venous  oxygen  persufflation.  Though  there  were  indications  to  suggest t hat 
pancreases  in t his  preservation  group  were  more  metabolically  active,  the 
evidence is not conclusive. It is possible that the preservation injury due to the 
prolonged  cold  ischaemia  may h ave  been  too  extreme.  The technique  of 
oxygenated reperfusion used may have been sub-optimal. Finally, reperfusion 212
injury i n  the  clinical  setting  progresses  over  a  period  of  hours  to  days.  It  is 
possible that the effects of improved preservation may not be evident within the 
first 60 minutes of warm reperfusion. 
Reperfusion  injury  activates  cellular  responses  through  a  multitude  of 
intracellular signalling pathways. While the activation of these pathways occurs 
during  cold  ischaemia  and  early  reperfusion,  their  effects  in  the  form of 
biochemical, physiological or morphological changes take longer to be apparent. 
Investigating  the  gene  expression  profile  early  in  reperfusion  can  provide  a 
better understanding of the effect of portal venous oxygen persufflation on the 
organs' response to ischemia reperfusion. 
These data suggest that the genes related to  the  death receptor pathway o f 
apoptosis were over-expressed in the portal venous oxygen persufflation group. 
This  included  the  caspases  3  and  8  and  Bid.  This  suggests  an  increased 
propensity for the portal venous oxygen persufflation group pancreas to undergo 
apoptosis.  Though  this  might  suggest  a  worse  outcome  for  this  preservation 
group,  it is n ot  necessarily  so.  Ischaemia and  reperfusion  will induce  severe 
cellular and mitochondrial injury in both preservation groups. Mitochondrial injury 
with mitochondrial permeability transition has been reported to be an important 
step  during  both  apoptosis  and  necrosis[244].   Cells undergo apoptosis  only 
when  sufficient  ATP  reserves  are  available.  Progression  of  apoptosis  cannot 
occur in ATP depleted cells which undergo death by necrosis. Necrotic death 
has the distinct disadvantage of exacerbating the inflammatory process leading 
to  continued  recruitment  of p ro-cell  death  pathways.  In a n  interesting  study, 213
Zhao et  al. investigated the  effect of artemisinin, a known inducer of cellular 
apoptosis  in e xperimental  acute  pancreatitis[245].  They f ound  that 
administration  of  this  drug  increased  apoptosis,  decreased  necrosis  and 
improved  the  markers  of  inflammation  such  as  serum  amylase,  histological 
grading and serum cytokine levels. Similar conclusions have been reached by 
other studies [246, 247]. In a study by Lemasters and co-workers in 2003 [248]
the  nature  of  hepatocyte  death  after  ischaemia reperfusion  was  investigated. 
They found that 4 hours of culture in anoxic medium followed by two hours of 
oxygenated reperfusion caused necrosis in 60% of cells. Provision of fructose 
for 20 minutes prior to start of reperfusion and during the reperfusion period lead 
to  increased  glycolysis,  increased  ATP,  increased  apoptosis  and  decreased 
necrosis. The authors concluded that both apoptosis and necrosis occur through 
mitochondrial  permeability  transition.  Induction  of  glycolysis  increases  the 
energy  status  of t issues  and  redirects  cellular  outcome  from  necrosis  to 
apoptosis.  
Increased expression of anti-apoptotic proteins was seen in both study groups. 
This  was  more  prominent  in  the  portal  venous  oxygen  persufflation  group 
indicating a more robust cellular response to ischaemia reperfusion injury. 
To summarise, reperfusion in both groups resulted in a significant up regulation 
of t he  processes  of t ranscription  and  inflammatory c ytokine  response.  We 
postulate that the increased expression of apoptotic and anti-apoptotic genes in 
the portal venous oxygen persufflation group reflects an improved energy status 
in the graft which helps it to circumvent cell death by necrosis.  214
6.1 Background
Numerous molecular pathways are activated after ischaemia reperfusion as the 
cells attempt to limit the extent of injury and survive. Multiple genes are over or 
under-expressed during this period. DNA microarrays are useful tools to study 
this complex cellular response.  
Flamant and  co-workers  in  2009 investigated  the  effect  of h ypoxia  alone  on 
inflammatory cytokine expression in cell lines. They identified increased levels of 
the alpha subunit of hypoxia inducible factor (HIFα) after 16 hours of hypoxia 
along with increased transcription of HIF- induced genes. There was decreased 
binding of NF-κB in hypoxic cells. This study investigated only the hypoxia part 
of IRI  and  did  not  investigate  the  gene  expression  after  re-oxygenation[249]. 
Supavekin and co-workers in 2003[250] studied the changes in gene expression 
in early  renal  ischemia reperfusion  injury  with  special  emphasis  on  apoptotic 
pathways.  Over-expression  of p ro-apoptotic and  anti-apoptotic  genes  was 
identified  by  three  hours  post  reperfusion.  Both  death  receptor  pathway  and 
mitochondrial pathway were activated. However, evidence of apoptosis in the 
form of positive TUNEL test and DNA laddering was identified only 12 and 24 
hours  post-reperfusion.  Aravindan and  co-workers  in  2006 [251] investigated 
gene expression after ischaemia reperfusion in rat kidneys. They identified up 
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regulation of over 70 genes related to apoptosis. Stegall and co-workers in 2002
investigated global gene expression in transplanted hearts after 3, 5 and 7 days 
post-transplant. They reported over-expression of genes related to MHC class 2 
antigens,  adhesion  molecules  and  inflammatory  cytokines.  Under-expressed 
genes were  primarily  related  to  metabolism  such  as  monoamine  oxidase, 
mitochondrial proteins and cytochrome oxidase subunits [252]. Drognitz and co-
workers in 2006 [253] investigated gene expression with microarrays in a rat 
model of pancreas transplantation . They compared the global gene expression 
in pancreases preserved by different preservation solutions and different cold 
ischaemia times. They identified a total of 49 genes that were consistently up 
regulated (more than threefold) in all three study groups. These genes included 
transcription  factors,  cytoskeletal  factors,  heat-shock  proteins  and  molecules 
involved in inflammation, signal transduction, and translation. Further analysis of 
up-regulated pathways was not carried out in this study. Benz and co-workers in 
2002 [254] used microarrays to study temporal changes in gene expression in 
pancreas during preservation and reperfusion. They found that the expression of 
genes was maximal during the reperfusion phase. Up regulated genes included 
those  coding  for  chaperone  proteins,  transcription  factors  and  inflammatory 
cytokines.
Significant up-regulation of inflammatory pathways occurs in grafts from non-
heart-beating-donors.  Factors  that  decrease  up-regulation  of  pro-death 
pathways a nd  increase  the  expression  of  pro-survival  pathways  will  have  a 
positive impact on graft survival and function. Microarrays are a useful screening 216
tool  to i nvestigate  such  factors.  Jassem and  co-workers  in  2009 [255]
investigated  the  effect  of t he  technique  of i schaemic  preconditioning  during 
donor liver retrieval on the expression of cell death and survival pathways after 
liver  transplantation  using  microarray  technology.  They  identified  60  genes 
involved  in  cell  death,  inflammation  and  immune  response  and  stress  which 
were  over-expressed  in t he  ischaemia  reperfusion  injury g roup.  Ischaemic 
preconditioning  led  to d ecreased  up-regulation  of  pro–cell  death  and  pro-
inflammatory  genes  and  increased  expression  of a nti–cell  death  and  anti-
inflammatory genes. 
Several researchers  have  investigated  the  mechanism  of  improved  organ 
preservation  with  venous  oxygen  persufflation[222,  256,  257]. Improved  ATP 
synthesis  during  persufflation  has  been  considered  the  main  reason  for 
improved  function  in  these  grafts.  Transplantation  of  non-heart-beating-donor 
grafts  induces  a  prominent  and  prolonged  ischaemia  reperfusion  injury. 
Improved  survival  of  these  grafts  can  only b e  expected  if  preservation 
techniques  precipitate a m odification  of  the  gene  expression  profile  through 
induction of  pro-survival pathways over pro-death pathways. To date there is no 
published literature investigating the  effect of venous oxygen  persufflation on 
global gene  expression. This i nformation,  when available, will  improve  our 
understanding  of  the  mechanism  of g raft  dysfunction  and  graft  protection. 
Identification of specific pathways involved in the injury and recovery of non-
heart-beating-donor pancreases will also provide an opportunity to selectively 
modify these pathways.  217
The aim of the study was to compare gene expression patterns following in vitro
reperfusion in rat pancreas exposed to warm ischaemia after static cold storage 
and portal venous oxygen persufflation. 
6.2 Methods
6.2.1 RNA samples for microarray analysis
Microarray analysis was performed by Dr Liming Wang from the Centre for Life, 
University of Newcastle  using the Affymetrix Rat Genome 230 2.0 Array. Three 
pooled  RNA  samples  were  analysed.  These  were  RNA  from  control  group 
pancreases and the two study groups i.e. non-heart-beating-donor pancreases 
preserved by static cold storage or portal venous oxygen persufflation. Gene 
expression  data  in  each  preservation group  were presented  as  fold  change 
(increased or decreased expression) of each identified gene in comparison to 
the control group pancreas. Three separate data matrices comparing static cold 
storage to control, portal venous oxygen persufflation to control and static cold 
storage (SCS) to portal venous oxygen persufflation (PVOP) were obtained for 
further analysis. All subsequent analysis and discussion relates to the differential 
expression of genes in each preservation group when compared to the control 
group (PVOP vs control and SCS vs control). Instances where differential gene 
expression between the two preservation groups (PVOP vs SCS) is presented 
will be specified.218
6.2.2 Gene Ontology analysis of microarray data
Genes with a fold change of greater than 2 (mRNA concentration for the gene 
was  more  than  double  or  less  than  half  the  specific  mRNA  concentration  of 
control group pancreas) were included in the analysis. Initial analysis to identify 
over-represented  Gene  Ontology (GO) terms  was  carried  out  using  DAVID 
bioinformatics  database  (available at  
http://david.abcc.ncifcrf.gov/tools.jsp)[258].  For  each  preservation  group,  the 
Affymetrix gene identifiers of the differentially expressed genes were uploaded. 
Highly  represented  GO terms for  the  uploaded  genes  were  identified. Terms 
with  a  gene  count between 5  and  50  and  with  an  EASE  score (modified 
Fischer's test used in DAVID) less than 0.01 were identified. Duplicate terms 
and  redundant  parent  terms  were  removed.  The  top  five  highly r epresented 
terms in each Ontology are presented.
6.2.3 Pathway analysis using microarray data
Data were analyzed through the use of Ingenuity Pathways Analysis (Ingenuity® 
Systems,  www.ingenuity.com)[259].  Briefly  the  dataset  containing  the  gene 
identifiers and the expression values was uploaded to the server. The Functional 
Analysis  identified  the  biological  functions  and/or  diseases  that  were  most 
significant to the data set. Fischer’s exact test was used to calculate a p-value 
determining the probability that each biological function and/or disease assigned 
to that data set is due to chance alone. Canonical pathways analysis identified 
the  pathways  from  the  Ingenuity Pathways  Analysis  library o f canonical 219
pathways  that  were  most  significant  to  the  data  set.  The  significance  of  the 
association between the data set and the canonical pathway was measured by 
the ratio of the  number of genes from the data set that map to the pathway 
divided by the total number of genes that map to the canonical pathway. The 
Fischer’s exact test was used to calculate a p-value determining the probability 
that  the  association  between  the  genes  in t he  dataset  and  the  canonical 
pathway is explained by chance alone. A p value less than 0.05 was considered 
statistically significant. 
The biological processes investigated were apoptosis, anti-apoptosis and anti-
oxidant mechanisms. The  canonical pathways investigated  were the Akt/PKB 
pathway,  NF-κB pathway  and  the MAPK pathways. Validated Map Annotator 
and Pathway Profiler (MAPP) sets available as free downloads from GenMAPP 
version  2.0[260] were  used  for  the  visualisation  of  the  pathways  of i nterest. 
MAPP builder functionality available in GenMAPP program was used to develop 
MAPP set for NF-κB pathway.  The relative expression (in terms of fold change) 
of pertinent genes in the two preservation groups was extracted from the dataset 
for each of the selected functions and pathways. Gene expression data were
presented  as  bar  charts  demonstrating both  over-expression  and  under-
expression of genes.220
6.3 Results
6.3.1 Pattern of differential gene expression
2441  gene  transcripts  were  identified  as  differentially e xpressed with  a  fold 
change  of  at  least 2.0 in  the  static  cold  storage  group when  compared  with 
control group. Similarly 2060 differentially expressed genes were identified in the 
portal  venous  oxygen  persufflation  group when  compared  to  control  group. 
There  was  significant  overlap  in t he  expression  of  genes  between  the  two 
preservation  groups.  Of  3238  genes  that  were  differentially e xpressed  by a t 
least 2 fold in either group, 1263 genes were common to both groups (39%). 
The  direction  of d ifferential  expression  was  the  same f or  1231  genes  (over-
expressed  or  under-expressed  in  both  preservation  groups) while  32  genes 
were  differentially  expressed  in  opposite  directions  (over-expressed  in  one 
group and under-expressed in the other group. Both preservation groups had 
genes  that  were  commonly u nder-expressed  or  over-expressed (Figures  53, 
54).
1129 genes were differentially over-expressed in the static cold storage group. 
These  were  genes  encoding  chaperone  proteins  (heat  shock  proteins), 
transcription  factors  (ATF3,  Fos,  EGR1)  and  genes  involved  in  cytokine 
response to cellular injury (Cxcl10,Cxcl1). 1312 genes were differentially under-
expressed.  These  genes  were  primarily  those  involved  in t he  cell’s  immune 
response to antigens and cell surface components (Tables 6, 7).
1266  genes  were  over-expressed  in t he  portal  venous  oxygen  persufflation 
group.  These  were  genes  involved  in  stress  response,  cellular  cytokine 221
response  and  transcription  factors.  794  genes  were  under-expressed.  These 
genes  were  primarily  those  involved  in h aemopoesis  and  lipid m etabolism
(Tables 8, 9).
Figure  53 Venn  diagram  showing  the  number  of  common  and  unique  differentially 
expressed genes in the two preservation groups-all genes
The number of differentially expressed genes in the two preservation groups is shown. 
2441 genes were identified as differentially expressed in static cold storage group with a 
fold change of 2.0 or more (blue circle). 2060 genes were differentially expressed with a 
fold change of 2.0 or more in the portal venous oxygen persufflation group (pink circle). 
Of  these, 1263  genes  were  common  to  both  preservation  groups. The  direction  of 
differential expression was the same for 1231 genes (over-expressed or under-expressed 
in both preservation groups) while 32 genes were differentially expressed in opposite 
directions (over-expressed in one group and under-expressed in the other group).  222
Static cold storage Portal venous oxygen 
persufflation
N= 798 N=331 N= 468
Static cold storage Portal venous oxygen 
persufflation
N= 433 N=879 N= 361
Over-expressed 
genes
Under-expressed 
genes
Figure  54 Venn  diagrams  showing  the  number  of c ommon  and  unique  differentially 
expressed genes in the two preservation groups- direction of differential expression
The number of differentially expressed genes in the two preservation groups is shown. 
The top Venn diagram shows the genes over-expressed in the static cold storage group. 
Similar numbers of genes were over-expressed in both preservation groups with a large 
number of common genes. The bottom Venn diagram shows the genes under-expressed 
in static cold storage group. Under-expressed genes were more common in the static 
cold storage group. Over twice as many genes were uniquely under-expressed in the 
static cold storage group as compared to the portal venous oxygen persufflation group. 223
Table 6 List of ten most over-expressed genes identified in the static cold 
storage group
The gene title, the biological function of its encoded protein is shown. The  Entrez gene 
identifier[261] for each gene was extracted from http://www.ncbi.nlm.nih.gov/gene. The 
fold increase in expression as compared to the control group pancreas is shown.  These 
were genes encoding chaperone proteins, transcription factors and genes involved in 
cytokine response to cellular injury. 
Gene title Function
Entrez 
gene 
Fold 
change
Heat shock protein 1B 
Chaperone 
protein 294254 3156.5
FBJ osteosarcoma oncogene
Transcription 
factor 314322 1235.8
Activating transcription factor 3
Transcription 
factor 25389 1058.5
Chemokine  (C-X-C  motif)  ligand 
10 Chemokine 245920 485.5
Heat shock protein 1A 
Chaperone 
protein 24472  449.8
Chemokine  (C-X-C  motif)  ligand 
1  Chemokine 81503 326.6
Protein  phosphatase  1, 
regulatory subunit 15A Enzyme 171071 243.4
Interleukin 6 Cytokine 24498 226.3
Early growth response 1
Transcription 
factor 24330 162.9
Zinc finger protein 36
RNA  binding 
protein  79426 162.6224
Table 7 List of ten most under-expressed genes in the static cold storage 
group 
The gene title and biological function of its encoded protein are shown. The  Entrez gene 
identifier[261] for each gene was extracted from http://www.ncbi.nlm.nih.gov/gene. The 
fold decrease in expression as compared to the control group pancreas is shown. These 
genes were primarily those involved in the cell’s immune response to antigens, cell 
surface components.
Gene title Function
Entrez 
gene 
Fold 
change
Immunoglobulin heavy chain 
(alpha polypeptide)
Immunoglobulin 
subunit 314487 289.3
Carbonic anhydrase 3 Enzyme 54232 246.2
Rho, GDP dissociation inhibitor 
(GDI) beta
Rho protein signal 
transduction 362456 152.6
Cd53 molecule
Cell membrane 
protein 24251 91.6
Beta globin minor gene
Haemoglobin 
subunit
LOC 
10013487
1 67.6
Similar to T-cell receptor alpha 
chain precursor V and C regions 
(TRA29)
Cell surface 
receptor 290071 59.6
Coronin, actin binding protein 
1A Cytoskeletal protein 155151 53.7
Membrane-spanning 4-
domains, subfamily A, member 
6B
Cell surface 
receptor 293749 50.0
T-cell receptor beta chain
Cell surface 
receptor 24820 48.3
Immunoglobulin joining chain
Immunoglobulin 
subunit 360922 46.1225
Table 8 List of top ten most over-expressed genes in the portal venous 
oxygen persufflation group 
The gene title and biological function of its encoded protein is shown. The  Entrez gene 
identifier [261] for each gene was extracted from http://www.ncbi.nlm.nih.gov/gene. 
The fold increase in expression as compared to the control group pancreas is shown. 
These were genes involved in stress response, cellular cytokine response and 
transcription factors.
Gene title Function Entrez 
gene 
Fold 
change
Heat shock protein 1B  Chaperone protein 294254 2139.7
FBJ osteosarcoma oncogene
Transcription 
factor 314322 1283.6
Activating transcription factor 3
Transcription 
factor 25389 935.4
Chemokine (C-X-C motif) ligand 1  Chemokine 81503 500.6
Heat shock protein 1A  Chaperone protein 24472  355.5
Interleukin 6 Cytokine 24498 246.6
Chemokine (C-X-C motif) ligand 2 Chemokine 114105 223.5
Protein phosphatase 1, regulatory 
(inhibitor) subunit 15A
Enzyme subunit
171071 189.3
SERTA domain containing 1
Transcription 
regulator 361526 184.8
Early growth response 1
Transcription 
factor 24330
151.5226
Table 9 List of top ten most under-expressed genes in the portal venous 
oxygen persufflation group
The gene title and biological function of its encoded protein is shown. The  Entrez gene 
identifier[261] for each gene was extracted from http://www.ncbi.nlm.nih.gov/gene. The 
fold decrease in expression as compared to the control group pancreas is shown. These 
genes were primarily those involved in haemopoesis and lipid metabolism.
Gene title Function Entrez 
gene 
Fold 
change
Haemoglobin alpha, adult chain 2 Subunit  of 
haemoglobin
25632 675.7
Carbonic anhydrase 3 Enzyme 54232 202.4
Haemoglobin, beta Subunit  of 
haemoglobin
24440 104.2
Aminolevulinate, delta-, synthase 2 Enzyme  (haeme 
synthesis)
25748 31.8
Adiponectin,  C1Q  and  collagen 
domain containing
Protein  hormone 
related  to  fat 
catabolism
246253 22.9
Complement factor B Complement factor 294257 13.2
Deoxyguanosine kinase Mitochondrial 
enzyme 
297389 8.9
Malic  enzyme  1,  NADP(+)-
dependent
Enzyme 24552 8.6
N-acylsphingosine amidohydrolase 
1
Enzyme 84431 8.4
Retinol binding protein 4, plasma Carrier protein 25703 7.4227
6.3.2  Analysis of the gene ontology of differentially expressed genes
Gene ontology analysis of the datasets of the two preservation groups showed 
multiple similarities. The five top represented terms in the three ontologies for 
both  preservation  groups  are  presented (Tables  10,  11). Common  biological 
processes identified in both preservation groups included cytokine production, 
cellular response to stress and negative regulation of apoptosis. Genes related 
to antigen processing and presentation were over-represented in the  static cold 
storage group. Interestingly, the majority of these genes were under-expressed 
in  the  static  cold  storage  group as  compared  to  control  group.  The  NF-κB
cascade  was  significantly  over-represented  in  the  portal  venous  oxygen 
persufflation group. Analysis of the cellular component terms showed that genes 
coding  for  cell  surface  components  and  major  histocompatibility  complex 
proteins  were  over-represented in  both  groups.  Transporter  associated  with 
antigen presentation (TAP) complex proteins were significantly over-represented 
in  the  static  cold  storage  group  alone.  Major  molecular  function  terms  over-
represented  were  related  to  transcription,  protein  kinase  and 
cytokine/chemokine  activity i n  both  groups.  GO  analysis  of t he  differentially 
expressed  genes  between  the  two  preservation  groups  identified  significant 
over-representation of GO terms related to antigen transport and presentation. 228
Table 10 Over-represented Gene Ontology terms in the static cold storage group
Results of the gene set for static cold storage group is shown. Rat230_2 array was used as the background while the Affymetrix 
identifiers of the differentially expressed genes were entered as the gene list. GO terms containing 5-50 genes with an EASE score 
less than 0.01 were selected. The top five distinct terms in each ontology are presented in the table. The  actual number of genes 
associated with each term is included. The actual p value, fold enrichment and false discovery rate (FDR) is included.
Ontology GO term description GO Term Gene 
Count
P value Fold 
Enrichment
FDR
Biological 
process
Cytokine production GO:0001816 28 5.04E-07 2.815835289 9.57E-04
Antigen processing and presentation GO:0019882 22 9.56E-06 2.839300583 0.018174
Negative regulation of transferase 
activity
GO:0051348 23 1.10E-05 2.740024339 0.020821
Regulation of immune response GO:0050776 29 1.20E-05 2.388966641 0.02275
Chemotaxis GO:0006935 30 1.20E-05 2.346529407 0.022876
Cellular 
component
TAP complex GO:0042825 9 2.24E-05 5.825789923 0.034499
Cell surface GO:0009986 41 6.46E-05 1.895693546 0.099309
Multivesicular body GO:0005771 7 5.92E-04 5.437403928 0.90596
Adherens junction GO:0005912 20 0.001462 2.157699972 2.22448
Caveola GO:0005901 15 0.00269 2.377873438 4.05578
Molecular 
function
Chemokine receptor binding GO:0042379 15 3.65E-05 3.421980242 0.064966
Peptide antigen-transporting ATPase 
activity
GO:0015433 9 5.25E-05 5.369876688 0.093406
Transcription repressor activity GO:0016564 42 2.61E-04 1.770502821 0.464423
Unfolded protein binding GO:0051082 22 0.001819 2.031461287 3.191087
Protein kinase inhibitor activity GO:0004860 12 0.002006 2.820541291 3.514229
Table 11 Over-represented Gene Ontology terms in the portal venous oxygen persufflation group
The DAVID genomic database was used to identify Gene ontology terms over-represented in the gene subsets. Results of the gene 
set for static cold storage group is shown. Rat230_2 array was used as the background while the Affymetrix identifiers of the 
differentially expressed genes were entered as the gene list. GO terms containing 5-50 genes with an EASE score less than 0.01 
were selected. The top 5 distinct terms win each ontology are presented in the table. The  actual number of genes associated with 
each term is included. The actual p value, fold enrichment and false discovery rate (FDR) is included.
Category GO description GO Term Count P value Fold 
Enrichment
FDR
Biological 
processes
I-kappaB kinase/NF-kappaB 
cascade
GO:0007249 31 1.24E-06 2.5880 0.0024
Cytokine production GO:0001816 24 4.78E-06 2.8363 0.0091
Response to biotic stimulus GO:0009607 41 1.34E-05 2.0388 0.0254
Response to unfolded protein GO:0006986 22 1.85E-05 2.7805 0.0351
Negative regulation of apoptosis GO:0043066 47 2.48E-05 1.8841 0.0472
Cellular 
component
Adherens junction GO:0005912 21 7.07E-05 2.6319 0.1086
MHC protein complex GO:0042611 13 1.23E-04 3.5548 0.1886
Cell junction GO:0030054 35 2.32E-04 1.9141 0.3553
Basement membrane GO:0005604 15 0.0014 2.5539 2.1964
Cell-matrix junction GO:0030055 13 0.0023 2.6661 3.4945
Molecular function Transcription repressor activity GO:0016564 44 7.34E-07 2.2029 0.0013
Chemokine receptor binding GO:0042379 13 1.41E-04 3.5223 0.2503
Cytokine activity GO:0005125 38 2.76E-04 1.8424 0.4913
Protein kinase inhibitor activity GO:0004860 11 0.0019 3.0707 3.3864
Unfolded protein binding GO:0051082 19 0.0034 2.0837 5.8835230
6.3.3 Identification of over-represented canonical pathways
Ingenuity p athway  analysis  identified  sixty c anonical  pathways  that were 
significantly o ver-expressed  in  the  static  cold  storage  group.  Thirty-six 
pathways  were  significantly o ver-expressed  in  the  portal  venous  oxygen 
persufflation group. Pathways involved in the cellular response to stress and 
inflammation  and  activation  of  transcription  were  over-represented  in  both 
preservation groups (Table 12).
The over-representation of the pathways of interest was compared between 
the two preservation groups. There was significant over-representation of all 
pathways in the static cold storage group. The PI3K/Akt signalling and NF-κB
signalling pathways  only were  significantly  over-represented  in  the  portal 
venous oxygen persufflation group (Table 13).231
Table 12 Over-represented canonical pathways in the two preservation 
groups
Table shows the top 5 over-represented canonical pathways related to ischaemia 
reperfusion injury in both the preservation groups when each was compared to the 
control group  pancreases.  Canonical  pathway  analysis  was  carried  out  using 
Ingenuity Pathways Analysis library of canonical pathways. The significance of the 
association between the data set and the canonical pathway was measured by the 
ratio of the number of genes from the data set that map to the pathway divided by the 
total number of genes that map to the canonical pathway. The Fischer’s exact test 
was used to calculate a p-value. A p value less than 0.05 was considered statistically 
significant.
There was over-representation of common pathways in both preservation groups. 
Glucocorticoid receptor signalling pathway is related to the binding of cortisol to the 
glucocorticoid receptor. Nuclear translocation of the ligand-receptor complex leads 
to increased transcription. Acute phase response signalling is the mechanism of the 
cell's  response to stress. This includes transcription of cytokines and chaperone 
proteins, and activation of the JAK/STAT pathway. Nuclear Factor 2 is activated by 
oxidative stress and induces the transcription of genes with anti-oxidant function. 
Hypoxia signalling is related to the  activation of the hypoxia inducible factor and 
the resultant transcription of proteins such as heat shock proteins, enzymes of the 
ubiquitin system and the NF-κB pathway. Interleukins 6 is involved in the local and 
systemic  inflammatory  response  to  ischaemia  reperfusion  injury.IL10  is  an  anti-
inflammatory  cytokine  and  inhibits  synthesis  of  pro-inflammatory  cytokines.
Canonical Pathway Static cold storage Portal  venous  oxygen 
persufflation
p value Ratio p value Ratio
Glucocorticoid Receptor 
Signalling
0.0001 0.19 0.024 0.15
Acute Phase Response 
Signalling
0.0006 0.22 0.0014 0.18
NRF2-mediated 
Oxidative  Stress 
Response
0.0015 0.20 0.0021 0.17
IL-6 Signalling 0.0018 0.25 0.0013 0.23
Hypoxia Signalling in 
the Cardiovascular 
System 0.0155 0.23 0.0026 0.24
IL-10 Signalling 0.0019 0.24 0.003 0.26232
Table 13 Over-representation of the pathways of interest in two 
preservation groups
Ingenuity Canonical Pathways Static cold storage Portal  venous 
oxygen persufflation
p value Ratio p value Ratio
ERK/MAPK Signalling 0.0042 0.18 0.2101 0.10
NF-κB Signalling 0.0159 0.18 0.0334 0.15
p38 MAPK Signalling 0.0200 0.21 0.1604 0.14
PI3K/Akt Signalling 0.0478 0.15 0.0235 0.15
Table shows the canonical pathways of interest in both the preservation groups when 
each was compared to the control group pancreases. Canonical pathways analysis was 
carried  out  using  Ingenuity  Pathways  Analysis  library  of  canonical  pathways.  The 
significance of the association between the data set and the canonical pathway was 
measured by the ratio of the number of genes from the data set that map to the pathway 
divided by the total number of genes that map to the canonical pathway. The Fischer’s 
exact test was used to calculate a p-value. A p value less than 0.05 was considered 
statistically significant.
There was significant over-representation of all four pathways in the static cold storage 
group. Only PI3K/Akt signalling and NF-κB signalling were over-represented in the 
portal  venous  oxygen  persufflation  group.  Over-representation  indicates  that  a 
significant number of genes related to the pathway were differentially expressed by a 
fold change of at least 2.0 in comparison to the control group pancreas. It does not take 
into  account  whether  the  genes  are  over-expressed  or  under-expressed.  Over-
representation  of  a  pathway  can  indicate  either  significant  over-expression  or 
suppression of that pathway in comparison to the control.233
6.3.6 PI3K/Akt/NF-κB pathway
The PI3K/Akt and NF-κB pathways are described in chapter 1. The following 
MAPP diagram (Figure 55) details the interactions and links between the two 
pathways.  Briefly,activation  of  growth  factor  receptors  by  growth  factors  or 
cellular  stress  leads  to t he  activation  of t he  phosphatidyl  inositol-3  kinases 
(PI3K). PI3K phosphorylate the inositol ring of phosphatidyl inositol to produce 
phosphatidyl  inositol  (3,4,5)-trisphosphate  (PIP3).  PIP3 activates  downstream 
serine-threonine protein kinases such as Protein kinase B (Akt/PKB) through the 
kinase PDK1. Activation of Akt/PKB is tightly regulated by the quantity of the 
second messenger phosphatidyl inositol triphosphate.(PIP3). Akt itself can be 
dephosphorylated  by t he  action  of  protein  phosphatases.  Akt  contributes  to 
several  cellular  functions  including  inhibition  of  apoptosis  and  cell  survival, 
nutrient metabolism, cell growth, transcriptional regulation. Akt inhibits apoptosis 
by the phosphorylated inhibition of BAD and caspase 9. It  phosphorylates and 
inactivates  the  enzyme  glycogen  synthetase  kinase  3  and  increases 
transcription  of  glucose  transporter  (GLUT  1)  and  the  glycolytic  enzyme 
phospho-fructo-2-kinase.  Akt  activates  the  NF-κB  pathway  through  direct 
activation of IKK and through phosphorylation of the MAP3K, Tpl2. Activation of 
the NF-κB pathway  also occurs through trans-membrane receptor complexes 
(TNF receptor superfamily, IL-1 receptor and the TLR  family). Hypoxia, reactive 
oxygen  species and  cytokines  such  as T NFα and  IL-1β a ctivate  the  NF-κB 
pathway through these receptors. NF-κB elements are usually  present in the 
cytoplasm  as homo  or  heterodimers. They a re  localised to t he  cytoplasm  by 234
being complexed to proteins called the Inhibitors of Kappa B (IκB). Activation of 
the NF-κB pathway involves the breakdown of these complexes by proteosomal 
degradation of the IκB subunits and translocation of the NF-κB elements into the 
nucleus. This is catalyzed by the action of protein kinases called the inhibitors of 
kappa  kinase  (IKK)  complex.  In the  nucleus  NF-κB e lements  induce  the 
transcription of genes related to cytokines, cell surface receptors, pro-apoptotic 
and  anti-apoptotic proteins,  adhesion  molecules  and  anti-oxidants.  NF-κB 
pathway is regulated by several feedback loops including increased transcription 
of the IκBε gene in response to NF-κB activation. 
Differential expression of pathways in two preservation groups
Differential  expression  of  the  catalytic  and  regulatory  subunits  of t he  PI3K 
enzyme was demonstrated in the two preservation groups. Static cold storage 
was  associated  with  decreased  expression  of t he  catalytic  subunit  and 
increased  expression  of t he  regulatory  subunit.  Portal  venous  oxygen 
persufflation  was  associated  with  a  decreased  expression  of t he  regulatory 
subunit without differential expression of the catalytic subunit as compared to 
control. This indicates a net over-expression of PI3K enzyme activity. There was 
no differential expression of the Akt isoforms in either groups. The expression of 
the catalytic subunit of protein phosphatase 2 was elevated in the static cold 
storage. 
The  levels  of  IKKβ were  over-expressed  in t he  portal  venous  oxygen 
persufflation group (2.3 fold) but not in the static cold storage group. There was 
increased  expression  of  three  NF-κB proteins  in  the  portal  venous  oxygen 235
persufflation  group  and  two  in  the  static  cold  storage  group.  IκBε was  over-
expressed in the portal venous oxygen persufflation group (4.5 fold) suggestive 
of increased NF-κB pathway activation.
Several genes  downstream  of  the  Akt/NF-κB pathway  were  differentially 
expressed.  Genes  coding  for  enzymes  involved  in  energy  metabolism  were 
over-expressed in the portal venous oxygen persufflation group. These included 
the glucose transporter GLUT-1(2.3 fold), hexokinase 2 (4.9 fold) and phospho-
fructokinase  platelet isoform (6.1 fold). Increased expression of anti-apoptotic 
genes such as Bcl2A1, CFLAR, BIRC2, BIRC3 was noted preferentially in the 
portal venous oxygen persufflation group. 236
Figure  55 MAPP  delineating  the  PI3Kinase-Akt-NF-ΚB pathway  and  the  differential 
expression of genes related to this pathway in the two preservation groups.
This MAPP was developed by this researcher (Mettu Reddy) for the purpose of this 
research project  using the MAPPbuilder facility available at GenMAPP version 2.1. 
The  final  version  of  the  MAPP  is  available  for  download  at 
http://www.wikipathways.org/index.php/Pathway:WP1491.
Genes are denoted by rectangles with arrows showing the relation between individual 
genes. Rat genes (Rattus norvegicus) were identified in the MAPP set by their Entrez 
identities. When multiple isoforms of a single gene were encountered,  the specific Affy 
id was used. The rectangle for each gene is split into two parts to show the nature of 
differential expression of that particular gene for each of the two preservation groups. 
The colour codes for over-expression and under-expression for each preservation group 
are noted in the diagram legend.237
Detailed legend in previous page238
6.3.7 Mitogen Activated Protein Kinase pathways
General description of the mitogen activated protein kinase (MAPK) pathways is 
given in chapter 1. The following MAPP diagram ( figure 57) details the different 
components of these pathways. 
The ERK/MAPK pathway is primarily activated by growth factors through cell 
surface  receptors.  Binding  of  growth  factors  to t he  receptors  leads  to t he 
activation of the G protein Ras. Activated Ras binds and activates the MAP3K 
(Raf).  Activation  of  Raf  also  occurs  through  the  diacyl  glycerol  pathway  via 
Protein kinase C and the calcium signalling pathway through rasGRP proteins. 
Raf phophorylates MAP2K1 and MAP2K2. These phosphorylate the MAPKs for 
this  pathway,  ERK1  or  ERK2.  ERK  activates  several  transcription  factors.  It 
activates the p90 ribosomal s6 kinase which is involved in translation. p90RSK 
also inhibits the pro-apoptotic Bcl2 protein BAD through phosphorylation. ERK 
pathway is mainly involved in cell proliferation and differentiation, cell division. 
The  p38  MAPK  pathway  is  activated  by  cellular  stress  factors  such  as  heat 
shock, reactive oxygen species, lipopolysaccharide and inflammatory cytokines. 
These act through a variety of protein kinases to activates multiple MAP3Ks. 
These in turn activate the specific MAP2Ks namely MAP2K3 and MAP2K6. The 
MAPK for this pathway is the p38 protein. p38 activates a variety of transcription 
factors  and  inflammatory  mediators  such  as  the  p53  pathway,ELK-1,  sap1a, 
gadd153,  transcription  factors  such  as  MAX,MEF2c,ATF2,  ATF4,heat  shock 
proteins and ATF4. The net result is the progression of the inflammatory process 239
and induction of apoptosis. The activation of this pathway is kept under control 
by the dual specificity phosphatases (DUSP) and protein tyrosine phosphatases 
(Ptpn) which inhibit the activation of p38. 
Jun amino-terminal kinases (JNK/MAPK) pathway is activated by a variety of 
environmental stresses and inflammatory cytokines. Stress signals are delivered 
to this pathway by GTPases such as Rac and Rho.  These activate a member of 
the mixed lineage kinases (MLK) that phosphorylate and activate MAP2K4 or 
MAP2K7.  This  activates  JNK  proteins  which  translocate  to  the  nucleus  and 
regulate the activity of multiple transcription factors involved in inflammation and 
apoptosis.
Differential expression of pathways in two preservation groups 
There  was  significant  over-representation  of  the  ERK/MAPK  pathway  in  the 
static cold storage group but not in the portal venous oxygen persufflation group 
(Figure  56).  Under-expression  of  growth  factor  receptors  was  seen 
predominantly  in t he  portal  venous  oxygen  persufflation  group.  Decreased 
expression of the RAS guanine nucleotide exchange factor and protein kinase C
was seen in the static cold storage group. These proteins are involved in the 
activation  of  the  MAP3K ( Raf)  through  calcium  signalling and  diacyl  glycerol 
pathway respectively. There was no differential expression of Raf and MEK1/2 
noted  in  either  preservation  groups.  However i ncreased  expression  of 
MAPK1/ERK  was  noted  in  the  static  cold  storage  group.  Dual  specificity 
phosphatases  were  over-expressed  in  both  preservation  groups.  Fifteen 240
downstream targets of the ERK/MAPK were differentially expressed in the two 
preservation  groups (Figure  56)  .  Ten were  over-expressed  in  both  groups. 
These  included  proteins  involved  in  transcription  (Myc,  Fos,MKNK2,  STAT3) 
and translation (EIF4E). Four were uniquely expressed in the static cold storage 
group. Phospholipase A2, ELF1 and Talin 1 were over-expressed while ETS1, a 
transcription factor, was under-expressed. One target gene p90 Ribosomal S6 
kinase 1 was uniquely over-expressed in the portal venous oxygen persufflation 
group.
There was significant over-representation of the p38 MAPK pathway in the static 
cold  storage  group  but  not  in  the  portal  venous  oxygen  persufflation  group
(Figure 57). In both preservation groups the inducers of p38 pathway such as 
TNFα, IL1β were over-expressed. Components of  TNFα receptor, TRAF 2 and 
6  were  differentially  expressed  in  portal  venous  oxygen  persufflation  (over 
expressed) and static cold storage (under-expressed) respectively. The MAP3K 
for  this  pathway  were  not  differentially  expressed  in e ither  group.  Over-
expression of Map2k3 and Map2k6 was seen in the static cold storage group 
while portal venous oxygen persufflation had up regulation of Map2k3 alone. 
None of the p38 isoforms  were differentially expressed in either group. Amongst 
the  downstream  products  for  this  pathway,  eight  downstream targets  of  the 
p38/MAPK  were  differentially  expressed  in the two  preservation  groups.  Five 
were  over-expressed  in  both  groups.  These  included  proteins  involved  in 
transcription such as Ddit3, My, SRF, MKNK2 and the histone protein H3F3C. 
One gene was under-expressed in both groups (Cell division cycle homolog B). 241
Two were uniquely expressed in the static cold storage group (Phospholipase 
A2 and MYC associated factor X).  242
Figure 56 Bar diagram comparing the differential expression of fifteen target genes of the 
ERK/MAPK pathway in both preservation groups
Fifteen downstream targets of the ERK/MAPK were differentially expressed in the two 
preservation  groups.  Eleven  were  over-expressed  in  both  groups.  These  included 
proteins involved in transcription (Myc, Fos,MKNK2, STAT3) and translation (EIF4E). 
Three  were  uniquely  expressed  in  the  static  cold  storage  group.  Phospholipase  A2, 
ELF1 and  Talin  1  were  over-expressed  while  ETS1 was  under-expressed.  p90 
Ribosomal  S6  kinase  1  was  uniquely  over-expressed  in  the  portal  venous  oxygen 
persufflation group.243
Figure 57 MAPP showing the MAPK pathways and the differential expression of genes in 
the two preservation groups
Figure in opposite page.
This MAPP was modified from the version available at GenMAPP version 2.1. Genes 
are denoted by rectangles with arrows showing the relation between individual genes. 
The rectangle for each gene is split into two parts to show the nature of differential 
expression of that particular gene for each of the two preservation groups. The colour 
codes for over-expression and under-expression for each preservation group are noted 
in the diagram legend. 244
Detailed legend in the previous page245
6.3.8 Expression of genes related to cell repair and metabolic activity
Transporter activity
Genes coding for the α and β subunits of haemoglobin were under-expressed in 
both groups. The suppression was greater in the  oxygen persufflation group. 
When  expression  of  genes  related  to  transporter  activity  was  compared,  42 
genes  were  differentially  expressed.  Of t hese, 32  genes  in t he  oxygen 
persufflation group were over-expressed when compared to ten genes in the 
static cold storage group. Over-expressed genes in the portal venous oxygen 
persufflation included transporters of glucose, amino-acids and phospholipids. 
Enzymes involved in the glycolytic pathway 
Hexokinase which catalyses the first rate-limiting step of glycolysis was over-
expressed in both static cold storage and Portal venous oxygen persufflation 
(2.1 fold vs. 4.9 fold). Phospho-fructokinase (PFK) is the enzyme catalysing the 
most  important  and  irreversible  step  in  glycolysis.  Over-expression  of t he 
platelet  isoform  of P FK  (PFKP)  was  noted  in  the  portal  venous  oxygen 
persufflation group (6.1 fold) while the liver isoform was under-expressed in the 
static cold storage group. Downstream to glycolysis, static cold storage group 
was characterised by increased activity of the pyruvate dehydrogenase kinase 
enzyme  which  inactivates  pyruvate  dehydrogenase.  Pyruvate  dehydrogenase 
catalyses  the  rate  limiting  step  in t he entry  to  Krebs  cycle.  Expression  of 
pyruvate  dehydrogenase phosphatase which  dephosphorylates  and  activates 
PDH were over expressed in both groups (Figure 58). 246
Sterol biosynthesis
Over-expression of genes related to sterol biosynthesis was noted in the portal 
venous oxygen persufflation group (Figure 59).247
Figure 58 MAPP of the glycolytic pathway comparing the differential expression of genes 
in the two preservation groups.
Both the  rate-limiting enzymes of glycolysis, hexokinase and phospho-fructokinase were 
over-expressed in the portal venous oxygen persufflation group. The liver isoform of 
phosphofructokinase  was  under-expressed  in  the  static  cold  storage  group.  Lactate 
dehydrogenase converts pyruvate to lactate, clears the end-product of glycolysis and 
drives glycolysis. This was under-expressed in the static cold storage group.248
Figure  59 MAPP  of  the  cholesterol  biosynthetic  pathway s howing  the  differential 
expression of genes in the two preservation groups.
The cholesterol biosynthetic pathway includes the melavonate pathway. The products of 
this pathway include dimethyl-allyl-pyrophosphate, isopentenyl pyrophosphate and 
cholesterol. These are required for the synthesis of molecules involved in cell membrane 
maintenance, protein folding, protein attachment to cell membranes and steroid 
biosynthesis. The rate-limiting enzyme for this pathway is Hydroxy-Methylglutaryl CoA 
reductase (Hmgcr). Portal venous oxygen persufflation was associated with the 
increased expression of several genes coding for enzymes involved in sterol biosynthesis 
including the rate-limiting enzyme Hmgcr.  249
6.4 Discussion
Gene microarray data give information regarding the relative difference in the 
amount of mRNA related to the genes of interest. Best practice suggests that 
microarray data should be confirmed with quantitative PCR. We have not done 
this  for  the  rat  pancreas  dataset.  However, the  validity o f  the  microarray
technique has been confirmed by our group in parallel microarray experiments 
using  RNA  from  rat  kidneys.  Good  concordance  of m icroarray  data  and 
quantitative  PCR  of s elected  genes in t his  dataset has  been  confirmed (Ms 
Kibondo, PhD student, University of Sunderland).
The amount of gene specific mRNA present in the cell depends both on gene 
transcription and the half-life of the specific mRNA. Half-life of mRNAs can vary 
from a few minutes to several hours and is related to their function rather than 
size[262-264]. Cellular mechanisms have been described which modulate this in 
response to the cell state [265, 266]. Cheadle et al.[267] reported that 50% of 
the  differential expression  data  obtained  using microarrays  can be  directly 
attributed to differences in half-lives of various mRNAs. Finally, gene expression 
is  only  the  beginning  of  the  overall  cellular  response.  Ultimate  response 
depends on the levels of proteins, their phosphorylation status and integration of 
multiple cellular pathways. We have not attempted to investigate these in our 
study. In view of these factors, the results from these experiments should be 
considered  preliminary  data  only  and  to  be  further  investigated  by s uitable 
experiments. 250
We h ave  identified  a  large  number of  differentially  expressed  genes  in b oth 
study groups compared to the control group. It is not possible to decide on a 
statistically sound cut-off fold change due to the absence of replicates in the 
study. The 2 fold change cut-off is an accepted compromise when there are no 
replicate samples to apply stricter tests to assess the validity of the data. This 
cut-off  also  gives  gene  lists o f  reasonable  size  for  downstream  analysis  (Dr 
H.Peters, Center for Life, University of Newcastle, personal communication).
Genes related to transcription, heat shock proteins and cytokine response were 
over-expressed  in  both  preservation  groups as  previously  reported  by o ther 
studies[253,  268].  Nearly  three  times more genes  were  uniquely  under-
expressed  in  the  static  cold  storage  than  in  the  portal  venous  oxygen 
persufflation group.  This  could  be  suggestive  of  a  partial  shut-down  of 
transcriptional activity or more rapid turnover of mRNAs in the static cold storage 
group. 
Analysis using the gene ontology terms database showed marked similarities in 
the  terms  over-represented  in  both  two  preservation  groups.  Biological 
processes such as cytokine production, antigen processing and presentation, 
chemotaxis,  apoptosis  were  identified  in b oth  preservation  groups and  have 
been previously reported. The overrepresented cellular component terms in both 
groups were related to the membrane structures and components involved in 
intercellular communications. The molecular processes over-represented in both 
groups were related to transcription and the immune response. Activation of NF-251
κB pathway,  was  significantly o ver-represented  in t he  portal  venous  oxygen 
persufflation group. 
Our  results  suggest that  the  genes  related  to  the death receptor  pathway o f 
apoptosis were over-expressed in the portal venous oxygen persufflation group. 
This included  the  caspases  3  and  8  and  Bid.  This  suggests  an  increased 
propensity for the portal venous oxygen persufflation group pancreas to undergo 
apoptosis.  Though  this  might  suggest  a  worse  outcome  for  this  preservation 
group, it is not necessarily so. Ischaemia and reperfusion  will induce severe
cellular and mitochondrial injury in both preservation groups. Mitochondrial injury 
with mitochondrial permeability transition has been reported to be an important 
step  during  both  apoptosis  and  necrosis[244].   C ells undergo  apoptosis  only 
when  sufficient  ATP  reserves  are  available.  Progression  of  apoptosis  cannot 
occur in ATP depleted cells which undergo death by necrosis. Necrotic death 
has the distinct disadvantage of exacerbating  the inflammatory process leading 
to  continued  recruitment  of p ro-cell  death  pathways.  In a n  interesting  study, 
Zhao et  al. investigated the  effect of artemisinin, a known inducer of cellular 
apoptosis  in e xperimental  acute  pancreatitis[245].  They f ound  that 
administration  of  this  drug  increased  apoptosis,  decreased  necrosis  and 
improved  the  markers  of  inflammation  such  as  serum  amylase,  histological 
grading and serum cytokine levels. Similar conclusions have been reached by 
other studies [246, 247]. In a study by Lemasters and co-workers in 2003 [248]
the  nature  of  hepatocyte  death  after  ischaemia reperfusion  was  investigated. 
They found that 4 hours  of culture in anoxic medium followed by two hours of 252
oxygenated reperfusion caused  necrosis in 60% of cells. Provision of fructose 
for 20 minutes prior to start of reperfusion and during the reperfusion period lead 
to  increased  glycolysis,  increased  ATP,  increased  apoptosis  and  decreased 
necrosis. The authors concluded that both apoptosis and necrosis occur through 
mitochondrial  permeability  transition.  Induction of  glycolysis  increases  the 
energy  status  of t issues  and  redirects  cellular  outcome  from  necrosis  to 
apoptosis.  
Increased expression of anti-apoptotic proteins was seen in both study groups. 
This  was  more  prominent  in  the  portal  venous  oxygen  persufflation  group 
indicating a more robust cellular response to ischaemia reperfusion injury. The 
increased  expression  of  genes  related  to t he  glycolytic  pathway,  decreased 
suppression of transporter gene expression and increased sterol synthesis are 
again  markers  of i ncreased  metabolic  activity and  initiation  of  cellular  repair 
processes in the portal venous oxygen persufflation group.
PI3K/Akt and the ERK/MAPK are important survival pathways involved in the 
recovery of cells after ischaemia reperfusion. Studies examining the biology of 
post-conditioning during myocardial reperfusion have identified these pathways 
to  be  responsible  for  the  beneficial  effect  [269].  Activation  of  both  these 
pathways  occurs classically through growth factor receptors. Activation of the 
ERK/MAPK  pathway  has  also  been  reported  through  the  protein  kinase  C 
pathway[103]. Similarly, activation of Akt by cytokines through PI3K and heat 
shock proteins has been described[110]. All these pathways are relevant in our 
model. Protein kinase C expression was decreased in the static cold storage 253
group.  Similarly  decreased  expression  of t he  catalytic  subunit  of  PI3K and 
increased expression of the regulatory unit indicate an overall decreased activity 
of the enzyme. This suggests a decreased induction of these survival pathways 
in the static cold storage group. 
Increased  activation  of  the  NF-κB pathway  was  also  identified  in t he  portal 
venous  oxygen  persufflation  group.  NF-κB is a  t ranscription  factor  with 
numerous  target  genes.  Its  role  in i schaemia  reperfusion  injury h as  been 
previously studied. The conclusions have varied in different studies. Chang and 
co-workers in 2003 reported that NF-κB activity decreased apoptosis induced by 
TNFα[125]. Sarkar and co-workers in 2009 reported that activation of NF-κB by 
cytokines in beta cells increased production of the anti-apoptotic proteins[270]. 
NF-κB activation has also been reported to inhibit the pro-apoptotic JNK/MAPK 
pathway through multiple mechanisms[126]. 
Activation  of  NF-κB can  occur  through  the  TNFα/FAS  receptor,  Toll  like 
receptor[117] and PI3K/Akt pathways. We have identified that all three pathways 
were relevant in our study. While increased expression of a variety of genes 
which are known downstream targets of NF-κB were identified in both groups 
this  was  more  prominent  in t he  portal  venous  oxygen  persufflation  group. 
Expression of IκBε which acts as marker of NF-κB activity was over-expressed 
in the portal venous oxygen persufflation group suggesting its preponderance in 
this group. 
Activation  of  NF-κB through  reactive  oxygen  species  has  been  studied  with 
interest  in t he  context  of  portal  venous  oxygen  persufflation.  It  has  been 254
suggested  that  portal  venous  oxygen  persufflation  when  carried  out  in t he 
presence of superoxide dismutase leads to the conversion of superoxide ions to 
hydrogen peroxide[198]. Hydrogen peroxide is well known to be an activator of 
NF-κB [271,  272].  Superoxide  dismutase  was  used  as  a  final  flush  in 
pancreases  of b oth  preservation  groups  in  our  study.  This  could  also  have 
contributed to the activation of NF-κB.
NF-κB has a central role in the cellular inflammatory response. Target genes of 
NF-κB are involved in every aspect of the inflammatory response. Controversy 
persists as to whether NF-κB activation is primarily pro-survival or anti-survival. 
This is probably academic as the ultimate effect depends on the integration of 
NF-κB activation with other inflammatory pathways.   
To summarise, reperfusion in both groups resulted in a significant up regulation 
of t he  processes  of t ranscription  and  inflammatory c ytokine  response.  We 
postulate that the increased expression of apoptotic and anti-apoptotic genes in 
the portal venous oxygen persufflation group reflects an improved energy status 
in  the  graft  which  helps  it  to  circumvent  cell  death  by n ecrosis.   I ncreased 
activation  of  the  pro-survival  pathways  and  evidence  of i ncreased  metabolic 
activity and  cell repair noted in t he  portal  venous  oxygen persufflation  group 
suggest  improved  preservation  of  the  pancreas. 255
Chapter 7 Overall discussion 
7.1 Discussion
The present work was aimed at identifying improved methods of preservation of 
the  non-heart-beating-donor  pancreas.  Hypothermic  machine  perfusion  and 
portal venous oxygen persufflation were studied in comparison with static cold 
storage which is the current standard for pancreas preservation. This is the first 
known report of the use of venous oxygen persufflation in the preservation of the 
pancreas. The data obtained from this study has been extremely encouraging. 
Portal venous oxygen persufflation caused a significant improvement in the yield 
of purified islet equivalents as compared to static cold storage or hypothermic 
machine  perfusion.  The  increased  islet  yield  with  this p reservation  was a lso 
associated with better islet morphology and marginally improved viability and in 
vitro function  compared  to t he  static  cold  storage  group.  The  severity of 
reperfusion  injury  in  the  pancreas  after  preservation  for  16  hours  with  portal 
venous  oxygen  persufflation  or  static  cold  storage.  There  was  no  definite 
evidence  of d ecreased  reperfusion  injury  in t he  portal  venous  oxygen 
persufflation  group.  Nevertheless,  several  indicators  of  increased  metabolic 
recovery were noted in the oxygen persufflation group. These included active 
duodenal  peristalsis during  reperfusion  which  was  seen  in  some  persufflated 
pancreases but in none of the static cold storage pancreases. 
This is also the first known report of the effect of oxygen persufflation on the
global gene expression in any organ. Ischaemia reperfusion injury is well known 256
to stimulate an intense transcriptional response. Genes related to cytokine and 
chemokine activity, chaperone proteins and innate immunity are well known to 
be  over-expressed  in  this  setting.  A  similar  transcriptional  response was 
identified in our study. Interestingly, pancreas preservation with portal venous 
oxygen persufflation was noted to cause over-expression of genes related to 
apoptosis, survival pathways such as PI3K/Akt and NF-κB. These are markers 
of improved recovery of the pancreas graft.   
Non-heart-beating-donor  pancreases  are  not  commonly  used  for  islet 
transplantation because of the concern of warm ischaemia induced islet injury 
affecting post transplant graft function. Early studies have shown poor islet yield 
from  pancreases  that  have  endured  warm  ischaemia  time  greater  than  30 
minutes[46]. These experiments have shown that the islet yield decreases with 
increasing warm ischaemia times. The yield of islets in pancreases with warm 
ischaemia  duration  of 3 0  minutes was less  than  50%  of t he  yield  in c ontrol 
animals. 
The success of clinical islet transplantation depends almost entirely on the total 
mass  of v iable  islets  transplanted.  The  use  of  pancreases  for  islet 
transplantation is limited to isolations that can provide at least 5000 IEQ/kg of 
recipient weight[32]. Studies have also shown that on average approximately 
12000 IEQ/kg body weight is required in humans to make them independent of 
insulin therapy[30]. This is the reason why patients need 2-3 islet transplants 
each  to  become  insulin  independent.  Decreased  islet  yield  from  non-heart-
beating-donor  pancreases  means  that  a  significant  proportion  of t hese 257
pancreases will not be suitable for islet transplantation as the islet yield does not 
make the above cut-off. It also means that a greater number of islet transplants 
will be necessary to make each of these patients insulin independent. Loss of 
islets  early  after  transplantation  due  to  ischaemia  reperfusion  injury i s  an 
important  cause  of g raft  failure.  Pancreas  preservation  techniques  that  can 
increase the islet yield and decrease the severity of ischaemia reperfusion injury 
can therefore increase the chance of success following transplantation. 
The  present  work  has  demonstrated  that  novel  preservation  methods  can 
improve  the  yield  of  islets from p ancreases  which  have  sustained  significant 
warm ischaemia injury. A non-heart-beating-donor pancreas model with a warm 
ischaemia  time  of 3 5  minutes was  developed.  This  ensured  a  significant 
decrease in the islet yield with traditional methods of pancreas preservation i.e. 
static  cold  storage.  These  experiments  have demonstrated  that  preservation 
techniques such as hypothermic machine perfusion and portal venous oxygen 
persufflation improve both the crude and purified islet yield as compared to static 
cold storage. 
Hypothermic machine perfusion of the pancreas has been attempted in previous 
studies[169, 173, 175]. This method of preservation presented logistic difficulties 
for everyday clinical use due to the size of the equipment. This has changed 
with the current availability of portable kidney perfusion equipment. Lifeport™
(Organ Recovery Systems Inc, Chicago, IL) a portable kidney perfusion machine 
has  revolutionised  the u se  of h ypothermic  machine  perfusion  in  kidney 
transplantation.  The  Lifeport™  pancreas  preservation  equipment used  in  our 258
porcine  experiments was  the  kidney  perfusion  machine  modified  for 
human/large  animal  pancreases  preservation  (Appendix 1).  The  feasibility o f 
machine  perfusion  of  porcine  pancreases  has  been  confirmed  by t he  study. 
After an initial learning curve, the back-table preparation of the pancreas and 
hypothermic perfusion of the graft could be carried out without major problems. 
Machine  perfused  pancreases  become  oedematous  even  with  low  pressure 
perfusion (perfusion pressure of 10mm Hg). However histological assessment 
showed that the oedema is primarily restricted to the interlobular septae and the 
exocrine compartment of the pancreas with relative sparing of the islets. This 
has the potential to improve islet isolation as pancreatic digestion and dispersion 
of the digested tissue could be easier when the pancreas is oedematous. Taylor
and co-workers in 2008 using the same machine have shown that the islet yield 
from pancreases preserved for 24 hours with machine perfusion was similar to 
fresh controls. In addition they reported that dithizone staining of the islets had 
revealed better quality digestion in the machine perfused pancreases [170]. Our 
work with preservation of rat non-heart-beating-donor pancreas using machine 
perfusion  has  also  shown  improved  islet  yield  as  compared  to  static  cold 
storage. Hypothermic machine perfusion for 4 hours lead to a 30% improvement 
in the purified islet equivalent yield as compared to static cold storage. However 
this  improvement  was  not  as  impressive  as  preservation  with  portal  venous 
oxygen persufflation. The concept of viability prediction using parameters that 
can  be  calculated  from  machine  perfusion  is w ell  established  in  non-heart-
beating-donor  kidney t ransplantation.  Perfusion  parameters  such  as  the  flow 259
resistance and perfusate biochemical markers such as glutathione-s-transferase 
have been reported to predict the risk of primary non-function and delayed graft 
function  in n on-heart-beating-donor  grafts[167,  168].  Its  use  during  pancreas 
preservation  with  machine  perfusion  will  provide  information  that  can  help 
decide  whether  a  pancreas  is s uitable  for  islet  isolation.  This  is  particularly 
important as islet isolation of a human pancreas is a costly and labour intensive 
process. Decreasing the frequency of unsatisfactory isolates by screening non-
heart-beating-donor pancreases prior to islet isolation makes financial sense as 
30% of the total cost of islet transplantation is for islet isolation [273]. The role of 
machine  perfusion  in  assessing  pancreas  viability  was f irst  reported  by 
Kenmochi and  co-workers  in  1992 [175].  They  used  non-heart-beating-donor 
canine  pancreas  grafts  which  were  perfused  for  one  hour.  They f ound  a 
correlation  between  the  tissue  flow rate  (perfusate  flow  per  sec  per  gram  of 
pancreas),  super-oxide  dismutase  levels  and  post-transplant  pancreas  graft 
function. The  present porcine pancreas perfusion experiments have shown a 
significant  positive  correlation  between  the  initial  flow  resistance  to p erfusion 
and activated caspase 3 levels in the pancreatic tissue at 18 hours. Similarly the 
rat  pancreas  preservation  experiments  have  shown  that  higher  perfusion 
pressures are associated with lower islet viability. 
Portal  venous  oxygen  persufflation  was  found  to  be  the  most  promising 
technique  of p reservation  of  the  non-heart-beating-donor  rat  pancreas  in  our 
study. Portal venous oxygen persufflation improved the purified islet yield (islet 
equivalents) significantly. Islet viability and isolation index were also better with 260
portal  venous  oxygen  persufflation  as  compared  to s tatic  cold  storage  and 
hypothermic machine perfusion. Portal venous oxygen persufflation islets were 
also more likely to be functional (stimulation index>1) than the islets from static 
cold  storage  group.  Portal  venous  oxygen  persufflation  was  associated  with 
improved  preservation  of i slet  morphology.  Islets  isolated  from  portal  venous 
oxygen  persufflation  pancreases  were  more  globular  with  less  fragmentation 
and  less peripheral irregularity. Islet morphology has been reported to be  an 
important prognostic  marker for  post  transplant  graft function in e xperimental 
and clinical settings[217, 218]. 
The  mechanism  of  action  of p ortal  venous  oxygen  persufflation  in  the 
preservation of the non-heart-beating-donor rat pancreas is unclear. Previous 
reports  of  the  use  of v enous  oxygen  persufflation  in l iver  preservation  have 
reported  increased tissue  ATP  levels[186].  Venous  oxygen  persufflation  has 
been reported to decrease the amount of apoptosis in the grafts[185]. Venous 
oxygen  persufflation  has  also  been  reported  to  maintain  cellular  and 
mitochondrial  integrity  [184].  It  is  possible  that  the  oxygen  provides  for  the 
production  of  ATP  to  initiate  the  repair  of  injury  sustained  during  warm 
ischaemia. Portal venous oxygen persufflation may also improve duct epithelial 
viability  and  maintain  the  pancreatic  ductal  architecture.  This  would  ensure 
uniform distension of the  entire  pancreas graft during intra-ductal injection of 
collagenase  solution.  Uniform  distension  implies  homogenous  digestion  and 
thus better islet yield. This hypothesis is supported by our experiments where 
pancreases  preserved  by  portal  venous  oxygen  persufflation  had  a  more 261
uniform  distension  of  the  entire  gland  as  compare  to  the  static  cold  storage 
group. One effect of portal venous oxygen persufflation may simply be to recruit 
a larger proportion of the pancreas for collagenase digestion. This could play a 
significant role in digestion of larger pancreases (porcine/human) as disrupted 
peripheral ductal architecture may prevent exposure of the entire pancreas to 
the collagenase injected into the main pancreatic duct.
The  reperfusion  experiments  were  set  up  to  investigate  the  severity  of 
reperfusion  injury  in pancreases  preserved  by  static  cold  storage  and  portal 
venous oxygen persufflation. It was expected that the pancreas will experience a 
more  severe  ischaemia  reperfusion  injury  as  compared  to  livers  or  kidneys 
because of the high concentration of autolytic enzymes present in the exocrine 
component[140]. This is a clinical reality as ischaemia reperfusion injury after 
pancreas transplantation causes significant morbidity in the form of pancreatitis,
graft thrombosis and bleeding. Ischaemia reperfusion injury is also responsible 
for the early loss of nearly 60-80% of the transplanted islet mass described as 
instant blood mediated inflammatory reaction (IBMIR)[14]. 
Our  experiments  failed  to  identify s ignificant  differences  in t he  markers  of 
ischaemia  reperfusion  injury.  There  was a  t rend  towards  increased lipid 
peroxidation in the oxygen persufflation group. There was also a suggestion of 
increased metabolic activity with higher lactate:pyruvate ratio at the beginning of 
reperfusion in the oxygen persufflation group. The lack of significant difference 
between the two groups could be due to the severity of the ischaemic insult 
sustained by the pancreas and the prolonged cold ischaemia period. Any small 262
differences between the two groups may also not have been evident due to the 
small numbers in each group.
Duodenal peristalsis was identified in three of portal venous oxygen persufflation 
pancreases  but  in n one  of  the  static  cold  storage  pancreases.  Though  the 
incidence  of  peristalsis  was  not  statistically  different  in  the  two  preservation 
groups, its occurrence only in the portal venous oxygen persufflation group is an 
important indicator of tissue viability. 
RNA microarray analysis was carried out to clarify the cellular mechanisms and 
pathways that were over-expressed in the portal venous oxygen persufflation 
group as compared to the static cold storage group. This is the first known report 
of t he  pattern of  gene  expression  in  an  organ  preserved  by  portal  venous 
oxygen persufflation. Despite the sub-optimal quality of RNA extracted from the 
pancreatic  tissue  we h ave  been  able to  identify  important  similarities  and 
differences in gene expression between the two preservation groups. We found 
increased  expression  of g enes  related  to  cellular  stress,  transcription  and 
inflammatory cytokines in both groups. Portal venous oxygen persufflation was 
associated with an over-representation of genes related to apoptosis and anti-
apoptosis. The portal venous oxygen persufflation group was characterised by 
up-regulation of the pro-survival PI3K/Akt and the NF-κB pathways. The pro-
inflammatory  p38  MAPK  pathway  was  preferentially o ver-represented  in  the 
static cold storage group. Increased expression of genes encoding for carrier 
proteins,  glycolytic  enzymes  and  steroid  biosynthesis  also  suggest  increased 
metabolic activity and cellular repair in the portal venous oxygen persufflation.263
Provision  of o xygen  to t he  non-heart-beating-donor  graft  during  the  cold 
ischaemia  phase  is  increasingly  accepted  as  an  important  means  of 
ameliorating  post-reperfusion  injury.  Availability  of  oxygen  enables  the 
production of ATP. ATP helps in the maintenance of the function of the sodium 
potassium  ATP  pump  thus  preventing  cellular  swelling.  The  ideal  mode  of 
delivering  this  is  however  contentious.  Two  layer  method  appears  to w ork 
because  of t he  oxygenation  of t he  outer  rim  of  pancreatic  tissue.  Its 
effectiveness in oxygenating the entire human pancreas is controversial as the 
diffusion of oxygen from the surface is limited[156]. In a recent review of the 
effectiveness of two layer method, Noguchi  and co-workers in 2009 suggested 
that the reported lack of benefit of TLM in large studies was due to problems 
with the technique used by inexperienced teams[150]. A recent report reported 
the possibility of using ductal injection of oxygenated perfluorocarbon solution as 
a means to improve pancreas preservation. They reported improved ATP levels 
in rat pancreases preserved by this technique[274]. Despite the attractiveness of 
this technique, it is not clear if ductal injection can ensure adequate oxygenation 
of large animal pancreases. 
Alternate methods of oxygenation of organs using the vascular system of the 
pancreas  are  being  investigated.  These  have  the  advantage  of  ensuring 
effective oxygenation of all parts of the organ. Warm oxygenated perfusion of 
the grafts has been reported to improve graft outcomes[275]. However, this is 
complicated  and  can  involve the use  of  blood  products.  Oxygenated 
hypothermic  machine  perfusion is a nother  attempt  in this d irection[276].  This 264
has  the  advantage  of  using  standard  preservation  solutions  saturated  with 
oxygen. Studies have reported that even a short period of oxygenated machine 
perfusion  prior  to  warm  reperfusion  can  improve  the  tissue  viability  and 
reperfusion injury[225, 277, 278]. They have suggested a post-conditioning like 
effect of oxygenated perfusion prior to warm reperfusion[278]. In other studies 
oxygenated  machine  perfusion  especially  when  prolonged  was  found  to 
increase endoplasmic reticulum stress leading to increased apoptosis and cell 
death [279].Minor and co-workers in 2009 compared the effectiveness of long-
term  oxygenated  machine  perfusion  and  venous  oxygen  persufflation  in 
preserving ischaemic rat livers. They found improved preservation and greater 
functional recovery with venous oxygen persufflation [280]. 
Scott  and  co-workers  in  2010  reported  initial  data  of p ancreas  preservation 
using oxygen persufflation through the arterial system. They reported improved 
ATP  levels,  better  preserved  histology  in  the  pancreases  as  compared  to 
preservation by TLM[281, 282].
7.2 Limitations of the study
Several limitations in the methodology used in the study research have been 
identified both during and since the completion of the laboratory work. Some of 
these  were  unavoidable  due  to r estrictions  of  animal  usage,  equipment 
availability and funds. With the benefit of hindsight some problems could have 
been avoided. A few  of them are detailed below. This should help place the 
findings of this research in the correct perspective.265
7.2.1 Experimental model
The  choice  of t he  animal  model p lays  an  important  role  in  extrapolating  the 
results  to c linical  application.  The  rat  model o f  pancreas  preservation  was 
chosen because of the simplicity of rat islet isolation and the lower expenses 
involved.  However, this  model i s  not  best  suited  for  studying  pancreas 
preservation techniques. Rat pancreas is a delicate and flimsy organ that is only 
a few millimetres thick. It cannot be ascertained whether the beneficial effect of 
portal venous oxygen persufflation seen in our study can be replicated by direct 
diffusion of oxygen across the pancreas capsule. This could have been clarified 
by including an additional arm in the study protocol where the pancreas was 
stored in UW solution with oxygen bubbled into the preservation fluid directly. 
Male Wistar rats were selected for the experiment once they had reached the 
required weight. Though this usually meant that the animals were of similar age, 
this was not specifically confirmed. In addition the weight range used (250-350g) 
meant that some of the pancreases were fattier than others. Age and adiposity 
of the pancreas has been reported to affect actual islet numbers in the pancreas 
and the quality of islet isolation and purification. 
In view of the small size of the pancreas it was expected that leakages on the 
arterial  or  the  portal  venous  side  could  not  be  avoided. E ach  pancreas  was 
checked on the back-table for leaks with gentle flushing or persufflation. Any 
obvious leaks were sutured. Pancreases with significant leaks that could not be 266
quickly  controlled were  discarded.  However  minor  leaks  during  hypothermic 
machine perfusion or portal venous oxygen persufflation might have remained. 
This could have compromised the effectiveness of the preservation techniques. 
Some studies have reported the use of dye injection to identify and repair small 
leaks. This was not considered feasible with the rat pancreas. Previous work on 
portal venous oxygen persufflation has been carried out in livers and kidneys. 
Here small punctures made on the organ surface acted as outlets for the oxygen 
persufflated into the organ. In the case of the rat pancreas this was complicated 
as punctures into the already flimsy pancreas would have made effective ductal 
injection of collagenase impossible. Punctures were instead made in the surface 
of the spleen and duodenum for efflux of oxygen. This had the disadvantage of 
not  providing  oxygen  to t he  pancreatic  capillaries  directly  and  the  recorded 
persufflation pressure may not be the actual pressure in the pancreatic capillary 
bed. However visible distension of the venules on the surface of the pancreas 
during persufflation was used as marker for satisfactory pancreatic persufflation. 
Some researchers have stressed the importance of confirming the effectiveness 
of o xygen  persufflation  by  demonstrating  increased  tissue  ATP  levels.  This 
could not be done.
7.2.2 Islet isolation and assessment experiments 
Shared use of perfusion and persufflation equipment in the labs meant that all 
preservation techniques were not continuously available. Random allocation of 
treatments, though initially planned was not always feasible. This problem was 267
handled by ensuring that continuous series of animals were not included in one 
preservation arm. Similarly change of the planned method of preservation was 
avoided once the pancreas retrieval procedure was started to minimise sampling 
error.
Rat pancreas islet isolation was carried out using collagenase ductal injection 
and  digestion  and  discontinuous  gradient  separation.  While  this  is  the  most 
commonly used technique in published literature there are several drawbacks to 
the technique as used in this study. The collagenase used had an incubation 
period of 50 minutes in accordance with the manufacturer’s recommendations 
and  our  own  lab  trials. This  was  carried  out  in  a static  water  bath.  Ongoing 
ischaemia to the pancreas during the digestion period would have had an effect 
on the viability of the isolated islets. There are recent reports of the benefit of 
oxygen treatment during the digestion phase either by direct oxygenation or by 
using oxygenated perfluorocarbon solution[193]. 
Whilst all attempts  were  made  to carry out  the entire digestion  and  isolation 
process in a clean environment this was not always feasible due to the exposure 
of the pancreas to enteric contents during retrieval. The affect was minimised by 
rinsing  the  pancreas  after  retrieval  in  fresh  wash  medium  prior  to  start  of 
preservation. Sterile environment and equipment was used for the final stages of 
islet purification and the islets were cultured overnight in sterile culture medium. 
It  is  possible  that  some  bacterial  growth  would  have  occurred  during  the 
preservation-digestion-culture period. 268
The viability testing of islets with exclusion dyes are not sensitive techniques to 
assess islet viability[217]. They identify dead cells but do not identify dying cells 
with  still  intact  cell  membrane  barrier  function.  Hence  these  would  tend  to 
underestimate  the  extent  of c ell  death.  It  is  also  well  known  that  after  islet 
separation  the  core  of  the  islet  is d ependent  on  diffusion  for  the  supply  of 
oxygen and nutrients. As the size of the islet increases there is an increasing 
risk of the core of the islet becoming ischaemia. The islets that were produced 
from the portal venous oxygen persufflation group tended to be larger than the 
static  cold  storage  and  hypothermic  machine  perfusion groups.  We h ave 
attempted to account for the core effect by standardised assessment in which 
islets with more than the central 25% staining blue are counted as being non-
viable.  However  this i s  still  a  subjective  method  of a ssessing  islet  viability. 
Improved  methods  of  viability a ssessment  such  as  oxygen  consumption 
rate[283] are more accurate methods of viability assessment. 
Static glucose stimulated insulin secretion is a rudimentary assay to explore in 
vitro function.  Results  are  variable  and  depend  of  the  exact  protocol  used. 
Standardisation of the technique with modifications to the incubation medium 
was helpful in decreasing the variability  of the results. The  variability can  be 
further  decreased  and  accuracy  of islet  function  improved  using  real  time 
methods of in vitro islet assessment such as the micro-perfusion technique. 
Islets with good viability on staining and good functional ability on in vitro testing 
may s till  not  succeed  in  providing  insulin  independence  after  clinical 
transplantation. The only true predictor of islet viability and post-islet transplant 269
success is its ability to reverse hyperglycaemia when transplanted into diabetic 
immuno-deficient mice. We have not done this in our study. Further evaluation 
of t he  use  of p ortal  venous  oxygen  persufflation  should  include  in  vivo
assessment of the islets.
Two layer method was not part of the initial study plan. It was included  as an 
additional study midway through phase 1 of the study when we were able to 
acquire a small quantity of perfluorocarbon solution. This group hence did not 
have sufficient numbers to compare the effectiveness of two layer method with 
the other preservation methods. 
7.2.3 Warm oxygenated reperfusion 
The warm reperfusion study was an exploratory study to evaluate the benefit of 
portal  venous  oxygen  persufflation  in  ischaemia  reperfusion.  Sample s ize 
calculations  were  not  done.  A  sample  size  of a t  least  six  animals  per 
preservation  group  was  considered  based  on  literature  review of  studies 
involving animal models of organ preservation and ischaemia reperfusion injury. 
The number of animals in each group ultimately depended on the constraints of 
time. 
The cold ischaemia time in the islet isolation phase of the study was 5 hours. 
For the warm reperfusion study, the duration of cold ischaemia was extended to 
16  hours. It is hence not possible to  compare the data from the two studies
directly.  The  usual  cold  ischaemia  times  in  clinical  pancreas  and  islet 
transplantations range from 12-14 hours[12, 32]. The cold ischaemia time for the 270
study  was  extended  as  4-5  hours  was  too  short  to  be  relevant  in c linical 
transplantation.
Duodenal  peristalsis  identified  during  oxygenated  reperfusion  is a n  important 
finding  in t his  study.  Though  the  phenomenon  was  video-recorded  for  two 
pancreases, objective documentation of the duration and intensity of peristalsis 
was not done. We had attempted continuous monitoring of the intra-duodenal 
pressure  using  a  luminal  pressure  probe  during  the  reperfusion  part  of  the 
experiment. Problems with the technique such as leakage of duodenal contents, 
blockage  of  the  transducer  cannula  and  slippage  of  the  cannula  were 
encountered  during  the  model  development  stage.  Hence  attempts  of i ntra-
duodenal pressure monitoring were abandoned.
Caspase 3 assay was used to measure the extent of apoptotic activation in the 
tissues. The protocol for the assay had to be modified to use it for estimation of 
caspase 3 levels in the tissue extracts. The modification included increasing the 
volume of the extracts in each well and by using appropriate negative control for 
each sample to account for the background. This is unlikely to be as accurate as 
the standard assay. However it is useful in giving some idea of the extent of 
caspase 3 activity in the extracts. 
Using  a  single  assay  to i dentify  the  extent o f  apoptosis  is  inadequate.  Most 
studies report the use of a battery of tests such as caspase activation, Tunel 
staining  of  tissue  sections  and  characteristic  DNA  fragmentation  to  quantify 
apoptosis.271
The major form of cell death in these experiments is cell necrosis. Confirmation 
of necrotic cell death is difficult as it does not have any characteristic features. 
Staining of tissue sections to quantify necrotic, apoptotic and viable cells could 
have helped in further clarifying the predominant form of cell death in the two 
preservation groups.
7.2.4 Microarray experiments
The quality of RNA extracted in the initial part of the study was of poor quality 
and could not be used for microarray experiments. The RNA from pancreases in 
the later part of the study was of better quality due to modifications in the 
extraction technique.  However, there were not  enough good quality RNA
samples in each study group to run replicates. Hence the data available for each 
study group was from a single RNA sample pooled from three RNA samples of 
that group. This is expected to increase the risk of sampling errors.
Confirmation of microarray findings using quantitative rtPCR is recommended by 
most researchers. This has not been done. In a parallel study of microarray 
analysis of RNA extracted from rat kidney, the microarray data was validated by
PCR and showed good correlation between the two.272
7.3 Future work 
Further work in this area should concentrate on validating the benefit of portal 
venous  oxygen  persufflation  on  a  large  animal  model  of  non-heart-beating-
donor. Following our experiments on porcine pancreas machine perfusion we 
have gained experience in porcine pancreas retrieval, back table preparation for 
machine perfusion. Using this model to study portal venous oxygen persufflation 
should be feasible. Porcine islet isolation is complicated and needs specialised 
equipment and expertise which is currently not available for our group. Use of 
normo-thermic  oxygenated reperfusion in the in vitro setting can be  used to 
investigate the effects of this preservation technique.
The feasibility of short term oxygen persufflation lasting 1-2 hours after a period 
of warm ischaemia and static cold storage to improve the outcomes of these 
grafts  should  be  investigated.  This  technique  of p ost-conditioning  has  been 
reported by researchers using venous oxygen persufflation in liver grafts and 
two layer method in p ancreas  grafts. The  advantage  of this technique in the 
clinical setting would be to avoid the use of complex preservation techniques at 
the donor hospital. Instead the pancreas can be transported in cold storage and 
then put through venous oxygen persufflation in the islet isolation facility for 1-2 
hours before the start of islet isolation or pancreas transplantation.
The results of microarray analysis are a guideline for further work in this area. 
We have identified increased expression of apoptotic and anti-apoptotic genes 
in  the  study.  The  net  effect  of  this  gene  expression  should  be  quantified  by 273
techniques such as Tunel staining of pancreas tissue sections. Tissue sections 
can also be used to compare the relative extent of cell necrosis and apoptosis in 
each  preservation method. This  would validate  our conclusion that increased 
apoptotic activation  in  the  venous  persufflation  group  is  associated  with
decreased cell necrosis. The microarray study has suggested upregulation of 
survival pathways in the portal venous oxygen persufflation. Confirmation of this 
through  cellular  protein  measurements  and pathway  specific r eporter  gene 
studies will further strengthen these conclusions. 
The  ultimate aim of this research area is to develop a suitable form of large 
animal  pancreas  preservation  that  can  improve  the  viability o f  the  marginal 
grafts and  identify p ancreases  that  have  sustained  irreversible  damage.  A 
possible system could include a short period of hypothermic machine perfusion
of n on-heart-beating-donor  pancreases  to  evaluate  viability  using  perfusion 
parameters.  Grafts  with  good  viability c an  undergo  immediate  islet  isolation. 
Short period of venous oxygen persufflation for grafts with marginal viability can 
be  followed  by islet isolation.  Grafts  with  obviously  poor  viability  on  machine 
perfusion can be discarded. This system can ensure full utilisation of the donor 
resource without the unnecessary expense of poor quality islet isolations. The 
technology for these  kind of interventions is available today. If validated with 
large  animal  pancreases,  it  can  be  immediately a pplied  to  clinical  pancreas 
preservation.274
Appendix 1  List of reagents and equipment used in the study
Reagents and chemicals
Carbogen (95% oxygen, 5% carbon-di-oxide) BOC
Caspase 3 colorimetric assay kit Sigma-Aldrich
Collagenase P Roche
Dulbecco’s Modified Eagle Medium (1X) without glucose Invitrogen
Griess reagent kit Invitrogen
Hanks' Buffered Salt Solution (10X) with phenol red Invitrogen
High range rat insulin Elisa kit Mercodia AB,Sweden
KPS-1 preservation solution Organ Recovery Systems
Lithium chloride (3.5N) Ambion
Microdialysis multiassay kit CMA Microdialysis AB
Nycoprep Axis-shield
Oxygen (100%) BOC
Quant-iT Protein Assay Kit Invitrogen
RNAsecure Ambion
RNAzap Ambion
Streptokinase (Streptase™) CSL Behring
Trizol reagent Ambion
Viaspan (UW solution) Du Pont pharma
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Equipment
1.5ml microcentrifuge tubes Eppendorf
50ml Centrifuge tubes Falcon
Centrifuge (lab) Harrier 15/80
Centrifuge (refrigerated) Mistral 3000
Class II safety cabinet Biomat-2
CMA 600 Microdialysis analyser Microdialysis AB
Elisa plate reader Dynatech Laboratories 
Eyepiece Graticule Pyse-SGI Ltd
Fluorescence microscope Nikon
Freezer (-20°C) Beko
Freezer (-80°C) Lab Impex Research
Gilson Pipettes Anachem
Incubator Sanyo
Inverting Microscope Olympus CK2
Microcentrifuge Hettich mikro 12-24
Microvials for Microdialysis analyser CMA Microdialysis AB
ML110 Bridge Amp AD Instruments
Multi-well plates (24,96 wells) Beckton Dickinson
Multiwell plates (6,24,96 wells) Iwaki
Peristaltic perfusion pump Watson Marlow 323
pH meter AII Orion
Powerlab 4/25 Data Acquisition system AD Instruments276
Refrigerator Electrolux
Sonicator Langford Ultrasonics
Spectrophotometer Uvikon
Syringe filter (0.2µm) Sartorius
Syringe pump driver Graseby 3150
Syringes (5ml,10ml,20ml,50ml) Beckton Dickinson
Water bath Grant Instruments277
Appendix  2  Methodology of assessment of lactate, pyruvate 
and glycerol in portal venous effluents 
These  assays  were  carried  out  using  the  CMA  600  Microdialysis  analyser.  Batch 
analysis of portal effluent samples stored at -20°C was carried out. Glycerol, lactate and 
pyruvate assays were used in the study.
Glycerol assay
Glycerol is phosphorylated by adenosine triphosphate (ATP) and glycerol kinase (GK) 
to glycerol-3-phosphate. This is subsequently oxidized in the presence of glycerol-3-
phosphate oxidase (GPO). The hydrogen peroxide formed reacts with 3,5-dichloro-2-
hydroxy-benzene  sulphonic  acid  (DCHBS)  and  4-amino-antipyrine.  This  reaction  is 
catalyzed by peroxidase (POD) and yields quinoneimine. Presented as mmoles/l.
Pyruvate assay
Pyruvate  is  enzymatically  oxidized  by  pyruvate  oxidase  (PyrOx).  The  hydrogen 
peroxide  formed r eacts with  N-ethyl-N-(2-hydroxy-3-sulfopropyl)-m-toluidine  (TOOS) 
and  4-amino-antipyrine.  This  reaction  is  catalyzed  by  peroxidase (POD)  and  yields 
quinonediimine. Presented as mmoles/l.
Lactate assay
Lactate is enzymatically oxidized by lactate oxidase. The hydrogen peroxide formed 
reacts  with  4-chlorophenol  and  4-amino-antipyrine.  This  reaction  is  catalyzed  by 
peroxidase (POD) and yields quinoneimine. Presented as mmoles/l.278
Appendix 3  Low pressure hypothermic machine perfusion of 
non-heart-beating-donor porcine pancreas
Background
Hypothermic machine perfusion has been successfully used in the preservation of non-
heart-beating-donor kidneys. It has been shown to improve preservation, decrease the 
duration of DGF and help in the assessment of the viability of graft kidneys. There is 
now increasing interest in the use of this technique to preserve non-heart-beating-donor
pancreases. Organ Recovery Systems Inc (Chicago, IL) has been providing portable 
systems for kidney machine perfusion. They have developed a protocol of a pancreas 
perfusion system on the same platform. One sample machine was provided to our unit 
to  evaluate  the  feasibility  of  machine  perfusion  of non-heart-beating-donor porcine 
pancreases.
Aims
 To  determine  the  perfusion  mechanics  of  non-heart-beating-donor porcine 
pancreas on low pressure hypothermic machine perfusion.
 To determine if perfusion parameters can predict warm ischaemic tissue injury.
 Compare the preservation of non-heart-beating-donor porcine pancreas by low-
pressure hypothermic machine perfusion and two layer method of preservation.
Methods
The Pancreas perfusion system was based on the current kidney perfusion system and 
shares the same platform. The organ chamber is modified to hold the pancreas.
The perfusion circuit has a split arterial inflow to simultaneously perfuse the splenic and 
the superior mesenteric artery so the entire pancreas and the adjoining duodenum can 
be perfused. Kidney Preservation Solution-1 (KPS) which is similar to the UW solution 
in composition was used as the perfusate (Figure 60).279
Figure 60 Hypothermic machine perfusion of porcine pancreas
Top figure shows the schematic representation of the machine perfusion circuit. It is 
based on the same platform as the LifePort™ kidney perfusion machine. The inflow for 
the pancreas is split to ensure perfusion through both the splenic artery and the superior 
mesenteric artery. This ensures perfusion of the entire pancreas. Outflow from the 
pancreas is through the cut portal vein. Bottom image shows the porcine pancreas after 
24 hours of machine perfusion. The duodenal distension and the pancreatic oedema is 
clearly seen.280
Retrieval of NHB porcine pancreases
Juvenile  landrace  pigs  used  for  another  project  investigating a  laparoscopic  renal 
cooling device were used as the source of the non-heart-beating-donor pancreases.
Briefly the pigs underwent a laparoscopic renal procedure under general anaesthesia. 
On completion of the experiment, the animal was sacrificed by a barbiturate overdose. 
After a period of warm ischaemia (30 minutes), laparotomy was done. The infra-renal 
aorta was cannulated after ligating the distal aorta. The supra-coeliac aorta was ligated
below  the  diaphragm. 1litre of  cold  Marshall’s  solution  containing  10000 units of 
unfractionated heparin was perfused through the aortic cannula. The IVC was incised to 
vent the blood. The lesser sac was packed with ice slush. The pancreas along with the 
spleen and adjoining duodenum along with a segment of aorta containing the celiac and 
superior mesenteric arteries was removed and placed in a bowl of ice-cold Marshall’s 
solution.  Back-table  dissection  involved  splenectomy,  shortening  of t he  duodenal 
segment, and cannulation of the coeliac and superior mesenteric arteries. Leakages 
from  the  arterial  side  were identified by  gentle flushing  of the arterial  cannulas  and 
ligated. The pancreas was weighed. 
Techniques of pancreas preservation
Two layer method
150 ml of perfluorocarbon (PFC) solution was transferred to the preservation chamber 
and connected to a source of 100% oxygen. Oxygen was bubbled through the solution 
for at least 30 minutes prior to start of preservation. The pancreas was placed in the 
oxygenated PFC and 500ml of cold KPS was transferred to the preservation chamber
to completely submerge the pancreas. The pancreas was stored for 24 hours.
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The perfusion circuit was primed with 750ml of KPS. The pancreas was transferred to 
the preservation chamber. The two arterial cannulas were connected to the perfusion 
circuit  according  to  suppliers  recommendations.  Perfusion  was  started  at  a  mean 
perfusion pressure of 10mmHg and continued for 24 hours.
Data collection
The  perfusion  parameters  were  recorded at  2,  4  &  6  hours of  perfusion. Pancreas 
biopsies were collected before the start of preservation and after 6 and 24 hours of 
preservation. Biopsies were stored immediately in liquid nitrogen or fixed in formalin.
Caspase 3 assay
Pancreas biopsies were snap frozen in liquid nitrogen and stored at -80°C. Biopsies 
were homogenized in bead beating tubes using a Precellys 24 Tissue Homogeniser. 
The supernatant was transferred to labelled tubes and stored at -80°C until analysis. 
Substrate based colorimetric Caspase 3 assay was used. The assay was carried out 
according to manufacturer’s instructions. 5µl of the test sample in duplicate was used. 
The plate was read after overnight incubation. The protein content in the tissue extracts 
was assayed using the Bradford assay after diluting the extract 1:200 and comparing it 
with prepared protein standards. The Caspase 3 activity in terms of µmoles of pNA 
released per min per mg of tissue protein extract was calculated. 
Histology
Formalin  fixed  biopsies  were  used  to  make p araffin  blocks.  6µm sections  were  cut 
manually.  The  sections  were  stained  with  eosin  and  haematoxylin  by  standard 
technique. The stained sections were examined for a qualitative estimation of the extent 
of tissue oedema.282
Results
Eight pancreases were used for the study. Five underwent machine perfusion while 
three were stored by two layer method (Table 14).
The  median  warm  ischaemia  time  was  35  minutes.  One  pancreas  had  a  warm 
ischaemia  time  of 6 0  minutes  as  in-situ  cold  perfusion  could  not  be  done  and  the 
pancreas was retrieved and flushed on the back-table (PP8).
Median weight of the pancreas was 175gm. The median weight gain after 6 hours of 
machine perfusion was 17.6%. The weight gain was 40% for PP3 which could not be 
cooled below 14°C due to problems with the perfusion circuit. There was no weight gain 
in the pancreases stored by TLM.
Perfusion parameters
The  perfusion  pressure  was  10mmHg.  Good  initial  flow  rates  were  achieved  by a ll 
pancreases except PP8 which had a high initial resistance and low flow rate. During the 
preservation period a gradual increase in flow rate with a decrease in resistance was 
noted in all but one pancreas (PP6) (Figure 61).283
Table 14 Details of the eight non-heart-beating-donor porcine pancreases preserved by two layer method or hypothermic 
machine perfusion.
TLM: Two layer method, HMP: Hypothermic machine perfusion
Cod
e
Preservation 
type
Warm 
ischaemia
(minutes)
Initial 
weight 
(grams)
Weight gain 
at 6  hours
(%)
Initial 
resistance
Flow rate 
(ml/min)
Problems 
PP1 HMP 35 170 17.60% 0.95 12
PP3 HMP 25 180 44% 1.03 10 Perfusion  fluid  temperature  did  not 
decrease below 12°C
PP6 HMP 35 200 10% 0.45 24 Good initial flow rate but did not improve 
during the preservation period
PP7 HMP 35 220 18% 0.45 20
PP8 HMP 60 220 13.60% 1.99 5 In-situ aortic flush not possible. Flushed on 
the back-table. Low initial flow rate. Patchy 
perfusion of the pancreas. 
PP2 TLM 30 130 0
PP4 TLM 40 140 0
PP5 TLM   ( could 
not perfuse)
30 160 0284
Figure 61 Trend in perfusion flow rate in the five machine perfused porcine pancreases
Perfusion flow rates for the initial 6 hours of machine perfusion are shown in the graph. 
The general trend was of gradual increase in the flow rates over time. This was 
associated with a fall in the flow resistance (data not shown). PP8 was associated with a 
much longer warm ischaemia period and had the lowest initial flow rate with some 
improvement over the perfusion period. PP6 had a good initial flow rate which failed to 
increase.285
Caspase 3 assay
Caspase 3 levels were highest at the start of preservation and then decreased over the 
preservation period in the machine perfused pancreases. The only exception was PP8 
which registered the highest levels at 6 hours of preservation. This persisted after 24
hours of preservation. No particular trend in serial caspase 3 estimations was noted in 
the TLM group. There was no significant difference in caspase 3 levels between the two 
preservation groups at all time points (Figure 62)
Significant positive correlation was noted between the initial flow resistance and the 
caspase  3  levels  after  24 hours  in  the  machine  perfused  pancreases (Pearson’s 
product correlation=0.948, p=0.014). 
Figure 62 Comparison of tissue caspase 3 levels in pancreases preserved by two layer 
method or hypothermic machine perfusion at different time points.
No difference in caspase 3 levels between the two preservation groups was noted at all 
three time points.286
Histology
Sections showed increased oedema in the interlobular septa in the machine perfused 
pancreases.  The  oedema  appeared  to  spare  the  islets.  There  was  no  significant 
oedema 
in the two layer method preservation pancreas (Figure 63).
Figure 63 Comparison of the extent of interstitial oedema in pancreas biopsies after 6 
hours of preservation
Photomicrographs of 6µm sections stained with H&E staining and examined under a 
microscope at 40X magnification. Interstitial edema is prominently seen in the 
hypothermic machine perfusion group pancreas.
Discussion
This was a feasibility study to evaluate the use of the modified LifePort™ machine for 
large  animal  pancreas  perfusion.  We h ave  been  able  to  delineate  the  perfusion 
dynamics during low pressure hypothermic machine perfusion.
Hypothermic machine perfusion Two layer method287
The  pancreases  were  retrieved  after  the  death  of  the  animal  to  simulate  the  warm 
ischaemia in a non-heart-beating-donor donor. The retrieval procedure was similar to 
the pancreas retrieval in a clinical setting. In one case, retrieval was complicated by the 
inability to properly carry out the aortic flush. This lead to prolonged warm ischaemia 
time. This pancreas flushed on the back-table with difficulty and had high resistance 
and low flow rates at start of perfusion. This improved only partially after six hours of 
perfusion. Tissue from this pancreas showed elevated caspase 3 levels.
There was increased weight gain in the machine perfusion group as compared to the 
TLM group. Initial weight in the perfusion group was higher as compared to TLM group 
(198 vs. 143 g). The flushing with preservation solution during back-table preparation in 
machine perfused pancreases to identify and repair leaks could be responsible for this.
The caspase 3 levels were not different in the TLM and HMP groups. The size of the 
study was however not designed to show a significant difference in the two groups. 
Caspase 3 is an effector enzyme of apoptosis and its levels increase significantly only 
in  the  reperfusion phase[284].  The  fall in  caspase  3  levels  during the  preservation 
period  could  be  due  to  the  gradual  breakdown  of  caspase  3  formed during warm 
ischaemia.
The significant correlation between the initial flow resistance and the caspase 3 levels 
at 24 hours of machine perfusion was interesting. It is possible that both are markers of 
significant  warm i schaemia  injury i n  the  pancreas.  Use  of p erfusion  parameters  as 
viability tests have been reported previously in pancreas preservation[175]. They are 
routinely used to assess non-heart-beating-donor kidneys. Further studies to evaluate 
perfusion parameters as markers of viability during pancreas preservation are needed. 
Pancreatic  oedema  was  seen  exclusively  in  machine  perfused organs.  Histology
suggested that the oedema was mainly located in the interlobar and interlobular septae. 288
Pancreatic oedema increases the risk of capsular tears and bleeding in the setting of 
whole organ pancreas transplantation. However it could be beneficial in islet isolation 
as it may improve the disruption of the pancreatic parenchyma and improve separation 
of islets from the exocrine tissue. Similar conclusions were reached by a recent study of 
pancreas perfusion using the same perfusion apparatus[170].289
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